Reynolds American Inc.
Table of Contents

 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 10-Q
(Mark One)
     
þ   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
    For the quarterly period ended September 30, 2008
OR
     
o   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from                      to                     
 
Commission file number: 1-32258
Reynolds American Inc.
(Exact name of registrant as specified in its charter)
     
North Carolina   20-0546644
(State or other jurisdiction of   (I.R.S. Employer Identification Number)
incorporation or organization)    
401 North Main Street
Winston-Salem, NC 27101

(Address of principal executive offices) (Zip Code)
(336) 741-2000
(Registrant’s telephone number, including area code)
(Former name, former address and former fiscal year, if changed from last report)
 
     Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YES þ NO o
     Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer”, “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one)
             
Large accelerated filer þ   Accelerated filer o   Non-accelerated filer o   Smaller reporting company o
        (Do not check if a smaller reporting company)    
     Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). YES o NO þ
     Indicate the number of shares outstanding of each of the issuer’s classes of common stock as of the latest practicable date: 291,452,662 shares of common stock, par value $.0001 per share, as of October 10, 2008
 
 

 


 

INDEX
         
    Page
       
 
       
    3  
    4  
    5  
    6  
 
    63  
 
    81  
 
    81  
 
       
 
    82  
 
    82  
 
    83  
 
    84  
 Exhibit 31.1
 Exhibit 31.2
 Exhibit 32.1

2


Table of Contents

PART I – Financial Information
Item 1. Financial Statements
REYNOLDS AMERICAN INC.
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(Dollars in Millions, Except Per Share Amounts)
(Unaudited)
                                 
    For the Three Months     For the Nine Months  
    Ended September 30,     Ended September 30,  
    2008     2007     2008     2007  
Net sales1
  $ 2,156     $ 2,174     $ 6,330     $ 6,419  
Net sales, related party
    116       123       338       374  
 
                       
Net sales
    2,272       2,297       6,668       6,793  
Costs and expenses:
                               
Cost of products sold1, 2, 3
    1,229       1,250       3,698       3,768  
Selling, general and administrative expenses
    375       440       1,148       1,237  
Amortization expense
    5       5       16       17  
Restructuring charge
    91             91        
Trademark impairment charge
    173             173        
 
                       
Operating income
    399       602       1,542       1,771  
Interest and debt expense
    68       81       208       257  
Interest income
    (16 )     (33 )     (51 )     (94 )
Gain on termination of joint venture
                (328 )      
Other (income) expense, net
    13       (7 )     3       8  
 
                       
Income from continuing operations before income taxes and extraordinary item
    334       561       1,710       1,600  
Provision for income taxes
    123       203       630       590  
 
                       
Income from continuing operations before extraordinary item
    211       358       1,080       1,010  
Extraordinary item – gain on acquisition
                      1  
 
                       
Net income
  $ 211     $ 358     $ 1,080     $ 1,011  
 
                       
 
                               
Basic income per share:
                               
Income from continuing operations before extraordinary item
  $ 0.72     $ 1.22     $ 3.68     $ 3.43  
Extraordinary item
                       
 
                       
Net income
  $ 0.72     $ 1.22     $ 3.68     $ 3.43  
 
                       
 
                               
Diluted income per share:
                               
Income from continuing operations before extraordinary item
  $ 0.72     $ 1.21     $ 3.68     $ 3.43  
Extraordinary item
                       
 
                       
Net income
  $ 0.72     $ 1.21     $ 3.68     $ 3.43  
 
                       
 
                               
Dividends declared per share
  $ 0.85     $ 0.85     $ 2.55     $ 2.35  
 
                       
 
1   Excludes excise taxes of $492 million and $521 million for the three months ended September 30, 2008 and 2007, respectively, and $1,429 million and $1,544 million for the nine months ended September 30, 2008 and 2007, respectively.
 
2   Includes Master Settlement Agreement and other state settlement agreements, collectively referred to as the MSA, expense of $695 million and $720 million for the three months ended September 30, 2008 and 2007, respectively, and $2,079 million and $2,145 million for the nine months ended September 30, 2008 and 2007, respectively.
 
3   Includes federal tobacco quota buyout expenses of $59 million and $61 million for the three months ended September 30, 2008 and 2007, respectively, and $186 million and $203 million for the nine months ended September 30, 2008 and 2007, respectively.
See Notes to Condensed Consolidated Financial Statements (Unaudited)

3


Table of Contents

REYNOLDS AMERICAN INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Dollars in Millions)
(Unaudited)
                 
    For the Nine Months Ended  
    September 30,  
    2008     2007  
Cash flows from (used in) operating activities:
               
Net income
  $ 1,080     $ 1,011  
Adjustments to reconcile to net cash flows from (used in) continuing operating activities:
               
Depreciation and amortization
    106       106  
Gain on termination of joint venture
    (328 )      
Restructuring charge, net of cash payments
    81       (11 )
Trademark impairment charge
    173        
Deferred income tax expense
    38       44  
Loss on extinguishment of debt
          19  
Extraordinary item–gain on acquisition
          (1 )
Other changes, that provided (used) cash:
               
Accounts and other receivables
    (48 )     (18 )
Inventories
    124       102  
Related party, net
    (14 )     (53 )
Accounts payable
    (49 )     (56 )
Accrued liabilities including income taxes and other working capital
    (28 )     363  
Tobacco settlement accruals
    (283 )     27  
Pension and postretirement
    (56 )     (323 )
Litigation bonds, net
    5       92  
Other, net
    27       (14 )
 
           
Net cash flows from operating activities
    828       1,288  
 
           
 
               
Cash flows from (used in) investing activities:
               
Purchases of short-term investments
    (56 )     (3,663 )
Proceeds from sale of short-term investments
    208       4,154  
Proceeds from settlement of long-term investments
    6        
Capital expenditures
    (95 )     (95 )
Distributions from equity investees
    27       9  
Proceeds from termination of joint venture
    164        
Other, net
    10       (4 )
 
           
Net cash flows from investing activities
    264       401  
 
           
 
               
Cash flows from (used in) financing activities:
               
Dividends paid on common stock
    (752 )     (665 )
Repayment of long-term debt
          (329 )
Proceeds from issuance of long-term debt
          1,547  
Repayment of term loan
          (1,542 )
Deferred debt issuance cost
          (15 )
Excess tax benefit from stock-based compensation
    2       1  
Proceeds from stock options exercised
    1        
Repurchase of common stock
    (207 )     (60 )
Other, net
    1        
 
           
Net cash flows used in financing activities
    (955 )     (1,063 )
 
           
 
               
Effect of exchange rate changes on cash and cash equivalents
    (23 )      
 
           
Net change in cash and cash equivalents
    114       626  
Cash and cash equivalents at beginning of period
    2,215       1,433  
 
           
Cash and cash equivalents at end of period
  $ 2,329     $ 2,059  
 
           
 
               
Income taxes paid, net of refunds
  $ 624     $ 106  
Interest paid
  $ 161     $ 205  
See Notes to Condensed Consolidated Financial Statements (Unaudited)

4


Table of Contents

REYNOLDS AMERICAN INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(Dollars in Millions)
(Unaudited)
                 
    September 30,     December 31,  
    2008     2007  
Assets
               
Current assets:
               
Cash and cash equivalents
  $ 2,329     $ 2,215  
Short-term investments
    52       377  
Accounts receivable, net of allowance (2008 – $1; 2007 – $1)
    79       73  
Accounts receivable, related party
    67       80  
Notes receivable
    33       1  
Other receivables
    63       25  
Inventories
    1,072       1,196  
Deferred income taxes, net
    852       845  
Prepaid expenses and other
    143       180  
 
           
Total current assets
    4,690       4,992  
Property, plant and equipment, net of accumulated depreciation (2008 – $1,558; 2007 – $1,517)
    1,053       1,073  
Trademarks, net of accumulated amortization (2008 – $529; 2007 – $524)
    3,229       3,407  
Goodwill
    8,174       8,174  
Other intangibles, net of accumulated amortization (2008 – $84; 2007 – $73)
    191       202  
Other assets and deferred charges
    1,081       781  
 
           
 
  $ 18,418     $ 18,629  
 
           
 
               
Liabilities and shareholders’ equity
               
Current liabilities:
               
Accounts payable
  $ 169     $ 218  
Tobacco settlement accruals
    2,159       2,449  
Due to related party
    2       7  
Deferred revenue, related party
    13       35  
Current maturities of long-term debt
    200        
Other current liabilities
    1,158       1,194  
 
           
Total current liabilities
    3,701       3,903  
Long-term debt (less current maturities)
    4,304       4,515  
Deferred income taxes, net
    1,220       1,184  
Long-term retirement benefits (less current portion)
    1,166       1,167  
Other noncurrent liabilities
    439       394  
Commitments and contingencies:
               
Shareholders’ equity:
               
Common stock (shares issued: 2008 – 291,452,779; 2007 – 295,007,327)
           
Paid-in capital
    8,459       8,653  
Accumulated deficit
    (541 )     (873 )
Accumulated other comprehensive loss (defined benefit pension and post- retirement plans: 2008 – $(293)
and 2007 – $(306), net of tax)
    (330 )     (314 )
 
           
Total shareholders’ equity
    7,588       7,466  
 
           
 
  $ 18,418     $ 18,629  
 
           
See Notes to Condensed Consolidated Financial Statements (Unaudited)

5


Table of Contents

Notes to Condensed Consolidated Financial Statements (Unaudited)
Note 1 — Business and Summary of Significant Accounting Policies
Overview
     The condensed consolidated financial statements (unaudited) include the accounts of Reynolds American Inc., referred to as RAI, and its wholly owned subsidiaries. RAI’s wholly owned subsidiaries include its operating subsidiaries, R. J. Reynolds Tobacco Company; Santa Fe Natural Tobacco Company, Inc., referred to as Santa Fe; Lane, Limited, referred to as Lane; R. J. Reynolds Global Products, Inc., referred to as GPI; and Conwood Company, LLC, Conwood Sales Co., LLC, Scott Tobacco LLC and Rosswil LLC, collectively referred to as the Conwood companies.
     RAI was incorporated as a holding company in the state of North Carolina on January 5, 2004, and its common stock is listed on the NYSE under the symbol “RAI.” RAI was created to facilitate the transactions on July 30, 2004, to combine the U.S. assets, liabilities and operations of Brown & Williamson Holdings, Inc., formerly known as Brown & Williamson Tobacco Corporation and referred to as B&W, an indirect, wholly owned subsidiary of British American Tobacco p.l.c., referred to as BAT, with R. J. Reynolds Tobacco Company, a wholly owned operating subsidiary of R.J. Reynolds Tobacco Holdings, Inc., referred to as RJR. These July 30, 2004, transactions generally are referred to as the B&W business combination.
     References to RJR Tobacco prior to July 30, 2004, relate to R. J. Reynolds Tobacco Company, a New Jersey corporation and a wholly owned subsidiary of RJR. References to RJR Tobacco on and subsequent to July 30, 2004, relate to the combined U.S. assets, liabilities and operations of B&W and R. J. Reynolds Tobacco Company, a North Carolina corporation.
     RAI’s reportable operating segments are RJR Tobacco and Conwood. RJR Tobacco consists of the primary operations of R. J. Reynolds Tobacco Company. Conwood consists of the Conwood companies and Lane. RAI’s wholly owned operating subsidiaries Santa Fe and GPI, among others, are included in All Other. The segments were identified based on how RAI’s chief operating decision maker allocates resources and assesses performance.
Basis of Presentation
     The accompanying interim condensed consolidated financial statements (unaudited) have been prepared in accordance with accounting principles generally accepted in the United States of America, referred to as GAAP, for interim financial information and, in management’s opinion, contain all adjustments, consisting only of normal recurring items, necessary for a fair presentation of the results for the periods presented. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. For interim reporting purposes, certain costs and expenses are charged to operations in proportion to the estimated total annual amount expected to be incurred primarily based on sales volumes. The results for the interim period ended September 30, 2008, are not necessarily indicative of the results that may be expected for the year ending December 31, 2008.
     The equity method is used to account for investments in businesses that RAI does not control, but has the ability to significantly influence operating and financial policies. The cost method is used to account for investments in which RAI does not have the ability to significantly influence operating and financial policies. RAI has no investments in entities greater than 20% for which it accounts by the cost method, and has no investments in entities greater than 50% for which it accounts by the equity method. All material intercompany balances have been eliminated.
     The condensed consolidated financial statements (unaudited) should be read in conjunction with the consolidated financial statements and related footnotes, which appear in RAI’s Annual Report on Form 10-K for the year ended December 31, 2007. Certain reclassifications were made to conform prior years’ financial statements to the current presentation. All dollar amounts, other than per share amounts, are presented in millions, except for amounts set forth in note 12 and as otherwise noted.
Pension and Postretirement
     Recognized gains or losses are annual changes in the amount of either the benefit obligation or the market-related value of plan assets resulting from experience different from that assumed or from changes in assumptions. The minimum amortization of unrecognized gains or losses, as described in Statement of Financial Accounting Standards,

6


Table of Contents

Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
referred to as SFAS,  No. 87, “Employers’ Accounting for Pensions,” was included in pension expense, and as described in SFAS No. 106, “Employers’ Accounting for Postretirement Benefits other than Pensions,” was included in the postretirement benefit cost. Prior service costs, which are changes in benefit obligations due to plan amendments, are amortized on a straight-line basis over the average remaining service period for active employees. The market-related value of plan assets recognizes changes in fair value in a systematic and rational manner over five years.
     The components of the pension benefits and the postretirement benefits are set forth below:
                                                                 
    For The Three Months Ended     For The Nine Months Ended  
    September 30,     September 30,  
                    Postretirement                     Postretirement  
    Pension Benefits     Benefits     Pension Benefits     Benefits  
    2008     2007     2008     2007     2008     2007     2008     2007  
Service cost
  $ 9     $ 10     $ 1     $ 1     $ 27     $ 30     $ 4     $ 4  
Interest cost
    80       78       23       22       239       235       68       68  
Expected return on plan assets
    (113 )     (109 )     (7 )     (6 )     (338 )     (327 )     (20 )     (20 )
Amortization of prior service cost (credit)
    5             4       (3 )     14       1       12       (9 )
Amortization of net loss (income)
    1       11       (3 )     6       4       32       (9 )     17  
 
                                               
Net periodic benefit (income) cost
    (18 )     (10 )     18       20       (54 )     (29 )     55       60  
Curtailments/special benefits1
    7                         7                    
Settlements
    4                         4                    
 
                                               
Total benefit (income) cost
  $ (7 )   $ (10 )   $ 18     $ 20     $ (43 )   $ (29 )   $ 55     $ 60  
 
                                               
 
1   See note 3 to condensed consolidated financial statements (unaudited) for more information on the special pension benefits related to a restructuring at RAI and RJR Tobacco.
Employer Contributions
     RAI disclosed in its financial statements for the year ended December 31, 2007, that it expected to contribute $7 million to its pension plans in 2008. As of September 30, 2008, RAI expects to contribute $17 million to its pension plans in 2008, of which $10 million was contributed during the first nine months of 2008.
     Due to the adverse changes in the financial markets, RAI’s pension assets have been negatively impacted. Through September 30, 2008, the overall year-to-date rate of return on the investments for the pension assets was approximately negative 16.3%.
Recently Adopted Accounting Pronouncements
     Effective January 1, 2008, RAI adopted SFAS No. 157, “Fair Value Measurements,” for financial assets and financial liabilities. SFAS No. 157 does not require any new fair value measurements but provides a definition of fair value, establishes a framework for measuring fair value and expands disclosure about fair value measurements. RAI will adopt SFAS No. 157 for nonfinancial assets and nonfinancial liabilities on January 1, 2009. The adoption of SFAS No. 157 on financial assets and financial liabilities did not have a material impact on RAI’s consolidated results of operations, financial position or cash flows. RAI is currently assessing the impact of SFAS No. 157 for nonfinancial assets and nonfinancial liabilities on its consolidated results of operations, financial position and cash flows.
     On October 10, 2008, the Financial Accounting Standards Board, referred to as FASB, issued FASB Staff Position, referred to as FSP, No. FAS 157-3, “Determining the Fair Value of a Financial Asset When the Market for That Asset Is Not Active.” FSP FAS 157-3 clarifies the application of SFAS No. 157, “Fair Value Measurements,” in a market that is not active and provides an example to illustrate key considerations in determining the fair value of a financial asset when the market for that financial asset is not active. FSP FAS 157-3 is effective immediately, including prior periods for which financial statements have not been issued. RAI has adopted FSP FAS 157-3 effective with the financial statements ended September 30, 2008. The adoption of FSP FAS 157-3 had no impact on RAI’s consolidated results of operations, financial position or cash flows.

7


Table of Contents

Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
Recently Issued Accounting Pronouncements
     In March 2008, the FASB issued SFAS No. 161, “Disclosures about Derivative Instruments and Hedging Activities-an amendment of FASB Statement No. 133.” SFAS No. 161 seeks qualitative disclosures about the objectives and strategies for using derivatives, quantitative data about the fair value of and gains and losses on derivative contracts, and details of credit-risk-related contingent features in hedged positions. SFAS No. 161 also seeks enhanced disclosure around derivative instruments in financial statements, accounted for under SFAS No. 133, “Accounting for Derivative Instruments and Hedging Activities,” and how hedges affect an entity’s financial position, financial performance and cash flows. SFAS No. 161 is effective for RAI as of January 1, 2009. RAI does not expect the adoption of SFAS No. 161 to have a material impact on its results of operations, financial position or cash flows.
     In April 2008, the FASB issued FSP No. FAS 142-3, “Determination of the Useful Life of Intangible Assets.” FSP FAS 142-3 amends the factors that should be considered in developing renewal or extension assumptions used to determine the useful life of a recognized intangible asset under SFAS No. 142, “Goodwill and Other Intangible Assets.” The objective of FSP FAS 142-3 is to improve the consistency between the useful life of a recognized intangible asset under SFAS No. 142 and the period of expected cash flows used to measure the fair value of the asset under SFAS No. 141(R) and GAAP. FSP FAS 142-3 is effective for financial statements issued for years beginning after December 15, 2008, and interim periods within those years and is applied prospectively to intangible assets acquired after the effective date. RAI does not expect the adoption of FSP FAS 142-3 to have a material impact on its financial position, results of operations or cash flows.
Note 2Intangible Assets
     The changes in the carrying amount of trademarks by segment during the nine months ended September 30, 2008, were as follows:
                                                 
    RJR Tobacco     Conwood     All Other        
    Indefinite     Finite     Indefinite     Finite     Indefinite        
    Life     Life     Life     Life     Life     Consolidated  
Balance as of January 1, 2008
  $ 1,826     $ 41     $ 1,374     $ 11     $ 155     $ 3,407  
Impairment included in operating income
    (173 )                             (173 )
Amortization expense
          (5 )                       (5 )
 
                                   
Balance as of September 30, 2008
  $ 1,653     $ 36     $ 1,374     $ 11     $ 155     $ 3,229  
 
                                   
     During the third quarter of 2008, RJR Tobacco made the decision to change its brand portfolio strategy and reclassified the KOOL brand from a growth brand to a support brand. RJR Tobacco recorded an impairment charge of $173 million during the third quarter of 2008 as a result of impairment testing conducted on the KOOL trademark triggered by this change in brand portfolio strategy. This charge was based on the excess of KOOL’s carrying value over its fair value using the present value of estimated future cash flows assuming a discount rate of 10.5%. The discount rate was determined by adjusting the enterprise discount rate by an appropriate risk premium to reflect an asset group risk. The impairment charge is reflected as a decrease in the carrying value of the KOOL trademark in the condensed consolidated balance sheet (unaudited) as of September 30, 2008, as a trademark impairment charge in the condensed consolidated statement of income (unaudited) for the three and nine months ended September 30, 2008, and had no impact on cash flows.
     The changes in the carrying amount of other intangibles by segment during the nine months ended September 30, 2008, were as follows:
                                 
    RJR Tobacco     All Other        
    Indefinite             Indefinite        
    Life     Finite Life     Life     Consolidated  
Balance as of January 1, 2008
  $ 55     $ 100     $ 47     $ 202  
Amortization expense
          (11 )           (11 )
 
                       
Balance as of September 30, 2008
  $ 55     $ 89     $ 47     $ 191  
 
                       

8


Table of Contents

Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
     Indefinite-lived intangibles include acquired trademarks and distribution rights and agreements. Finite-lived intangible assets as of September 30, 2008, were as follows:
                         
            Accumulated        
    Gross     Amortization     Net  
Contract manufacturing
  $ 151     $ 62     $ 89  
Technology-based
    3       3        
 
                 
Total other intangibles
    154       65       89  
Trademarks
    95       48       47  
 
                 
 
  $ 249     $ 113     $ 136  
 
                 
     As of September 30, 2008, the estimated remaining amortization associated with finite-lived intangible assets was expected to be expensed as follows:
           
Year     Amount  
Remainder of 2008
    $ 6  
2009
      22  
2010
      20  
2011
      20  
2012
      19  
2013
      18  
Thereafter
      31  
 
       
 
    $ 136  
 
       
Note 3—Restructuring
     In the third quarter of 2008, RAI and RJR Tobacco announced changes in their organizational structures to streamline non-core business processes and programs in order to allocate additional resources to strategic growth initiatives. The reorganizations will result in the elimination of approximately 600 full-time jobs, expected to be substantially completed by December 31, 2009.
     Under existing benefit plans, $84 million of severance-related cash benefits and $7 million of non-cash pension-related benefits comprised a restructuring charge of $91 million. Of this charge, $81 million was recorded in the RJR Tobacco segment. None of the cash portion of the charge was paid as of September 30, 2008. Accordingly, in the condensed consolidated balance sheet (unaudited) as of September 30, 2008, $36 million was included in other current liabilities and $48 million was included in other noncurrent liabilities. The cash benefits are expected to be substantially paid by December 31, 2010.
     The component of the restructuring charge accrued and utilized was as follows:
         
    Employee Severance  
    and Benefits  
Original accrual
  $ 91  
Utilized in 2008
    (7 )
 
     
Balance as of September 30, 2008
  $ 84  
 
     
Note 4Termination of Joint Venture
     In 2002, R.J. Reynolds Tobacco C.V., an indirect wholly owned subsidiary of RAI and referred to as RJRTCV, and an affiliate of Gallaher Group Plc, referred to as Gallaher, formed a joint venture, with each party owning a 50% membership interest. The joint venture, R. J. Reynolds-Gallaher International Sarl, marketed American-blend cigarettes primarily in Italy, France and Spain.
     On April 18, 2007, an affiliate of Japan Tobacco Inc. acquired Gallaher, and Gallaher subsequently notified RJRTCV that the acquisition constituted a change of control of Gallaher within the meaning of the joint venture

9


Table of Contents

Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
agreement. Pursuant to the terms of the joint venture agreement, RJRTCV elected to terminate the joint venture prior to its expiration date. The joint venture was terminated on December 31, 2007.
     The joint venture agreement provided that upon a termination of the joint venture, the value of all the trademarks each joint venture member or its affiliate licensed to the joint venture, other than NATURAL AMERICAN SPIRIT, would be calculated and that the party whose licensed trademarks were determined to be of greater value would be required to pay the other party an amount, referred to as the Termination Amount, equal to one-half of the difference between the values of the parties’ respective trademarks. On February 20, 2008, following the parties’ negotiations regarding the trademarks’ values, RJRTCV and Gallaher Limited, an affiliate of Gallaher, entered into a valuation payment settlement agreement, pursuant to which Gallaher Limited agreed to pay RJRTCV a Termination Amount equal to euros 265 million, or approximately $388 million using a February 20, 2008, exchange rate of 1.4625. Of this amount, euros 106 million, or 40%, was paid in April 2008, and the remaining 60% is to be paid in six equal annual installments commencing April 2009. Of this receivable, $32 million, including imputed interest, and $161 million are included in notes receivable and other assets and deferred charges, respectively, in RAI’s condensed consolidated balance sheet (unaudited) as of September 30, 2008. Related to the gain on termination of the joint venture of $328 million, approximately $118 million of deferred tax was recorded and included in deferred income taxes, net in the noncurrent liability section of the condensed consolidated balance sheet (unaudited) as of September 30, 2008.
     In the first quarter of 2008, an indirect subsidiary of RJR Tobacco sold the AUSTIN trademark, a brand formerly sold through the joint venture, resulting in a gain of $6 million. GPI continues to sell NATURAL AMERICAN SPIRIT to the primary markets of the former joint venture in addition to other international markets.
Note 5—Income Per Share
     The components of the calculation of income per share were as follows:
                                 
    For the Three Months     For the Nine Months  
    Ended September 30,     Ended September 30,  
    2008     2007     2008     2007  
Income from continuing operations before extraordinary item
  $ 211     $ 358     $ 1,080     $ 1,010  
Extraordinary item — gain on acquisition
                      1  
 
                       
Net income
  $ 211     $ 358     $ 1,080     $ 1,011  
 
                       
 
Basic weighted average shares, in thousands1
    291,425       294,169       293,083       294,454  
Effect of dilutive potential shares:
                               
Options
    190       243       209       249  
Restricted stock
    428       294       427       226  
 
                       
Diluted weighted average shares, in thousands
    292,043       294,706       293,719       294,929  
 
                       
 
1   Outstanding contingently issuable restricted stock of 0.9 million shares and 0.8 million shares for the three-month periods, and 1.0 million shares and 0.8 million shares for the nine-month periods, ended September 30, 2008 and 2007, respectively, were excluded from the basic share calculation, as the related vesting provisions had not been met.
Note 6—Fair Value Measurement
     On January 1, 2008, RAI adopted SFAS No. 157, “Fair Value Measurements,” as clarified by FSP FAS 157-3 “Determining the Fair Value of a Financial Asset When the Market for That Asset Is Not Active,” for financial assets and financial liabilities. SFAS No. 157 provides a definition of fair value, establishes a framework for measuring fair value and expands disclosure about fair value measurements. SFAS No. 157 establishes a fair value hierarchy that distinguishes between market participant assumptions developed based on market data obtained from sources independent of the reporting entity, and the reporting entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances.
     SFAS No. 157 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, essentially an exit price.

10


Table of Contents

Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
     The levels of the fair value hierarchy established by SFAS No. 157 are:
Level 1: inputs are quoted prices, unadjusted, in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.
Level 2: inputs are other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. A Level 2 input must be observable for substantially the full term of the asset or liability.
Level 3: inputs are unobservable and reflect the reporting entity’s own assumptions about the assumptions that market participants would use in pricing the asset or liability.
     Financial assets carried at fair value as of September 30, 2008, were as follows:
                                 
    Level 1     Level 2     Level 3     Total  
Money market funds
  $ 2,023     $     $ 52     $ 2,075  
Auction rate notes
                108       108  
Mortgage-backed securities
                27       27  
Assets held in grantor trusts
    16                   16  
Interest rate swaps
          106             106  
 
                       
Total assets at fair value
  $ 2,039     $ 106     $ 187     $ 2,332  
 
                       
     The fair value for the interest rate swaps, classified as a Level 2, was derived using the notional amount of the interest rate swap multiplied by the observable inputs of time to maturity, interest rates and credit spreads.
     The fair value for the money market funds, classified as a Level 3, were based upon expected future cash flows from accumulated cash in the fund and future maturities of the remaining held securities. During September 2008, the managers of the Reserve Fund-Primary Fund and Reserve Fund-International Liquidity Fund, both AAA-rated money market funds, quit accepting purchases into the funds and did not honor redemption requests that would cause the fund to liquidate outstanding holdings into a volatile market at a loss. At September 30, 2008, there still had not been any purchases into or redemptions out of these money market funds. In addition, no valuations had been issued by either fund. RAI was unable to identify a similar fund that carried identical holdings. As a result, the observable transactions or pricing were not current. The funds did issue a detailed listing of the securities that were held and not matured, as well as their face value and maturity date. This observable data, along with unobservable factors such as discount rate, and assumptions about fund liquidation of accumulated cash and the collectability of the outstanding underlying securities were used to determine the fair value of the funds as of September 30, 2008.
     The fair values for the auction securities, whose risk is tied to longer term debt or capital issued by a diverse range of corporations, including but not limited to, manufacturing, financial and insurance sectors, classified as a Level 3, were based upon calculating the weighted average present value of future cash payments, given the probability of certain events occurring within the market. Although RAI considers the market for auction rate notes to be inactive, the models utilized observable inputs, including LIBOR-based interest rate curves, corporate credit spreads and corporate ratings/market valuations. Additionally, unobservable factors incorporated into the models included default probability assumptions, recovery potential and how these factors changed as collateral ratings migrated from one level to another.
     The fair values for the mortgage-backed securities, classified as a Level 3, were based upon the calculation of an overall weighted average valuation, derived from the actual, or modeled, market pricing of the specific collateral, depending on availability. These mortgage-backed securities have not had any market activity throughout 2008, and therefore, RAI has deemed the market for these securities to be inactive. However, the underlying collateral continues to perform favorably, and the security continues to pay interest on time and within terms.

11


Table of Contents

Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
     The changes in the Level 3 investments as of September 30, 2008, were as follows:
                                                                         
    Money Market Funds     Auction Rate Notes     Mortgage-Backed Securities  
            Gross                     Gross                     Gross        
            Realized     Estimated             Unrealized     Estimated             Unrealized     Estimated  
    Cost     Loss     Fair Value     Cost     Loss     Fair Value     Cost     Loss     Fair Value  
Balance as of January 1, 2008
  $     $     $     $ 145     $ (18 )   $ 127     $ 45     $ (1 )   $ 44  
Transfers into Level 3
    54             54                                      
Unrealized losses
                            (19 )     (19 )           (11 )     (11 )
Realized losses
          (2 )     (2 )                                    
Settlements
                                        (6 )           (6 )
 
                                                     
Balance as of September 30, 2008
  $ 54     $ (2 )   $ 52     $ 145     $ (37 )   $ 108     $ 39     $ (12 )   $ 27  
 
                                                     
Note 7—Investments
     Short-term investments classified as available-for-sale were as follows:
                                                 
    September 30, 2008     December 31, 2007  
            Gross                     Gross        
            Realized     Estimated             Unrealized     Estimated  
    Cost     Loss     Fair Value     Cost     Loss     Fair Value  
Reserve Fund — Primary Fund
  $ 37     $ (1 )   $ 36     $     $     $  
Reserve Fund — International Liquidity Fund
    17       (1 )     16                    
Federal agency securities and treasury bills and notes
                      206             206  
Auction rate notes
                      145       (18 )     127  
Mortgage-backed securities
                      45       (1 )     44  
 
                                   
 
  $ 54     $ (2 )   $ 52     $ 396     $ (19 )   $ 377  
 
                                   
     During the third quarter of 2008, the Reserve Funds, which are money market funds, were reclassified to short-term investments from cash equivalents due to the liquidity restrictions issued by the fund managers preventing immediate withdrawals. The Primary Fund is made up of investments in securities that primarily include bank notes, certificates of deposit, commercial paper and floating-rate discount notes. The International Liquidity Fund consists of investments in securities that include bank notes, certificates of deposit, commercial paper and floating-rate discount notes. Included in both the Primary Fund and the International Liquidity Fund were investments in Lehman Brothers Holdings Inc., referred to as Lehman. On September 15, 2008, Lehman filed for protection under Chapter 11 of the federal Bankruptcy Code. The value of RAI’s pro rata share of indirect holdings in the Lehman investments has been impaired and recognized as a loss in other (income) expense, net in the condensed consolidated statement of income (unaudited) for the three- and nine-month periods ended September 30, 2008.
     No additional impairment was recorded on the Reserve Funds beyond the Lehman impairment as the Reserve Funds will distribute cash as assets mature or are sold. In addition, RAI has the intent and the ability to hold the investments in the Reserve Funds until maturity and, at this time, the Reserve Funds expect maturity at stated face value.
     The investments in federal agency securities and treasury bills and notes were liquidated during the second quarter of 2008 to meet working capital needs.
     Auction rate notes are instruments with long-term contractual maturities, but have historically been highly liquid. Historically, they have repriced at intervals ranging from 7 to 49 days, and therefore, the fair values have approximated carrying values. However, during 2007, adverse changes in the financial markets caused certain auction rate notes to revalue lower than their carrying value and become less liquid. The auction rate notes were reclassified to a long-term investment during the second quarter of 2008 as RAI believes a successful auction is not likely to occur within the next year. The auction rate notes were included in other assets and deferred charges in RAI’s condensed consolidated balance sheet (unaudited) as of September 30, 2008. The funds associated with the auction rate notes will not be accessible until a successful auction occurs or a buyer is found.
     The mortgage-backed securities were reclassified to a long-term investment as of March 31, 2008, as a result of a restructuring with the original issuer. These securities were included in other assets and deferred charges in RAI’s condensed consolidated balance sheet (unaudited) as of September 30, 2008. This restructured investment extends the

12


Table of Contents

Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
life of the security, but is supported by the same underlying collateral that carries the same economic risks. As of September 30, 2008, RAI received $6 million in principal payments on these mortgage-backed securities.
     RAI intends, and has the ability, to hold the auction rate notes and mortgage-backed securities for a period of time sufficient to allow for the anticipated recovery in fair value. These investments will be evaluated on a quarterly basis.
     Long-term investments classified as available-for-sale were as follows:
                         
    September 30, 2008  
            Gross        
            Unrealized     Estimated  
    Cost     Loss     Fair Value  
Auction rate notes
  $ 145     $ (37 )   $ 108  
Mortgage-backed securities
    39       (12 )     27  
 
                 
 
  $ 184     $ (49 )   $ 135  
 
                 
     There were no long-term investments classified as available-for-sale at December 31, 2007.
     RAI reviews impairments associated with the above in accordance with SFAS No. 115, “Accounting for Certain Investments in Debt and Equity Securities,” and FSP FAS 115-1 and FAS 124-1, “The Meaning of Other-Than-Temporary Impairment and Its Application to Certain Investments,” to determine the classification of the impairment as temporary or other-than-temporary. RAI considers the auction rate notes and mortgage-backed securities to be temporarily impaired as of September 30, 2008, with the unrealized loss included in accumulated other comprehensive loss in the condensed consolidated balance sheet (unaudited) as of September 30, 2008. Such unrealized loss did not reduce net income for the three- or nine-month periods ended September 30, 2008.
Note 8—Inventories
     The major components of inventories were as follows:
                 
    September 30,     December 31,  
    2008     2007  
Leaf tobacco
  $ 841     $ 967  
Other raw materials
    51       45  
Work in process
    55       48  
Finished products
    172       163  
Other
    33       24  
 
           
Total
    1,152       1,247  
Less LIFO allowance
    80       51  
 
           
 
  $ 1,072     $ 1,196  
 
           
     RJR Tobacco will perform its annual LIFO inventory valuation at December 31, 2008, as interim periods represent an estimate of the expected annual valuation.
Note 9—Income Taxes
     The provision for income taxes in the third quarter of 2008 was $123 million, or an effective rate of 36.8%, compared with $203 million, or an effective rate of 36.2%, in the third quarter of 2007. The provision for income taxes for the first nine months of 2008 was $630 million, or an effective rate of 36.8%, compared with $590 million, or an effective rate of 36.9%, in the first nine months of 2007. The effective rate for the first nine months of 2008 was favorably impacted by a lower tax rate related to the gain on the termination of the Reynolds-Gallaher International Sarl joint venture.

13


Table of Contents

Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
     The effective rate exceeds the federal statutory rate of 35% primarily due to the impact of state taxes and certain other nondeductible items, offset by the domestic production activities deduction of the American Jobs Creation Act enacted on October 22, 2004.
     The gross accruals for unrecognized income tax benefits, including interest and penalties, reflected in other noncurrent liabilities were $164 million and $172 million at September 30, 2008, and December 31, 2007, respectively. RAI accrues interest and penalties related to accruals for income taxes and reflects these amounts in tax expense. The gross amount of interest accrued at September 30, 2008, and December 31, 2007, was $50 million and $49 million, respectively. The gross amount of penalties of $12 million was accrued at each of September 30, 2008, and December 31, 2007.
     The gross increases in unrecognized tax benefits related to tax positions were $13 million for the nine months ended September 30, 2008. Included in this amount were $10 million attributable to current year tax positions and $3 million attributable to prior-year tax positions.
     The gross decreases in unrecognized tax benefits were $22 million for the nine months ended September 30, 2008. Included in this amount were $3 million attributable to prior-year tax positions, $14 million attributable to settlements with taxing authorities and $5 million attributable to statute of limitation expirations.
     As of September 30, 2008, $60 million of unrecognized tax benefits and $43 million of interest and penalties, if recognized, would affect the effective tax rate.
     Included in the provision for income taxes for the three months and nine months ended September 30, 2008, was $2 million and $11 million of additional tax expense including $1 million and $3 million of interest expense, net of federal benefit, and penalties associated with unrecognized tax benefits, respectively. Comparable amounts for the three months and nine months ended September 30, 2007, were $4 million and $12 million of additional tax expense, including $1 million and $5 million of interest expense, net of federal benefit, and penalties, respectively.
     RAI and its subsidiaries may be subject to income taxes in the United States, certain foreign jurisdictions and multiple state jurisdictions. A number of years may elapse before a particular matter for which RAI has established an accrual is audited and finally resolved. The number of years with open tax audits varies depending on the tax jurisdiction. RAI’s major taxing jurisdictions and related open tax audits are discussed below.
     The IRS completed its examination and issued an assessment for the years 2002 and 2003. RAI filed a protest in 2006, and a formal settlement agreement was signed during the first quarter of 2008. Overpayments from prior year audits exceed the settlement agreement amount, and a refund of $2 million was received in April 2008. Amended state returns will be prepared in 2008 to reflect these federal adjustments. The additional state income tax associated with these returns is reflected in the accruals for unrecognized income tax benefits.
     RAI has filed a federal consolidated income tax return for the years 2004 through 2007. The statute of limitations remains open for the years 2005 through 2007. There are no IRS examinations scheduled at this time for these open years.
     In December 2007, North Carolina completed its examination of RJR Tobacco for years 2000 through 2002 and issued a total assessment of $37 million: $21 million related to tax, $8 million related to interest and $8 million related to penalties. RJR Tobacco filed a protest in January 2008. RJR Tobacco will continue to work with North Carolina to resolve issues identified and assessed for years 2000 through 2002. A complete resolution is not anticipated within the next 12 months. However, in the event a complete resolution of this audit is reached during the next 12 months, RJR Tobacco could recognize additional expense of up to $13 million, inclusive of tax, interest, net of federal benefit, and penalties.
     It is expected that the amount of unrecognized tax benefits will change in the next 12 months. Excluding the impact of North Carolina’s assessment for years 2000 through 2002, RAI does not expect the change to have a significant impact on its consolidated results of operations, financial position or cash flows.

14


Table of Contents

Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
Note 10—Borrowing Arrangements
     On June 28, 2007, RAI entered into a Fifth Amended and Restated Credit Agreement, which, as subsequently amended, is referred to as the Credit Facility. The Credit Facility provides for a five-year, $550 million revolving credit facility, which may be increased to $900 million at the discretion of the lenders upon the request of RAI. The Credit Facility’s maturity date of June 28, 2012, may be extended, at the discretion of the lenders upon RAI’s request, in two separate one-year increments. Effective March 31, 2008, the Credit Facility was amended by:
    adding a further exception to the covenant that restricts the sale of assets, so as to permit the disposition of real properties and related assets, whether by donation or sale below fair market value, in an aggregate amount not to exceed $15 million;
 
    modifying the covenant limiting the amount of cash, Marketable Investments and Investment Equities that a Non-Guarantor Subsidiary, that is not a Domestic Subsidiary, as such terms are defined in the Credit Facility, may hold; and
 
    modifying certain related definitions.
     On October 5, 2008, Lehman Commercial Paper Inc., a lender in the Credit Facility and referred to as LCPI, filed for protection under Chapter 11 of the federal Bankruptcy Code. RAI has never borrowed under the Credit Facility, but given LCPI’s bankruptcy filing, there can be no assurance that LCPI would loan to RAI LCPI’s pro rata share of any borrowing requests made by RAI. Subject to the terms and conditions in the Credit Facility, RAI has the right to replace a lender in certain circumstances, including upon a lender defaulting in its obligation to make loans. If any lender were to default in its obligation to make loans, there can be no assurance as to when or whether RAI could find an acceptable replacement lender. LCPI’s commitment under the Credit Facility is $52 million.
     Certain of RAI’s subsidiaries, including its material domestic subsidiaries, referred to as the Guarantors, have guaranteed RAI’s obligations under the Credit Facility and under RAI’s outstanding senior notes, referred to as the Notes. Until the credit ratings actions described below, RAI had pledged substantially all of its assets, including the stock of its direct subsidiaries, to secure its obligations under the Credit Facility, and the Guarantors had pledged substantially all of their assets to secure their guarantees of RAI’s obligations under the Credit Facility. Until such credit ratings actions, the Notes and related guarantees had been secured by any Principal Property, as such term is defined in the indenture governing the Notes, of RAI and certain of the Guarantors, and the stock, indebtedness or other obligations of RJR Tobacco.
     On May 2, 2008, S&P raised its corporate credit rating for RAI from BB+, a non-investment grade rating, and a positive outlook, to BBB-, an investment grade rating, and a stable outlook. On June 20, 2008, Moody’s, consistent with its notching practices for an investment grade issuer, withdrew its corporate credit rating of Ba1, a non-investment grade rating, for RAI, and upgraded the Notes from Ba1 to Baa3, an investment grade rating. Moody’s also revised its outlook for RAI from positive to stable.
     Pursuant to the terms of the loan documents relating to the Credit Facility, Notes and related guarantees, which terms provide for a release of collateral if RAI obtains investment grade corporate credit ratings, with not worse than stable outlooks, from each of S&P and Moody’s, the collateral securing the Credit Facility, Notes and related guarantees was released automatically on June 20, 2008, upon the ratings issued by Moody’s on that date. The relevant loan documents do not provide for a release of the Guarantors’ guarantees of the Credit Facility and the Notes upon any ratings upgrades and, therefore, such guarantees remain in effect. In addition, on June 20, 2008, given the release of the collateral which had secured the Credit Facility and the related guarantees, Moody’s lowered the investment grade rating for the Credit Facility from Baa1 to Baa3. The collateral for the Credit Facility, Notes and related guarantees will be reinstated if RAI’s corporate credit rating issued by each of S&P and Moody’s is lowered to at least one level below the lowest rating level established as investment grade, or if RAI’s corporate credit rating issued by either S&P or Moody’s is lowered to at least two levels below the lowest rating level established as investment grade.
Note 11—Financial Instruments
     RAI and RJR use interest rate swaps to manage interest rate risk on a portion of their respective debt obligations. When entered into, these financial instruments are designated as hedges of underlying exposures.

15


Table of Contents

Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
     Swaps existed on $1.6 billion principal amount of debt as of September 30, 2008. Including the impact of swaps, the average interest rate on the principal amount of RAI’s consolidated $4.4 billion long-term debt was 5.87% as of September 30, 2008.
     The interest rate swaps’ notional amounts and termination dates match those of the corresponding outstanding notes. As of September 30, 2008, these fair value hedges were perfectly effective, resulting in no recognized net gain or loss. The unrealized gains on the hedges resulting from the change in the hedges’ fair value were $106 million and $119 million at September 30, 2008, and December 31, 2007, respectively, included in other assets and deferred charges in the condensed consolidated balance sheets (unaudited) and were equal to the increase in the fair value of the hedged long-term debt.
     Under certain conditions, any fair value that results in a liability position of certain interest rate swaps may require full collateralization with cash or securities. No swaps were in a liability position as of September 30, 2008.
Note 12—Commitments and Contingencies
Tobacco Litigation — General
Introduction
     Various legal proceedings or claims, including litigation claiming that cancer and other diseases, as well as addiction, have resulted from the use of, or exposure to, RAI’s operating subsidiaries’ products, are pending or may be instituted against RJR Tobacco, the Conwood companies or their affiliates, including RAI and RJR, or indemnitees, including B&W. These pending legal proceedings include claims relating to cigarette products manufactured by RJR Tobacco or certain of its affiliates and indemnitees, as well as claims relating to smokeless tobacco products manufactured by the Conwood companies. A discussion of the legal proceedings relating to cigarette products is set forth below under the heading “— Litigation Affecting the Cigarette Industry.” All of the references under that heading to tobacco-related litigation, smoking and health litigation and other similar references are references to legal proceedings relating to cigarette products and are not references to legal proceedings involving smokeless tobacco products, and case numbers under that heading include only cases involving cigarette products. The legal proceedings relating to the smokeless tobacco products manufactured by the Conwood companies are discussed separately under the heading “— Smokeless Tobacco Litigation” below.
     In connection with the B&W business combination, RJR Tobacco agreed to indemnify B&W and its affiliates against certain liabilities, costs and expenses incurred by B&W or its affiliates arising out of the U.S. cigarette and tobacco business of B&W. As a result of this indemnity, RJR Tobacco has assumed the defense of pending B&W-specific tobacco-related litigation, has paid the judgments and costs related to certain pre-business combination tobacco-related litigation of B&W, and has posted bonds on behalf of B&W, where necessary, in connection with cases decided since the B&W business combination. In addition, pursuant to this indemnity, RJR Tobacco expensed less than $1 million during the first nine months of 2008 and $2 million during the first nine months of 2007, for funds to be reimbursed to BAT for costs and expenses incurred arising out of certain tobacco-related litigation.
Certain Terms and Phrases
     Certain terms and phrases used in this disclosure may require some explanation. The term “judgment” or “final judgment” refers to the final decision of the court resolving the dispute and determining the rights and obligations of the parties. At the trial court level, for example, a final judgment generally is entered by the court after a jury verdict and after post-verdict motions have been decided. In most cases, the losing party can appeal a verdict only after a final judgment has been entered by the trial court.
     The term “damages” refers to the amount of money sought by a plaintiff in a complaint, or awarded to a party by a jury or, in some cases, by a judge. “Compensatory damages” are awarded to compensate the prevailing party for actual losses suffered, if liability is proved. In cases in which there is a finding that a defendant has acted willfully, maliciously or fraudulently, generally based on a higher burden of proof than is required for a finding of liability for compensatory damages, a plaintiff also may be awarded “punitive damages.” Although damages may be awarded at the trial court stage, a losing party generally may be protected from paying any damages until all appellate avenues have been exhausted by posting a supersedeas bond. The amount of such a bond is governed by the law of the relevant

16


Table of Contents

Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
jurisdiction and generally is set at the amount of damages plus some measure of statutory interest, modified at the discretion of the appropriate court or subject to limits set by court or statute.
     The term “settlement” refers to certain types of cases in which cigarette manufacturers, including RJR Tobacco and B&W, have agreed to resolve disputes with certain plaintiffs without resolving the case through trial. The principal terms of certain settlements entered into by RJR Tobacco and B&W are explained below under “— Accounting for Tobacco-Related Litigation Contingencies.”
Theories of Recovery
     The plaintiffs seek recovery on a variety of legal theories, including negligence, strict liability in tort, design defect, special duty, voluntary undertaking, breach of warranty, failure to warn, fraud, misrepresentation, unfair trade practices, conspiracy, unjust enrichment, medical monitoring, public nuisance and violations of state and federal antitrust laws. In certain of these cases, the plaintiffs claim that cigarette smoking exacerbated injuries caused by exposure to asbestos.
     The plaintiffs seek various forms of relief, including compensatory and punitive damages, treble or multiple damages and statutory damages and penalties, creation of medical monitoring and smoking cessation funds, disgorgement of profits, and injunctive and other equitable relief. Although alleged damages often are not determinable from a complaint, and the law governing the pleading and calculation of damages varies from state to state and jurisdiction to jurisdiction, compensatory and punitive damages have been specifically pleaded in a number of cases, sometimes in amounts ranging into the hundreds of millions and even billions of dollars.
Defenses
     The defenses raised by RJR Tobacco, the Conwood companies and their affiliates and indemnitees include, where applicable and otherwise appropriate, preemption by the Federal Cigarette Labeling and Advertising Act of some or all claims arising after 1969, or by the Comprehensive Smokeless Tobacco Health Education Act, the lack of any defect in the product, assumption of the risk, contributory or comparative fault, lack of proximate cause, remoteness, lack of standing and statutes of limitations or repose. RAI and RJR have asserted additional defenses, including jurisdictional defenses, in many of the cases in which they are named.
Accounting for Tobacco-Related Litigation Contingencies
     In accordance with GAAP, RAI and its subsidiaries, including RJR Tobacco and the Conwood companies, as applicable, record any loss concerning litigation at such time as an unfavorable outcome becomes probable and the amount can be reasonably estimated. For the reasons set forth below, RAI’s management continues to conclude that the loss of any particular pending smoking and health tobacco litigation claim against RJR Tobacco or its affiliates or indemnitees, or the loss of any particular claim concerning the use of smokeless tobacco against the Conwood companies, when viewed on an individual basis, is not probable.
     RJR Tobacco and its affiliates believe that they have valid defenses to the smoking and health tobacco litigation claims against them, as well as valid bases for appeal of adverse verdicts against them. RAI, RJR Tobacco and their affiliates and indemnitees have, through their counsel, filed pleadings and memoranda in pending smoking and health tobacco litigation that set forth and discuss a number of grounds and defenses that they and their counsel believe have a valid basis in law and fact. RJR Tobacco and its affiliates and indemnitees continue to win the majority of smoking and health tobacco litigation claims that reach trial, and a very high percentage of the tobacco-related litigation claims brought against them continue to be dismissed at or before trial. Based on their experience in the smoking and health tobacco litigation against them and the strength of the defenses available to them in such litigation, RJR Tobacco and its affiliates believe that their successful defense of smoking and health tobacco litigation in the past will continue in the future.
     No liability for pending smoking and health tobacco litigation was recorded in RAI’s consolidated balance sheet (unaudited) as of September 30, 2008. RJR has liabilities totaling $94 million that were recorded in 1999 in connection with certain indemnification claims not related to smoking and health asserted by Japan Tobacco, Inc., referred to as JTI, against RJR and RJR Tobacco relating to certain activities of Northern Brands International, Inc., a now inactive, indirect subsidiary of RAI formerly involved in the international tobacco business, referred to as Northern Brands. For further information on Northern Brands and related litigation and the indemnification claims of JTI, see “—

17


Table of Contents

Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
Litigation Affecting the Cigarette Industry — Other Litigation and Developments” and “— Other Contingencies” below.
          Generally, RJR Tobacco and its affiliates and indemnitees have not settled, and currently RJR Tobacco and its affiliates do not intend to settle, any smoking and health tobacco litigation claims. It is the policy of RJR Tobacco and its affiliates to vigorously defend all tobacco-related litigation claims.
          The only smoking and health tobacco litigation claims settled by RJR Tobacco and B&W involved:
      the Master Settlement Agreement and other settlement agreements with the states of Mississippi, Florida, Texas and Minnesota, and the funding by various tobacco companies of a $5.2 billion trust fund contemplated by the Master Settlement Agreement to benefit tobacco growers; and
      the original Broin flight attendant case discussed below under “— Litigation Affecting the Cigarette Industry — Class-Action Suits.”
          The circumstances surrounding the MSA and the funding of a trust fund to benefit the tobacco growers are readily distinguishable from the current categories of smoking and health cases involving RJR Tobacco or its affiliates and indemnitees. The claims underlying the MSA were brought on behalf of the states to recover funds paid for health-care and medical and other assistance to state citizens suffering from diseases and conditions allegedly related to tobacco use. The MSA settled all the health-care cost recovery actions brought by, or on behalf of, the settling jurisdictions and contain releases of various additional present and future claims. In accordance with the MSA, various tobacco companies agreed to fund a $5.2 billion trust fund to be used to address the possible adverse economic impact of the MSA on tobacco growers. A discussion of the MSA, and a table depicting the related payment schedule, is set forth below under “— Litigation Affecting the Cigarette Industry — Health-Care Cost Recovery Cases — MSA.”
          The states were a unique set of plaintiffs and are not involved in any of the smoking and health cases remaining against RJR Tobacco or its affiliates and indemnitees. Although RJR Tobacco and certain of its affiliates and indemnitees continue to be defendants in health-care cost recovery cases similar in theory to the state cases but involving other plaintiffs, such as hospitals, Native American tribes and foreign governments, the vast majority of such cases have been dismissed on legal grounds. RJR Tobacco and its affiliates, including RAI, believe that the same legal principles that have resulted in dismissal of health-care cost recovery cases either at the trial court level or on appeal should compel dismissal of the similar pending cases.
          The pending U.S. Department of Justice case brought against various industry members, including RJR Tobacco and B&W, discussed below under “— Litigation Affecting the Cigarette Industry — Health-Care Cost Recovery Cases,” also can be distinguished from the circumstances surrounding the MSA. Under its Medical Care Recovery Act and Medicare Secondary Payer Act claims, the federal government made arguments similar to the states and sought to recover federal funds expended in providing health care to smokers who have developed diseases and injuries alleged to be smoking-related. These claims were dismissed, and the only claim remaining in the case involves alleged violations of civil provisions of the federal Racketeer Influenced and Corrupt Organizations Act, referred to as RICO. A comprehensive discussion of this case is set forth below under “— Litigation Affecting the Cigarette Industry — Health-Care Cost Recovery Cases.”
          As with claims that were resolved by the MSA, the other cases settled by RJR Tobacco can be distinguished from existing cases pending against RJR Tobacco and its affiliates and indemnitees. The original Broin case, discussed below under “— Litigation Affecting the Cigarette Industry — Class-Action Suits,” was settled in the middle of trial during negotiations concerning a possible nation-wide settlement of claims similar to those underlying the MSA.
          Likewise, RJR Tobacco and B&W separately settled the antitrust case DeLoach v. Philip Morris Cos., Inc., which was brought by a unique class of plaintiffs: a class of all tobacco growers and tobacco allotment holders. Despite valid legal defenses, RJR Tobacco and B&W separately settled this case to avoid a long and contentious trial with the tobacco growers. The DeLoach case and the antitrust cases currently pending against RJR Tobacco and B&W involve different types of plaintiffs and different theories of recovery under the antitrust laws than other cases pending against RJR Tobacco and its affiliates and indemnitees.
          Finally, as discussed under “— Litigation Affecting the Cigarette Industry — MSA - Enforcement and Validity,” RJR Tobacco and B&W each has settled certain cases brought by states concerning the enforcement of the MSA. Despite valid legal defenses, these cases were settled to avoid further contentious litigation with the states involved. Each MSA enforcement action involves alleged breaches of the MSA based on specific actions taken by the

18


Table of Contents

Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
particular defendant. Accordingly, any future MSA enforcement action will be reviewed by RJR Tobacco on the merits and should not be affected by the settlement of prior MSA enforcement cases.
          The Conwood companies also believe that they have valid defenses to the smokeless tobacco litigation against them. The Conwood companies have asserted and will continue to assert some or all of these defenses in each case at the time and in the manner deemed appropriate by the Conwood companies and their counsel. No verdict or judgment has been returned or entered against the Conwood companies on any claim for personal injuries allegedly resulting from the use of smokeless tobacco. The Conwood companies intend to defend vigorously all smokeless tobacco litigation claims asserted against them. No liability for pending smokeless tobacco litigation was recorded in RAI’s consolidated balance sheet (unaudited) as of September 30, 2008.
Cautionary Statement
          Even though RAI’s management continues to conclude that the loss of any particular pending smoking and health tobacco litigation claim against RJR Tobacco or its affiliates or indemnitees, or the loss of any particular pending case concerning the use of smokeless tobacco against the Conwood companies, when viewed on an individual basis, is not probable, the possibility of material losses related to such litigation is more than remote. Litigation is subject to many uncertainties, and generally it is not possible to predict the outcome of any particular litigation pending against RJR Tobacco, the Conwood companies or their affiliates or indemnitees, or to reasonably estimate the amount or range of any possible loss.
          Although RJR Tobacco believes that it has valid bases for appeals of adverse verdicts in its pending cases, and RJR Tobacco and RAI believe they have valid defenses to all actions, and intend to defend all actions vigorously, it is possible that there could be further adverse developments in pending cases, and that additional cases could be decided unfavorably against RAI, RJR Tobacco or their affiliates or indemnitees. Determinations of liability or adverse rulings in such cases or in similar cases involving other cigarette manufacturers as defendants, even if such judgments are not final, could materially adversely affect the litigation against RJR Tobacco or its affiliates or indemnitees and could encourage the commencement of additional tobacco-related litigation. In addition, a number of political, legislative, regulatory and other developments relating to the tobacco industry and cigarette smoking have received wide media attention. These developments may negatively affect the outcomes of tobacco-related legal actions and encourage the commencement of additional similar litigation.
          Although it is impossible to predict the outcome of such events on pending litigation and the rate new lawsuits are filed against RJR Tobacco or its affiliates or indemnitees, a significant increase in litigation or in adverse outcomes for tobacco defendants could have a material adverse effect on any or all of these entities. Moreover, notwithstanding the quality of defenses available to it and its affiliates and indemnitees in litigation matters, it is possible that RAI’s results of operations, cash flows or financial position could be materially adversely affected by the ultimate outcome of certain pending litigation matters against RJR Tobacco or its affiliates or indemnitees.
          Similarly, smokeless tobacco litigation is subject to many uncertainties. Notwithstanding the quality of defenses available to the Conwood companies, it is possible that RAI’s results of operations, cash flows or financial position could be materially adversely affected by the ultimate outcome of certain pending litigation matters against the Conwood companies.
Litigation Affecting the Cigarette Industry
Overview
          Introduction.  In connection with the B&W business combination, RJR Tobacco agreed to indemnify B&W and its affiliates against, among other things, certain litigation liabilities, costs and expenses incurred by B&W or its affiliates arising out of the U.S. cigarette and tobacco business of B&W. Accordingly, the cases discussed below include cases brought solely against RJR Tobacco and its affiliates, including RAI and RJR; cases brought against both RJR Tobacco, its affiliates and B&W; and cases brought solely against B&W and assumed by RJR Tobacco in the B&W business combination.
          During the third quarter of 2008, 24 tobacco-related cases were served against RJR Tobacco or its affiliates or indemnitees. On September 30, 2008, there were 3,207 cases, including 686 individual smoker cases pending in West Virginia state court as a consolidated action and 2,310 Engle Progeny Cases, involving 8,827 individual plaintiffs, pending in the United States against RJR Tobacco or its affiliates or indemnitees, as compared with 1,283 total cases on

19


Table of Contents

Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
September 30, 2007, and 1,419 total cases on September 30, 2006, pending in the United States against RJR Tobacco or its affiliates or indemnitees.
          As of October 10, 2008, 922 tobacco-related cases were pending against RJR Tobacco or its affiliates or indemnitees: 917 in the United States; one in Puerto Rico; three in Canada; and one in Israel. Of the 917 total U.S. cases, 25 cases are pending against B&W that are not also pending against RJR Tobacco. The U.S. case number does not include the 2,620 Broin II or the 2,310 Engle Progeny Cases, as discussed below, pending as of October 10, 2008. The following table lists the number of U.S. tobacco-related cases by state that were pending against RJR Tobacco or its affiliates or indemnitees as of October 10, 2008, exclusive of the Broin II and Engle Progeny Cases:
         
    Number of
State   U.S. Cases
West Virginia
    692 *
Maryland
    38  
New York
    24  
Florida
    24  
Missouri
    20  
Louisiana
    17  
Mississippi
    14  
California
    11  
Illinois
    7  
Connecticut
    4  
Ohio
    4  
Pennsylvania
    4  
Kentucky
    4  
District of Columbia
    3  
Georgia
    3  
Delaware
    2  
Washington
    2  
Alabama
    2  
Kansas
    2  
Maine
    2  
Minnesota
    2  
New Mexico
    2  
North Carolina
    2  
South Dakota
    2  
Tennessee
    2  
Vermont
    2  
Wisconsin
    2  
Arizona
    1  
Michigan
    1  
New Jersey
    1  
Oregon
    1  
South Carolina
    1  
Alaska
    1  
Arkansas
    1  
Colorado
    1  
Hawaii
    1  
Idaho
    1  
Indiana
    1  
Iowa
    1  
Mariana Islands
    1  
Massachusetts
    1  
Montana
    1  
Nebraska
    1  
Nevada
    1  
New Hampshire
    1  

20


Table of Contents

Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
         
    Number of
State   U.S. Cases
North Dakota
    1  
Oklahoma
    1  
Rhode Island
    1  
Utah
    1  
Virginia
    1  
Wyoming
    1  
 
       
 
       
Total
    917 **
 
       
 
*   687 of the 692 cases are pending as a consolidated action In re: Tobacco Litigation Personal Injury Cases, Circuit Court, Ohio County, West Virginia, consolidated January 11, 2000. On February 11, 2008, the trial court stayed the trial of the initial phase indefinitely pending the U.S. Supreme Court review in Good v. Altria Group, Inc., a “lights” class action filed in August 2005 in the United States District Court for the District of Maine against Philip Morris USA and its parent company, Altria Group, Inc. On February 25, 2008, the U.S. Supreme Court denied the defendants’ petition for certiorari asking the Court to review the trial plan for the West Virginia cases. Oral argument in Good v. Altria Group, Inc. occurred in the U.S. Supreme Court on October 6, 2008. A decision is pending.
 
**   Of the 917 pending U.S. cases, 30 are pending in federal court, 886 in state court and 1 in tribal court.
          The following table lists the categories of the U.S. tobacco-related cases pending against RJR Tobacco or its affiliates or indemnitees as of October 10, 2008, compared with the number of cases pending against RJR Tobacco, its affiliates or indemnitees as of July 11, 2008, as reported in RAI’s Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2008, filed with the SEC on August 4, 2008, and a cross-reference to the discussion of each case type.
                         
            Change in Number    
    RJR Tobacco’s   of Cases Since    
    Case Numbers as of   July 11, 2008    
Case Type   October 10, 2008   Increase/(Decrease)   Page Reference
Individual Smoking and Health
    825       8       29  
Engle Progeny (Number of Plaintiffs)*
    2,310 (8,825)       67       30  
Broin II
    2,620       (1 )     31  
Class-Action
    15       (1 )     31  
Health-Care Cost Recovery
    4     No Change     36  
MSA-Enforcement and Validity
    60     No Change     40  
Antitrust
    2     No Change     42  
Other Litigation
    11       1       43  
 
*   The Engle Progeny Cases have been separated from the Individual Smoking and Health cases for reporting purposes. Plaintiffs’ counsel are attempting to include multiple plaintiffs in most of the cases filed. The increase in the number of cases includes new cases served and new cases filed by severed plaintiffs.
          Four pending cases against RJR Tobacco and B&W have attracted significant attention: the Florida state court class-action case, Engle v. R. J. Reynolds Tobacco Co., the Louisiana state court class-action case, Scott v. American Tobacco Co., the federal RICO case brought by the U.S. Department of Justice, and the federal lights class action Schwab [McLaughlin] v. Philip Morris USA, Inc.
          In 2000, a jury in Engle rendered a punitive damages verdict in favor of the “Florida class” of approximately $145 billion against all defendants. On July 6, 2006, the Florida Supreme Court, among other things, affirmed an appellate court’s reversal of the punitive damages award, decertified the class going forward, preserved several class-wide findings from the trial, including that nicotine is addictive and cigarettes are defectively designed, and authorized class members to avail themselves of these findings in individual lawsuits under certain conditions. After subsequent motions were resolved, the Florida Supreme Court issued its mandate on January 11, 2007, thus beginning a one-year period in which former class members were permitted to file individual lawsuits. On October 1, 2007, the U.S. Supreme Court denied the defendants’ petition for writ of certiorari. As of October 10, 2008, RJR Tobacco had been served in 2,310 Engle Progeny Cases in both state and federal courts in Florida. These cases include approximately 8,825 plaintiffs. The number of cases likely will change due to individual plaintiffs being severed from multi-plaintiff cases.

21


Table of Contents

Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
          In 2004, a jury in Scott returned a verdict in favor of the “Louisiana class” for $591 million to establish a state-wide smoking cessation program. In 2007, the Louisiana Court of Appeals upheld class certification, significantly reduced the scope of recovery, and remanded the case for further proceedings. The Louisiana and U.S. Supreme Courts denied the defendants’ applications for writ of certiorari. In July 2008, the trial court entered an amended judgment in favor of the class for approximately $263 million plus interest from June 30, 2004. The defendants have filed an emergency application for writ of mandamus or supervisory writ with the Louisiana Court of Appeals.
          In the U.S. Department of Justice case, brought in 1999 in the U.S. District Court for the District of Columbia, the government sought, among other forms of relief, the disgorgement of profits pursuant to the civil provisions of RICO. The U.S. Court of Appeals for the District of Columbia ruled in 2005 that disgorgement is not an available remedy in the case. The bench trial ended in June 2005, and the court, in August 2006, issued its ruling, among other things, finding certain defendants, including RJR Tobacco and B&W, liable for the RICO claims, imposing no direct financial penalties on the defendants, but ordering the defendants to make certain “corrective communications” in a variety of media and enjoining the defendants from using certain brand descriptors. Both sides have appealed to the U.S. Court of Appeals for the District of Columbia, and the trial court’s order has been stayed pending the appeal. Oral argument occurred on October 14, 2008. A decision is pending.
          In September 2006, the U.S. District Court for the Eastern District of New York in Schwab certified a nation-wide class of “lights” smokers. On November 16, 2006, the U.S. Court of Appeals for the Second Circuit granted the defendants’ motions to stay the district court proceedings and for review of the class certification ruling. On April 3, 2008, the Second Circuit decertified the class. The case was returned to the trial court for further proceedings.
          For a detailed description of these cases, see “— Class-Action Suits — Engle Case,” “— Class-Action Suits – Medical Monitoring and Smoking Cessation Cases,” “— Health-Care Cost Recovery Cases — Department of Justice Case” and “— Class-Action Suits — ‘Lights’ Cases” below.
          In November 1998, the major U.S. cigarette manufacturers, including RJR Tobacco and B&W, entered into the MSA with 46 U.S. states and certain U.S. territories and possessions. These cigarette manufacturers previously settled four other cases, brought on behalf of Mississippi, Florida, Texas and Minnesota, by separate agreements with each state. The MSA, including the four other state settlement agreements:
      settled all health-care cost recovery actions brought by, or on behalf of, the settling jurisdictions;
      released the major U.S. cigarette manufacturers from various additional present and potential future claims;
      imposed payment obligations in perpetuity on RJR Tobacco, B&W and other major U.S. cigarette manufacturers; and
      placed significant restrictions on their ability to market and sell tobacco products.
          MSA payments are subject to adjustments for, among other things, the volume of cigarettes sold, market share and inflation. See “— Health-Care Cost Recovery Cases — MSA” below for a detailed discussion of the MSA, including RAI’s operating subsidiaries’ monetary obligations under these agreements. RJR Tobacco records the allocation of settlement charges as products are shipped.
          Scheduled Trials.  Trial schedules are subject to change, and many cases are dismissed before trial. The following table lists the trial schedule, as of October 10, 2008, for RJR Tobacco or its affiliates and indemnitees through September 30, 2009.
             
Trial Date   Case Name/Type   Defendant(s)   Jurisdiction
 
October 6, 2008
[ONGOING]
  Vermont v. R.J. Reynolds Tobacco Co.   RJR Tobacco   Superior Court
Chittenden County
 
  [MSA Enforcement (Eclipse)]       (Burlington, VT)
 
November 24, 2008
  Hess v. R.J. Reynolds Tobacco Co.   RJR Tobacco   Circuit Court
 
  [Engle Progeny]       Broward County
 
          (Ft. Lauderdale, FL)
 

22


Table of Contents

Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
             
Trial Date   Case Name/Type   Defendant(s)   Jurisdiction
 
December 1, 2008
  Sherman v. R.J. Reynolds Tobacco Co.
[Engle Progeny]
  RJR Tobacco   Circuit Court
Broward County
 
          (Ft. Lauderdale, FL)
 
December 17, 2008
  Williams v. Brown & Williamson   RJR Tobacco, B&W   Circuit Court
 
  [Individual]       City of St. Louis
 
          (St. Louis, MO)
 
January 5, 2009
  Hargroves v. R.J. Reynolds Tobacco Co.
[Engle Progeny]
  RJR Tobacco   Circuit Court
Hillsborough County
 
        (Miami, FL)
 
January 5, 2009
  Brown v. R.J. Reynolds Tobacco Co.   RJR Tobacco   Circuit Court
 
  [Engle Progeny]       Broward County
 
          (Ft. Lauderdale, FL)
 
January 5, 2009
  Cohen v. R.J. Reynolds Tobacco Co.   RJR Tobacco   Circuit Court
 
  [Engle Progeny]       Broward County
 
          (Ft. Lauderdale, FL)
 
January 5, 2009
  Stephens v. R.J. Reynolds Tobacco Co.
[Engle Progeny]
  RJR Tobacco   Circuit Court
Broward County
 
        (Ft. Lauderdale, FL)
 
January 19, 2009
  Levine v. R.J. Reynolds Tobacco Co.   RJR Tobacco, B&W   Circuit Court
 
  [Individual]       Palm Beach County
 
          (West Palm Beach, FL)
 
February 2, 2009
  Tate v. R.J. Reynolds Tobacco Co.   RJR Tobacco   Circuit Court
 
  [Engle Progeny]       Broward County
 
          (Ft. Lauderdale, FL)
 
February 2, 2009
  Cohen v. R.J. Reynolds Tobacco Co.   RJR Tobacco   Circuit Court
 
  [Engle Progeny]       Broward County
 
          (Ft. Lauderdale, FL)
 
February 2, 2009
  Goldthorpe v. R.J. Reynolds Tobacco Co.
[Engle Progeny]
  RJR Tobacco   Circuit Court
Broward County
 
        (Ft. Lauderdale, FL)
 
March 9, 2009
  Gelep v. R.J. Reynolds Tobacco Co.   RJR Tobacco   Circuit Court
 
  [Engle Progeny]       Pinellas County
 
          (St. Petersburg, FL)
 
April 27, 2009
  Abbott v. Philip Morris USA Inc.   RJR Tobacco   Circuit Court
 
  [Engle Progeny]       Broward County
 
          (Ft. Lauderdale, FL)
 
April 27, 2009
  Barbanell v. R.J. Reynolds Tobacco Co.
[Engle Progeny]
  RJR Tobacco   Circuit Court
Broward County
 
          (Ft. Lauderdale, FL)
 
April 27, 2009
  Bronstein v. R.J. Reynolds Tobacco Co.
[Engle Progeny]
  RJR Tobacco   Circuit Court
Broward County
 
          (Ft. Lauderdale, FL)
 
April 27, 2009
  Cohen v. R.J. Reynolds Tobacco Co.   RJR Tobacco   Circuit Court
 
  [Engle Progeny]       Broward County
 
          (Ft. Lauderdale, FL)
 
April 27, 2009
  Dawson v. R.J. Reynolds Tobacco Co.   RJR Tobacco   Circuit Court
 
  [Engle Progeny]       Broward County
 
          (Ft. Lauderdale, FL)
 
April 27, 2009
  Kaplan v. R.J. Reynolds Tobacco Co.   RJR Tobacco   Circuit Court
 
  [Engle Progeny]       Broward County
 
          (Ft. Lauderdale, FL)
 
April 27, 2009
  Lapidus-Carlson v. R.J. Reynolds Tobacco Co.
[Engle Progeny]
  RJR Tobacco   Circuit Court
Broward County
 
          (Ft. Lauderdale, FL)

23


Table of Contents

Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
             
Trial Date   Case Name/Type   Defendant(s)   Jurisdiction
 
April 27, 2009
  Lopez v. R.J. Reynolds Tobacco Co.   RJR Tobacco   Circuit Court
 
  [Engle Progeny]       Broward County
 
          (Ft. Lauderdale, FL)
 
April 27, 2009
  Marrazzo v. R.J. Reynolds Tobacco Co.
[Engle Progeny]
  RJR Tobacco   Circuit Court
Broward County
 
          (Ft. Lauderdale, FL)
 
April 27, 2009
  Morrissette-Stege v. R.J. Reynolds Tobacco Co.
[Engle Progeny]
  RJR Tobacco   Circuit Court
Broward County
 
          (Ft. Lauderdale, FL)
 
April 27, 2009
  Palmieri v. R.J. Reynolds Tobacco Co.
[Engle Progeny]
  RJR Tobacco   Circuit Court
Broward County
 
          (Ft. Lauderdale, FL)
 
April 27, 2009
  Rohr v. R.J. Reynolds Tobacco Co.   RJR Tobacco   Circuit Court
 
  [Engle Progeny]       Broward County
 
          (Ft. Lauderdale, FL)
 
April 27, 2009
  Salvino v. R.J. Reynolds Tobacco Co.
[Engle Progeny]
  RJR Tobacco   Circuit Court
Broward County
 
          (Ft. Lauderdale, FL)
 
April 27, 2009
  Tucci v. R.J. Reynolds Tobacco Co.   RJR Tobacco   Circuit Court
 
  [Engle Progeny]       Broward County
 
          (Ft. Lauderdale, FL)
 
April 27, 2009
  Walsh v. R.J. Reynolds Tobacco Co.
[Engle Progeny]
  RJR Tobacco   Circuit Court
Broward County
(Ft. Lauderdale, FL)
 
June 29, 2009
  Digati v. R.J. Reynolds Tobacco Co.   RJR Tobacco   Circuit Court
 
  [Engle Progeny]       Broward County
 
          (Ft. Lauderdale, FL)
 
June 29, 2009
  Greene v. R.J. Reynolds Tobacco Co.   RJR Tobacco   Circuit Court
 
  [Engle Progeny]       Broward County
 
          (Ft. Lauderdale, FL)
 
June 29, 2009
  Grossman v. R.J. Reynolds Tobacco Co.
[Engle Progeny]
  RJR Tobacco   Circuit Court
Broward County
 
          (Ft. Lauderdale, FL)
 
June 29, 2009
  Naugle v. R.J. Reynolds Tobacco Co.   RJR Tobacco   Circuit Court
 
  [Engle Progeny]       Broward County
 
          (Ft. Lauderdale, FL)
 
June 29, 2009
  Samuels v. R.J. Reynolds Tobacco Co.
[Engle Progeny]
  RJR Tobacco   Circuit Court
Broward County
(Ft. Lauderdale, FL)
 
July 13, 2009
  Bell v. Brown & Williamson Tobacco Corp.
[Individual]
  RJR Tobacco; B&W   Circuit Court
Jackson County
 
          (Independence, MO)
 
August 3, 2009
  Woods v. R.J. Reynolds Tobacco Co.   RJR Tobacco; B&W   U.S. District Court
 
  [Individual]       Southern District
 
          (Jackson, MS)
 
August 5, 2009
  Coley v. 3M Company   RJR Tobacco   Superior Court
 
  [Other]       New Castle County
 
          (Wilmington, DE)
 
          Trial Results.  From January 1, 1999 through October 10, 2008, 54 smoking and health and health-care cost recovery cases in which RJR Tobacco or B&W were defendants were tried. Verdicts in favor of RJR Tobacco, B&W and, in some cases, RJR Tobacco, B&W and other defendants, were returned in 37 cases, including four mistrials, tried in Florida (11), New York (4), Missouri (4), Tennessee (3), Mississippi (2), California (2), West Virginia (2), Ohio (2), Connecticut (1), Louisiana (1), New Jersey (1), Pennsylvania (1), South Carolina (1), Texas (1) and Washington (1).

24


Table of Contents

Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
          Additionally, from January 1, 1999 through October 10, 2008, verdicts were returned in 22 smoking and health cases in which RJR Tobacco, B&W, or their respective affiliates were not defendants. Verdicts were returned in favor of the defendants in 13 cases — five in Florida, three in California, and one in each of New Hampshire, New York, Pennsylvania, Rhode Island and Tennessee. Verdicts in favor of the plaintiffs were returned in nine cases — four in California, two in each of Florida and Oregon and one in Illinois.
          No cases were tried in the first nine months of 2008 in which RJR Tobacco was a defendant.
          The following chart reflects the verdicts and post-trial developments in the smoking and health cases that have been tried and remain pending as of October 10, 2008, in which verdicts have been returned in favor of the plaintiffs and against RJR Tobacco or B&W, or both.
                 
Date of Verdict   Case Name/Type   Jurisdiction   Verdict   Post-Trial Status
 
July 7, 1999-Phase I
April 7, 2000-Phase II
July 14, 2000-Phase III
  Engle v. R. J.
Reynolds Tobacco Co.

[Class Action]
  Circuit Court,
Miami-Dade County
(Miami, FL)
  $12.7 million compensatory damages against all the defendants; $145 billion punitive damages against all the defendants, of which approximately $36.3 billion and $17.6 billion was assigned to RJR Tobacco and B&W, respectively.   On May 21, 2003, Florida’s Third District Court of Appeal reversed the trial court and remanded the case to the Miami-Dade County Circuit Court with instructions to decertify the class. The Florida Supreme Court on July 6, 2006, affirmed the dismissal of the punitive damages award and decertified, on a going-forward basis, the class. The court preserved a number of class-wide findings from Phase I of the Engle trial, and authorized class members to avail themselves of those findings in individual lawsuits, provided they commence those lawsuits within one year of the date the court’s decision becomes final. In addition, the court reinstated compensatory damage verdicts in favor of two plaintiffs in the amounts of $2.85 million and $4.023 million, respectively. In the third quarter of 2007, the U.S. Supreme Court denied the defendants’ petition for writ of certiorari and petition for rehearing. As a result, on February 8, 2008, RJR Tobacco paid approximately $5.9 million relating to the damages verdicts mentioned above, which was determined using the total amount of the verdicts together with accrued interest beginning November 7, 2000. On May 14, 2008, the trial court granted the parties’

25


Table of Contents

Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
                 
Date of Verdict   Case Name/Type   Jurisdiction   Verdict   Post-Trial Status
 
 
              motion to sever moving plaintiffs’ claims. Plaintiffs Raymond Lacey, Michael Matyi and Loren Lowery have filed new cases. Plaintiff Howard Engle filed a stipulation for dismissal with prejudice, which the court ordered on July 2, 2008. On July 2, 2008, plaintiff Marilyn Calhoun filed a motion for relief from judgment.
 
               
June 11, 2002
  Lukacs v. R. J.
Reynolds Tobacco Co.

[Engle class member]
  Circuit Court,
Miami-Dade County
(Miami, FL)
  $500,000 economic damages, $24.5 million non-economic damages and $12.5 million loss of consortium damages against Philip Morris, B&W and Liggett, of which B&W was assigned 22.5% of liability. Final judgment was entered in the amount of $24.8 million plus interest applicable at the yearly statutory rates from July 11, 2002. RJR Tobacco was dismissed from the case in May 2002, prior to trial.   Judge reduced damages to $25.125 million of which B&W’s share is approximately $6 million. On January 2, 2007, the defendants moved to set aside the June 11, 2002, verdict and to dismiss the plaintiffs’ punitive damages claim. On January 3, 2007, the plaintiffs filed a motion for entry of judgment, which the court deferred until the U.S. Supreme Court completed review of Engle and after further submissions by the parties. On January 28, 2008, the defendants filed a submission asking the court to set aside the verdict and to dismiss the case. The court granted the plaintiff’s motion for entry of judgment on August 14, 2008. Pursuant to that verdict, the plaintiff will recover the sum of $24.8 million plus interest at the yearly statutory rates from July 11, 2002. On August 25, 2008, the defendants filed a motion for reconsideration of, or in the alternative, to alter or amend the order on the plaintiffs’ motion for entry of judgment. A hearing occurred on October 21, 2008. A decision is pending.
 
               
December 18, 2003
  Frankson v. Brown &
Williamson Tobacco Corp.

[Individual]
  Supreme Court,
Kings County
(Brooklyn, NY)
  $350,000 compensatory damages; 50% fault assigned to B&W and two industry organizations; $20   On January 21, 2005, the plaintiff stipulated to the court’s reduction in the amount of punitive damages from $20

26


Table of Contents

Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
                 
Date of Verdict   Case Name/Type   Jurisdiction   Verdict   Post-Trial Status
 
 
          million in punitive damages, of which $6 million was assigned to B&W, $2 million to a predecessor company and $12 million to two industry organizations.   million to $5 million, apportioned as follows: $0 to American Tobacco; $4 million to B&W; $500,000 to the Council for Tobacco Research and $500,000 to the Tobacco Institute. On June 26, 2007, final judgment was entered in the amount of approximately $6.8 million, including interest and costs. The defendants filed a notice of appeal on July 3, 2007. Briefing is complete. Oral argument has not been scheduled. Pursuant to its agreement to indemnify B&W, RJR Tobacco posted a supersedeas bond in the amount of $8.018 million on July 5, 2007.
 
               
May 21, 2004
  Scott v. American Tobacco Co. [Class Action]   District Court,
Orleans Parish
(New Orleans, LA)
  $591 million against RJR Tobacco, B&W, Philip Morris, Lorillard, and the Tobacco Institute, jointly and severally, for a smoking cessation program.   On September 29, 2004, the defendants posted a $50 million bond and noticed their appeal to the Louisiana Court of Appeal. RJR Tobacco posted $25 million toward the bond. On February 7, 2007, the Louisiana Court of Appeals limited the size of the class, and rejected the award of pre-judgment interest and most of the specific components of the smoking cessation program. However, the court upheld the class certification and found the defendants responsible for funding smoking cessation for eligible class members. On July 21, 2008, the trial court entered an amended judgment in the case. The court found that the defendants are jointly and severally liable for funding the cost of a court-supervised smoking cessation program and ordered the defendants to deposit approximately $263 million, together with interest from June 30, 2004, into a trust for the funding of the program. The court also stated that it would favorably

27


Table of Contents

Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
                 
Date of Verdict   Case Name/Type   Jurisdiction   Verdict   Post-Trial Status
 
 
              consider a motion to return to defendants a portion of unused funds at the close of each program year in the event the monies allocated for the preceding program year were not fully expended because of a reduction in class size or underutilization by the remaining plaintiffs. On August 27, 2008, the court denied the defendants’ request for permission to pursue an appeal. On September 9, 2008, the defendants filed an emergency application for writ of mandamus or supervisory writ with request for stay and expedited consideration. The same day, the Louisiana Court of Appeals stayed all proceedings pending further order of the court.
 
               
February 2, 2005
  Smith v. Brown &
Williamson Tobacco Corp.

[Individual]
  Circuit Court,
Jackson County
(Independence, MO)
  $2 million in compensatory damages which was reduced to $500,000 because of jury’s findings that the plaintiff was 75% at fault; $20 million in punitive damages.   On June 1, 2005, B&W filed its notice of appeal. On July 31, 2007, the Missouri Court of Appeals affirmed the compensatory damages award but ordered a new trial on punitive damages. The Missouri Supreme Court accepted transfer of the case from the court of appeals, but on July 31, 2008, retransferred the case to the Missouri Court of Appeals.
 
               
March 18, 2005
  Rose v. Brown & Williamson Tobacco Corp. [Individual]   Supreme Court,
New York County
(Manhattan, NY)
  RJR Tobacco found not liable; $3.42 million in compensatory damages against B&W and Philip Morris, of which $1.71 million was assigned to B&W; $17 million in punitive damages against Philip Morris only.   On August 18, 2005, B&W filed its notice of appeal. Pursuant to its agreement to indemnify B&W, RJR Tobacco posted a supersedeas bond in the amount of $2.058 million on February 7, 2006. On April 10, 2008, the New York Supreme Court, Appellate Division reversed the judgment in the plaintiffs’ favor and ordered that the case be dismissed. On May 8, 2008, the plaintiffs filed a notice of appeal. Oral argument is scheduled for November 18, 2008.

28


Table of Contents

Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
                 
Date of Verdict   Case Name/Type   Jurisdiction   Verdict   Post-Trial Status
 
August 17, 2006
  United States v.
Philip Morris USA, Inc.

[Governmental
Health-Care Cost
Recovery]
  U.S. District Court, District of Columbia (Washington, DC)   RJR Tobacco and B&W were found liable for civil RICO claims; were enjoined from using certain brand descriptors and from making certain misrepresentations; and were ordered to make corrective communications on five subjects, including smoking and health and addiction, to reimburse the U.S. Department of Justice appropriate costs associated with the lawsuit, and to maintain document web sites.   On September 11, 2006, RJR Tobacco and B&W filed their notices of appeal. On October 16, 2006, the government filed its notice of appeal. The court of appeals granted the defendants’ motion to stay the district court’s order on October 31, 2006. Oral argument occurred on October 14, 2008. A decision is pending.
 
               
May 2, 2007
  Whiteley v. R.J.
Reynolds Tobacco Co.

[Individual]
  Superior Court,
San Francisco County,
(San Francisco, CA)
  $2.46 million in compensatory damages jointly against RJR Tobacco and Philip Morris; $250,000 punitive damages against RJR Tobacco only.   On September 5, 2007, the court denied RJR Tobacco’s motion for judgment notwithstanding the verdict or, in the alternative, for a new trial. RJR Tobacco filed its notice of appeal on October 3, 2007. Briefing is underway. On May 5, 2008, the court issued an order approving deposit in lieu of appellate bond. RJR Tobacco purchased and deposited with the court approximately $2.6 million in U.S. Treasury bills in lieu of a supersedeas bond to stay enforcement of the judgment pending appeal.
Individual Smoking and Health Cases
          As of October 10, 2008, 825 individual cases, including 687 individual smoker cases in West Virginia state court in a consolidated action, were pending in the United States against RJR Tobacco, B&W, as its indemnitee, or both. This category of cases includes smoking and health cases alleging personal injury brought by or on behalf of individual plaintiffs, but does not include the Broin II or Engle Progeny Cases discussed below. A total of 822 of the individual cases are brought by or on behalf of individual smokers or their survivors, while the remaining three cases are brought by or on behalf of individuals or their survivors alleging personal injury as a result of exposure to ETS.
          Below is a description of the individual smoking and health cases against RJR Tobacco or B&W, or both, which went to trial or were decided during the period from January 1, 2008, to September 30, 2008, or remained on appeal as of September 30, 2008.
          In Whiteley v. R. J. Reynolds Tobacco Co., the retrial of Whiteley v. Raybestos-Manhattan, a case filed in April 1999 in Superior Court, San Francisco County, California and originally tried in 2000, the jury awarded the plaintiff $2.46 million in compensatory damages jointly against RJR Tobacco and Philip Morris on May 2, 2007, and returned a punitive damages verdict award of $250,000 against RJR Tobacco on May 9, 2007. RJR Tobacco’s motion for judgment notwithstanding the verdict or, in the alternative, for a new trial was denied on September 5, 2007. RJR Tobacco filed its notice of appeal to the Court of Appeal for the State of California, First Appellate District, on October 3, 2007. Briefing is underway. On May 5, 2008, the court issued an order approving deposit in lieu of appellate bond. RJR Tobacco purchased and deposited with the court approximately $2.6 million in U.S. Treasury bills in lieu of a supersedeas bond to stay enforcement of the judgment pending appeal.

29


Table of Contents

Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
     On August 15, 2003, a jury returned a verdict in favor of B&W in Eiser v. Brown & Williamson Tobacco Corp., a case filed in March 1999 in the Court of Common Pleas, Philadelphia County, Pennsylvania. The plaintiff, Lois Eiser, sought compensatory and punitive damages in an amount in excess of $50,000, together with interest, costs and attorneys’ fees in this wrongful death action against B&W. On January 19, 2006, the Superior Court of Pennsylvania affirmed the verdict. On September 22, 2006, the Pennsylvania Supreme Court granted the plaintiff’s petition to appeal, and on December 28, 2007, remanded the case to the Eastern District of the Superior Court for further review. Briefing is underway.
     On December 18, 2003, in Frankson v. Brown & Williamson Tobacco Corp., a case filed in August 2000 in Supreme Court, Kings County, New York, a jury awarded $350,000 in compensatory damages against B&W and two former tobacco industry organizations, the Tobacco Institute and the Council for Tobacco Research, in an action brought against the major U.S. cigarette manufacturers, including RJR Tobacco, who was dismissed prior to trial, and B&W, seeking $270 million in compensatory damages, unspecified punitive damages, attorneys’ fees, costs and disbursements. Other manufacturers were dismissed before trial. The plaintiff, Gladys Frankson, alleged that Mr. Frankson became addicted to nicotine, was unable to cease smoking, developed lung cancer and died as a result. The defendants as a group and the deceased smoker were each found to be 50% at fault. On January 8, 2004, the jury awarded $20 million in punitive damages, assigning $6 million to B&W, $2 million to American Tobacco, a predecessor company to B&W, and $6 million to each of the Council for Tobacco Research and the Tobacco Institute. On June 22, 2004, the trial judge granted a new trial unless the parties consented to an increase in compensatory damages to $500,000 and a decrease in punitive damages to $5 million, of which $4 million would be assigned to B&W. On January 21, 2005, the plaintiff stipulated to the reduction in punitive damages.
     After all post-trial motions, and appeals there from, were denied, judgment was entered in favor of the plaintiffs for $175,000 in compensatory damages, the original jury award reduced by 50%, and $5 million in punitive damages, the amount to which the plaintiff stipulated. On June 26, 2007, final judgment was entered against the defendants in the amount of approximately $6.8 million, including interest and costs. The defendants filed a notice of appeal to the Appellate Division, New York Supreme Court, Second Department on July 3, 2007. Briefing is complete. Oral argument has not been scheduled. Pursuant to its agreement to indemnify B&W, RJR Tobacco posted a supersedeas bond in the amount of $8.018 million on July 5, 2007.
     On February 1, 2005, a jury returned a split verdict in Smith v. Brown & Williamson Tobacco Corp., a case filed in May 2003 in Circuit Court, Jackson County, Missouri, finding in favor of B&W on two counts, fraudulent concealment and conspiracy, and finding in favor of the plaintiff on negligence, which incorporates failure to warn and product defect claims. The plaintiff, Lincoln Smith, claimed that the defendant’s tobacco products caused Mrs. Smith’s death from lung cancer and sought an unspecified amount of compensatory and punitive damages. The plaintiff was awarded $2 million in compensatory damages and $20 million in punitive damages; however, the jury found the plaintiff to be 75% at fault, and B&W 25% at fault, and thus the compensatory award was reduced to $500,000. B&W appealed to the Missouri Court of Appeals, and on July 31, 2007, the court affirmed the compensatory damages and ordered a new trial on punitive damages. The Missouri Supreme Court agreed to accept transfer of the case from the court of appeals, and on July 31, 2008, retransferred the case to the Missouri Court of Appeals.
     On March 18, 2005, in Rose v. Brown & Williamson Tobacco Corp., a case filed in December 1996 in New York Supreme Court, County of New York, a jury returned a verdict in favor of RJR Tobacco, but returned a $3.42 million compensatory damages verdict against B&W and Philip Morris, of which $1.71 million was assigned to B&W. A punitive damages verdict of $17 million against Philip Morris only was returned by the jury on March 28, 2005. The action was brought against the major U.S. cigarette manufacturers, including RJR Tobacco and B&W, seeking to recover $15 million in compensatory damages and $35 million in punitive damages. The plaintiffs, Norma Rose and Leonard Rose, allege that their use of the defendants’ products caused them to become addicted to nicotine and develop lung cancer, chronic obstructive pulmonary disease and other smoking related conditions and/or diseases. Oral argument on B&W’s appeal in the Appellate Division, New York Supreme Court, First Department occurred on December 12, 2006. Pursuant to its agreement to indemnify B&W, RJR Tobacco posted a supersedeas bond in the amount of $2.058 million on February 7, 2006. On April 10, 2008, the Appellate Division reversed the judgment in the plaintiffs’ favor and ordered that the case be dismissed. On May 8, 2008, the plaintiffs filed a notice of appeal. Oral argument is scheduled for November 18, 2008.
Engle Progeny Cases

30


Table of Contents

Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
     Pursuant to the Florida Supreme Court’s July 6, 2006, ruling in Engle v. R. J. Reynolds Tobacco Co., which decertified the class, former class members had one year from January 11, 2007, in which to file individual lawsuits. In addition, some individuals who filed suit prior to January 11, 2007, and who claim they meet the conditions in Engle, also are attempting to avail themselves of the Engle ruling. Lawsuits by individuals requesting the benefit of the Engle ruling, whether filed before or after the January 11, 2007, mandate, are referred to as the Engle Progeny Cases. As of October 10, 2008, RJR Tobacco had been served in 2,310 Engle Progeny Cases in both state and federal courts in Florida. These cases include approximately 8,825 plaintiffs. The number of cases likely will change due to individual plaintiffs being severed from multi-plaintiff cases. For further information on the Engle case, see “— Class-Action Suits — Engle Case,” below.
Broin II Cases
     As of October 10, 2008, there were 2,620 lawsuits pending in Florida brought by individual flight attendants for personal injury as a result of illness allegedly caused by exposure to ETS in airplane cabins, referred to as the Broin II cases. In these lawsuits, filed pursuant to the terms of the settlement of the Broin v. Philip Morris, Inc. class action, discussed below under “— Class-Action Suits,” each individual flight attendant will be required to prove that he or she has a disease and that the individual’s exposure to ETS in airplane cabins caused the disease. Punitive damages are not available in these cases.
     On October 5, 2000, the Broin court entered an order applicable to all Broin II cases that the terms of the Broin settlement agreement do not require the individual Broin II plaintiffs to prove the elements of strict liability, breach of warranty or negligence. Under this order, there is a rebuttable presumption in the plaintiffs’ favor on those elements, and the plaintiffs bear the burden of proving that their alleged adverse health effects actually were caused by exposure to ETS in airplane cabins, that is, specific causation. Below is a description of the only Broin II case against RJR Tobacco and B&W that went to trial or was decided during the period from July 1, 2008 to September 30, 2008, or remained on appeal as of September 30, 2008.
     In Janoff v. Philip Morris, Inc., a case filed in February 2000 in Circuit Court, Miami-Dade County, Florida, a jury found in favor of the defendants, including RJR Tobacco and B&W, on September 5, 2002, in an action brought against the major U.S. cigarette manufacturers seeking to recover compensatory damages pursuant to the Broin settlement. The plaintiff, Suzette Janoff, alleged that as a result of exposure to ETS in airline cabins, she suffered from, among other illnesses, chronic sinusitis, chronic bronchitis and other respiratory and pulmonary problems. The judge granted the plaintiff’s motion for a new trial on January 8, 2003. The new trial date has not been scheduled.
Class-Action Suits
     Overview.  As of October 10, 2008, 15 class-action cases, exclusive of antitrust class actions, were pending in the United States against RJR Tobacco or its affiliates or indemnitees. In May 1996, in Castano v. American Tobacco Co., the Fifth Circuit Court of Appeals overturned the certification of a nation-wide class of persons whose claims related to alleged addiction to tobacco products. Since this ruling by the Fifth Circuit, most class-action suits have sought certification of state-wide, rather than nation-wide, classes. Class-action suits based on claims similar to those asserted in Castano or claims that class members are at a greater risk of injury or injured by the use of tobacco or exposure to ETS are pending against RJR Tobacco and its affiliates and indemnitees in state or federal courts in California, Florida, Illinois, Louisiana, Minnesota, Missouri, New York and West Virginia. All pending class-action cases are discussed below.
     The pending class-actions against RJR Tobacco or its affiliates or indemnitees include seven cases alleging that the use of the term “lights” constitutes unfair and deceptive trade practices under state law or violates the federal RICO statute. Such suits are pending in state or federal courts in Illinois, Minnesota, Missouri and New York.
     Finally, certain third-party payers have filed health-care cost recovery actions in the form of class-actions.
     Few smoker class-action complaints have been certified or, if certified, have survived on appeal. Eighteen federal courts, including two courts of appeals, and most state courts that have considered the issue have rejected class certification in such cases. Apart from the Castano case discussed above, only two smoker class actions have been certified by a federal court: In re Simon (II) Litigation and Schwab [McLaughlin] v. Philip Morris USA, Inc., discussed below under “— ‘Lights’ Cases,” both of which were filed in the U.S. District Court for the Eastern District of New York and ultimately decertified.

31


Table of Contents

Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
     Medical Monitoring and Smoking Cessation Cases.  On November 5, 1998, in Scott v. American Tobacco Co., a case filed in May 1996 in District Court, Orleans Parish, Louisiana, the trial court certified a medical monitoring or smoking cessation class of Louisiana residents who were smokers on or before May 24, 1996, in an action brought against the major U.S. cigarette manufacturers, including RJR Tobacco and B&W, seeking to recover an unspecified amount of compensatory and punitive damages. The plaintiffs allege that their use of the defendants’ products caused them to become addicted to nicotine. On July 28, 2003, the jury returned a verdict in favor of the defendants on the plaintiffs’ claim for medical monitoring and found that cigarettes were not defectively designed. However, the jury also made certain findings against the defendants on claims relating to fraud, conspiracy, marketing to minors and smoking cessation. Notwithstanding these findings, this portion of the trial did not determine liability as to any class member or class representative. What primarily remained in the case was a class-wide claim that the defendants pay for a program to help people stop smoking.
     On March 31, 2004, phase two of the trial began to address only the scope and cost of smoking cessation programs. On May 21, 2004, the jury returned a verdict in the amount of $591 million on the class’s claim for a smoking cessation program. On September 29, 2004, the defendants posted a $50 million bond, pursuant to legislation that limits the amount of the bond to $50 million collectively for MSA signatories, and noticed their appeal. RJR Tobacco posted $25 million, that is, the portions for RJR Tobacco and B&W, towards the bond. On February 7, 2007, the Louisiana Court of Appeals upheld the class certification and found the defendants responsible for funding smoking cessation for eligible class members. The appellate court also ruled, however, that the defendants were not liable for any post-1988 claims, rejected the award of prejudgment interest and struck eight of the 12 components of the smoking cessation program. In particular, the appellate court ruled that no class member, who began smoking after September 1, 1988, could receive any relief, and that only those smokers, whose claims accrued on or before September 1, 1988, would be eligible for the smoking cessation program. Plaintiffs have expressly represented to the trial court that none of their claims accrued before 1988 and that the class claims did not accrue until around 1996, when the case was filed. On March 2, 2007, the defendants’ application for rehearing and clarification was denied. The defendants’ application for writ of certiorari with the Louisiana Supreme Court was denied on January 7, 2008. The defendants’ petition for writ of certiorari with the U.S. Supreme Court was denied on June 10, 2008. On July 21, 2008, the trial court entered an amended judgment in the case. The court found that the defendants are jointly and severally liable for funding the cost of a court-supervised smoking cessation program and ordered the defendants to deposit approximately $263 million, together with interest from June 30, 2004, into a trust for the funding of the program. The court also stated that it would favorably consider a motion to return to defendants a portion of unused funds at the close of each program year in the event the monies allocated for the preceding program year were not fully expended because of a reduction in class size or underutilization by the remaining plaintiffs.
     On August 27, 2008, the court denied the defendants’ request for permission to pursue an appeal. On September 9, 2008, the defendants filed an emergency application for writ of mandamus or supervisory writ with request for stay and expedited consideration. The same day, the Louisiana Court of Appeals stayed all proceedings pending further orders of the court.
     Engle Case.  Trial began in July 1998 in Engle v. R. J. Reynolds Tobacco Co., a case filed in May 1994, and pending in Circuit Court, Miami-Dade County, Florida, in which a class consisting of Florida residents, or their survivors, alleges diseases or medical conditions caused by their alleged “addiction” to cigarettes. The action was brought against the major U.S. cigarette manufacturers, including RJR Tobacco and B&W, seeking actual damages and punitive damages in excess of $100 billion each and the creation of a medical fund to compensate individuals for future health-care costs. On July 7, 1999, the jury found against RJR Tobacco, B&W and the other cigarette-manufacturer defendants in the initial phase, which included common issues related to certain elements of liability, general causation and a potential award of, or entitlement to, punitive damages.
     The second phase of the trial, which consisted of the claims of three of the named class representatives, began on November 1, 1999. On April 7, 2000, the jury returned a verdict against all the defendants. It awarded plaintiff Mary Farnan $2.85 million, the estate of plaintiff Angie Della Vecchia $4.023 million and plaintiff Frank Amodeo $5.831 million.
     The trial court also ordered the jury in the second phase of the trial to determine punitive damages, if any, on a class-wide basis. On July 14, 2000, the jury returned a punitive damages verdict in favor of the “Florida class” of approximately $145 billion against all the defendants, with approximately $36.3 billion and $17.6 billion being assigned to RJR Tobacco and B&W, respectively.

32


Table of Contents

Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
     On November 6, 2000, the trial judge denied all post-trial motions and entered judgment. In November 2000, RJR Tobacco and B&W posted appeal bonds in the amount of $100 million each and initiated the appeals process. On May 21, 2003, Florida’s Third District Court of Appeal reversed the trial court’s final judgment and remanded the case to the Miami-Dade County Circuit Court with instructions to decertify the class. The class appealed, and the Florida Supreme Court accepted the case on May 12, 2004.
     On July 6, 2006, the court affirmed the dismissal of the punitive damages award and decertified the class, on a going-forward basis. The court preserved a number of class-wide findings from Phase I of the trial, including that cigarettes can cause certain diseases, that nicotine is addictive and that defendants placed defective and unreasonably dangerous cigarettes on the market, and authorized former class members to avail themselves of those findings under certain conditions in individual lawsuits, provided they commence those lawsuits within one year of the date the court’s decision became final. The court specified that the class is confined to those Florida citizen residents who suffered or died from smoking-related illnesses that “manifested” themselves on or before November 21, 1996, and that were caused by an addiction to cigarettes. In addition, the court reinstated the compensatory damages awards of $2.85 million to Mary Farnan and $4.023 million to Angie Della Vecchia, but ruled that the claims of Frank Amodeo were barred by the statute of limitations. Finally, the court reversed the Third District Court of Appeal’s 2003 ruling that class counsel’s improper statements during trial required reversal.
     On August 7, 2006, RJR Tobacco and the other defendants filed a rehearing motion arguing, among other things, that the findings from the Engle trial are not sufficiently specific to serve as the basis for further proceedings and that the Florida Supreme Court’s decision denied defendants due process. On the same day, the plaintiffs also filed a rehearing motion arguing that some smokers who became sick after November 21, 1996, and who are therefore not class members, should nevertheless have the statute of limitations tolled since they may have refrained from filing suit earlier in the mistaken belief that they were Engle class members. On December 21, 2006, the Florida Supreme Court withdrew its July 6, 2006, decision and issued a revised opinion, in which it set aside the jury’s findings of a conspiracy to misrepresent and clarified that the Engle jury’s finding on express warranty were preserved for use by eligible plaintiffs. The court also denied the plaintiffs’ motion and confirmed that the class was limited to those individuals who developed alleged smoking-related illnesses that manifested themselves on or before November 21, 1996. The court issued its mandate on January 11, 2007, which began the one-year period for former class members to file individual lawsuits. As of October 10, 2008, 2,310 individual cases were filed in Florida as a result of the Engle decision. These cases include approximately 8,825 plaintiffs. For further information on the individual cases, see “— Engle Progeny Cases” above.
     On April 17, 2007, RJR Tobacco’s motions for discharge of RJR Tobacco’s and B&W’s civil supersedeas bonds related to the punitive damages award were granted. During the second quarter of 2007, RJR Tobacco received the full amount of the $100 million cash collateral that it had posted. On October 1, 2007, the defendants’ petition for writ of certiorari with the U.S. Supreme Court was denied. On November 26, 2007, the defendants’ petition for rehearing with the U.S. Supreme Court was denied. As a result, the verdicts in favor of Mary Farnan and Angie Della Vecchia, mentioned above, became final. On February 8, 2008, RJR Tobacco paid approximately $5.9 million relating to the compensatory damages verdicts mentioned above, which amount was determined using the total amount of the verdicts together with accrued interest beginning November 7, 2000. A final computation of interest due on those judgments will be determined by the trial court in 2008. On May 14, 2008, the court entered an order granting the motion for discharge and return of compensatory damages supersedeas bond. During the second quarter of 2008, RJR Tobacco received the cash collateral of $3.8 million that it posted for the compensatory damages bond. Also on May 14, 2008, plaintiffs Mary Farnan and Ralph Della Vecchia, as representative of the estate of Angie Della Vecchia, filed satisfactions of judgment and waived all claims for punitive damages and acknowledged full payment in satisfaction of the November 7, 2000, amended final judgment. The same day, the court granted the parties’ joint motion to sever moving plaintiffs’ claims. Plaintiffs Raymond Lacey, Michael Matyi and Loren Lowery have filed new cases. Plaintiff Howard Engle filed a stipulation for dismissal with prejudice, which the court ordered on July 2, 2008. On July 2, 2008, plaintiff Marilyn Calhoun filed a motion for relief from judgment.
     Prior to the Florida Supreme Court ruling on July 6, 2006, RJR Tobacco and/or B&W were named as a defendant(s) in several individual cases filed by members of the Engle class. One such case, Lukacs v. Philip Morris, Inc., a case filed in February 2001, and pending in Circuit Court, Miami-Dade County, Florida, was tried against Philip Morris, Liggett and B&W, and resulted in a verdict for the plaintiffs on June 11, 2002, in a personal injury action brought against the major U.S. cigarette manufacturers, including RJR Tobacco and B&W, seeking to recover an unspecified amount in compensatory and punitive damages. The plaintiff, John Lukacs, alleged that his use of the defendants’ brands caused his development of bladder, throat, oral cavity and tongue cancer. RJR Tobacco was voluntarily dismissed on May 1, 2002. The Florida state court jury awarded the plaintiffs a total of $37.5 million in compensatory damages. The jury assigned 22.5% fault to B&W, 72.5% fault to the other defendants and 5% fault to

33


Table of Contents

Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
plaintiff John Lukacs. On April 1, 2003, the Miami-Dade County Circuit Court granted in part the defendants’ motion for remittitur and reduced the jury’s award to plaintiff Yolanda Lukacs, on the loss of consortium claim, from $12.5 million to $0.125 million decreasing the total award to $25.125 million. On August 2, 2006, the plaintiffs filed a motion for entry of partial judgment and notice of jury trial on punitive damages. On January 2, 2007, the defendants asked the court to set aside the jury’s June 11, 2002, verdict for the plaintiffs and to dismiss the plaintiffs’ punitive damages claim. On January 3, 2007, the plaintiffs filed a motion for entry of judgment, which the court deferred until the U.S. Supreme Court has completed its review of Engle and after further submissions by the parties. On January 28, 2008, the defendants filed a submission asking the court to set aside the verdict and to dismiss the case. The court granted the plaintiffs’ motion for entry of judgment on August 14, 2008. Pursuant to the verdict rendered, the plaintiff, Robin Lukacs, as personal representative of the estate of John and Yolanda Lukacs, will recover the sum of $24,835,000 and interest applicable at the yearly statutory rates from June 11, 2002. On August 25, 2008, the defendants filed a motion for reconsideration of, or in the alternative, to alter or amend the order on the plaintiffs’ motion for entry of judgment. A hearing on the motion occurred on October 21, 2008. A decision is pending. On October 17, 2008, the plaintiff withdrew her request for punitive damages.
     California Business and Professions Code Cases.   On April 11, 2001, in Brown v. American Tobacco Co., Inc., a case filed in June 1997 in Superior Court, San Diego County, California, the court granted in part the plaintiffs’ motion for certification of a class composed of residents of California who smoked at least one of the defendants’ cigarettes from June 10, 1993 through April 23, 2001, and who were exposed to the defendants’ marketing and advertising activities in California. The action was brought against the major U.S. cigarette manufacturers, including RJR Tobacco and B&W, seeking to recover restitution, disgorgement of profits and other equitable relief under California Business and Professions Code § 17200 et seq. and § 17500 et seq. Certification was granted as to the plaintiffs’ claims that the defendants violated § 17200 of the California Business and Professions Code pertaining to unfair competition. The court, however, refused to certify the class under the California Legal Remedies Act and on the plaintiffs’ common law claims. On March 7, 2005, the court granted the defendants’ motion to decertify the class. On September 5, 2006, the California Court of Appeal affirmed the judge’s order decertifying the class. On November 1, 2006, the plaintiffs’ petition for review with the California Supreme Court was granted. Supplemental briefing is complete. A decision is pending.
     “Lights” Cases.  As noted above, “lights” class-action cases are pending against RJR Tobacco or B&W in Illinois (2), Missouri (2), Minnesota (2) and New York (1). The classes in these cases generally seek to recover $50,000 to $75,000 per class member for compensatory and punitive damages, injunctive and other forms of relief, and attorneys’ fees and costs from RJR Tobacco and/or B&W. In general, the plaintiffs allege that RJR Tobacco or B&W made false and misleading claims that “lights” cigarettes were lower in tar and nicotine and/or were less hazardous or less mutagenic than other cigarettes. The cases typically are filed pursuant to state consumer protection and related statutes.
     The seminal “lights” class-action case involved RJR Tobacco’s competitor, Philip Morris, Inc. Trial began in Price v. Philip Morris, Inc. in January 2003. In March 2003, the trial judge entered judgment against Philip Morris in the amount of $7.1 billion in compensatory damages and $3 billion in punitive damages to the State of Illinois. Based on Illinois law, the bond required to stay execution of the judgment was set initially at $12 billion. Philip Morris pursued various avenues of relief from the $12 billion bond requirement. In December 2005, the Illinois Supreme Court reversed the lower court’s decision and sent the case back to the trial court with instructions to dismiss the case. In December 2006, the defendants’ motion to dismiss and for entry of final judgment was granted, and the case was dismissed with prejudice the same day. The plaintiffs’ motion to vacate and/or withhold judgment was dismissed by the court on August 30, 2007.
     In Turner v. R. J. Reynolds Tobacco Co., a case filed in February 2000 in Circuit Court, Madison County, Illinois, a judge certified a class on November 14, 2001. On June 6, 2003, RJR Tobacco filed a motion to stay the case pending Philip Morris’s appeal of the Price v. Philip Morris Inc. case mentioned above, which the judge denied on July 11, 2003. On October 17, 2003, the Illinois Fifth District Court of Appeals denied RJR Tobacco’s emergency stay/supremacy order request. On November 5, 2003, the Illinois Supreme Court granted RJR Tobacco’s motion for a stay pending the court’s final appeal decision in Price. On October 11, 2007, the Illinois Fifth District Court of Appeals dismissed RJR Tobacco’s appeal and remanded the case to the circuit court. There is currently no activity in the case.
     In Howard v. Brown & Williamson Tobacco Corp., another case filed in February 2000 in Circuit Court, Madison County, Illinois, a judge certified a class on December 18, 2001. On June 6, 2003, the trial judge issued an order staying all proceedings pending resolution of the Price v. Philip Morris, Inc. case mentioned above. The plaintiffs

34


Table of Contents

Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
appealed this stay order to the Illinois Fifth District Court of Appeals, which affirmed the Circuit Court’s stay order on August 19, 2005. There is currently no activity in the case.
     In the event RJR Tobacco and its affiliates or indemnitees lose the Turner or Howard cases, or one or more of the other pending “lights” class-action suits, RJR Tobacco could face bonding difficulties depending upon the amount of damages ordered, if any, which could have a material adverse effect on RJR Tobacco’s, and consequently RAI’s, results of operations, cash flows or financial position.
     Schwab [McLaughlin] v. Philip Morris USA, Inc., a nation-wide “lights” class-action, was filed on May 11, 2004, in the U.S. District Court for the Eastern District of New York, against RJR Tobacco and B&W, as well as other tobacco manufacturers. The plaintiffs brought the case pursuant to RICO, challenging the practices of the defendants in connection with the manufacturing, marketing, advertising, promotion, distribution and sale of cigarettes that were labeled as “lights” or “light.” On September 25, 2006, the court issued its decision, among other things, granting class certification. On November 16, 2006, the U.S. Court of Appeals for the Second Circuit granted the defendants’ motions to stay the district court proceedings and for review of the class certification ruling. On April 3, 2008, the Second Circuit decertified the class. The case was returned to the trial court for further proceedings.
     A “lights” class-action case is pending against each of RJR Tobacco and B&W in Missouri. In Collora v. R. J. Reynolds Tobacco Co., a case filed in May 2000 in Circuit Court, St. Louis County, Missouri, a judge in St. Louis certified a class on December 31, 2003. On April 9, 2007, the court granted the plaintiffs’ motion to reassign Collora and the following cases to a single general division: Craft v. Philip Morris Companies, Inc. and Black v. Brown & Williamson Tobacco Corp., discussed below. On April 16, 2008, the court stayed the case pending U.S. Supreme Court review in Good v. Altria Group, Inc., a “lights” class action pending against Altria and Philip Morris USA.
     In Black v. Brown & Williamson Tobacco Corp., a case filed in November 2000 in Circuit Court, City of St. Louis, Missouri, B&W removed the case to the U.S. District Court for the Eastern District of Missouri on September 23, 2005. On October 25, 2005, the plaintiffs filed a motion to remand, which was granted on March 17, 2006. On April 16, 2008, the court stayed the case pending U.S. Supreme Court review in Good v. Altria Group, Inc.
     In Dahl v. R. J. Reynolds Tobacco Co., a case filed in April 2003, and pending in District Court, Hennepin County, Minnesota, a judge dismissed the case on May 11, 2005, ruling the “lights” claims are preempted by the Federal Cigarette Labeling and Advertising Act. On July 11, 2005, the plaintiffs filed a notice of appeal with the Minnesota Court of Appeals for the Fourth Judicial District. During the pendency of the appeal, RJR Tobacco removed the case to the U.S. District Court for the District of Minnesota. On February 28, 2007, the Eighth Circuit remanded the case to the Minnesota Court of Appeals, which on December 4, 2007, reversed the judgment in favor of the defendants on preemption grounds and remanded the case to the District Court of Hennepin County. On February 27, 2008, RJR Tobacco’s motion to stay its January 3, 2008 petition for review until the completion of the U.S. Supreme Court review in Good v. Altria Group, Inc. was granted.
     In Thompson v. R. J. Reynolds Tobacco Co., a case filed in February 2005 in District Court, Hennepin County, Minnesota, RJR Tobacco removed the case on September 23, 2005 to the U.S. District Court for the District of Minnesota. On August 7, 2006, the parties filed a stipulation to stay the case pending resolution of the appeal in Dahl v. R. J. Reynolds Tobacco Co. On October 29, 2007, the U.S. District Court remanded the case to the District Court for Hennepin County. On February 1, 2008, the court stayed the case until the completion of the appeal in Dahl v. R. J. Reynolds Tobacco Co. and Good v. Altria Group, Inc.
     Finally, Rios v. R. J. Reynolds Tobacco Co., a case filed in February 2002 in Circuit Court, Palm Beach County, Florida, is dormant pending plaintiffs’ counsel’s attempt to appeal the Florida Fourth District Court of Appeal’s decertification in Hines v. Philip Morris, Inc., a “lights” class-action case filed in February 2001 in Circuit Court, Palm Beach County, Florida against Phillip Morris only. On January 14, 2008, the Florida Supreme Court refused to hear plaintiff’s appeal in Hines v. Philip Morris, Inc. The plaintiffs in Rios brought the action against RJR Tobacco and RJR. On February 19, 2008, the court dismissed the case.
     Other Class Actions.  In Cleary v. Philip Morris, Inc., a case filed in June 1998, and pending in Circuit Court, Cook County, Illinois, the plaintiffs filed their motion for class certification on December 21, 2001, in an action brought against the major U.S. cigarette manufacturers, including RJR Tobacco and B&W. The case is brought on behalf of persons who have allegedly been injured by (1) the defendants’ purported conspiracy pursuant to which defendants

35


Table of Contents

Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
concealed material facts regarding the addictive nature of nicotine, (2) the defendants’ alleged acts of targeting its advertising and marketing to minors, and (3) the defendants’ claimed breach of the public right to defendants’ compliance with the laws prohibiting the distribution of cigarettes to minors. The plaintiffs request that the defendants be required to disgorge all profits unjustly received through its sale of cigarettes to plaintiffs and the class, which in no event will be greater than $75,000 per each class member, inclusive of punitive damages, interest and costs. On March 27, 2006, the court dismissed count V, public nuisance, and count VI, unjust enrichment. On July 11, 2006, the plaintiffs filed a renewed motion for class certification.
     Young v. American Tobacco Co., Inc., a case filed in November 1997 in Circuit Court, Orleans Parish, Louisiana, is an ETS class action against U.S. cigarette manufacturers, including RJR Tobacco and B&W, and parent companies of U.S. cigarette manufacturers, including RJR, on behalf of all residents of Louisiana who, though not themselves cigarette smokers, have been exposed to secondhand smoke from cigarettes which were manufactured by the defendants, and who allegedly suffered injury as a result of that exposure. The plaintiffs seek to recover an unspecified amount of compensatory and punitive damages. On October 13, 2004, the trial court stayed this case pending the outcome of the appeal in Scott v. American Tobacco Co., Inc., discussed above under “— Medical Monitoring and Smoking Cessation Cases.”
     In Parsons v. A C & S, Inc., a case filed in February 1998 in Circuit Court, Ohio County, West Virginia, the plaintiff sued asbestos manufacturers, U.S. cigarette manufacturers, including RJR Tobacco and B&W, and parent companies of U.S. cigarette manufacturers, including RJR, seeking to recover $1 million in compensatory and punitive damages individually and an unspecified amount for the class in both compensatory and punitive damages. The class is brought on behalf of persons who allegedly have personal injury claims arising from their exposure to respirable asbestos fibers and cigarette smoke. The plaintiffs allege that Mrs. Parsons’ use of tobacco products and exposure to asbestos products caused her to develop lung cancer and to become addicted to tobacco. The case has been stayed pending a final resolution of the plaintiffs’ motion to refer tobacco litigation to the judicial panel on multi-district litigation filed in In Re: Tobacco Litigation in the Supreme Court of Appeals of West Virginia. On December 26, 2000, three defendants, Nitral Liquidators, Inc., Desseaux Corporation of North American and Armstrong World Industries, filed bankruptcy petitions in the U.S. Bankruptcy Court for the District of Delaware, In re Armstrong World Industries, Inc. Pursuant to section 362(a) of the Bankruptcy Code, Parsons is automatically stayed with respect to all defendants.
     Finally, in Jones v. American Tobacco Co., Inc., a case filed in December 1998 in Circuit Court, Jackson County, Missouri, the defendants removed the case to the U.S. District Court for the Western District of Missouri on February 16, 1999. The action was brought against the major U.S. cigarette manufacturers, including RJR Tobacco and B&W, and parent companies of U.S. cigarette manufacturers, including RJR, on behalf of tobacco product users and purchasers on behalf of all similarly situated Missouri consumers. The plaintiffs allege that their use of the defendants’ tobacco products has caused them to become addicted to nicotine. The plaintiffs seek to recover an unspecified amount of compensatory and punitive damages. The case was remanded to the Circuit Court on February 17, 1999. There has been limited activity in this case.
     Broin Settlement.  RJR Tobacco, B&W and other cigarette manufacturer defendants settled Broin v. Philip Morris, Inc. in October 1997. This case had been brought in Florida state court on behalf of flight attendants alleged to have suffered from diseases or ailments caused by exposure to ETS in airplane cabins. The settlement agreement required the participating tobacco companies to pay a total of $300 million in three annual $100 million installments, allocated among the companies by market share, to fund research on the early detection and cure of diseases associated with tobacco smoke. It also required those companies to pay a total of $49 million for the plaintiffs’ counsel’s fees and expenses. RJR Tobacco’s portion of these payments was approximately $86 million; B&W’s portion of these payments was approximately $57 million. The settlement agreement bars class members from bringing aggregate claims or obtaining punitive damages and also bars individual claims to the extent that they are based on fraud, misrepresentation, conspiracy to commit fraud or misrepresentation, RICO, suppression, concealment or any other alleged intentional or willful conduct. The defendants agreed that, in any individual case brought by a class member, the defendant will bear the burden of proof with respect to whether ETS can cause certain specifically enumerated diseases, referred to as “general causation.” With respect to all other issues relating to liability, including whether an individual plaintiff’s disease was caused by his or her exposure to ETS in airplane cabins, referred to as “specific causation,” the individual plaintiff will have the burden of proof. On September 7, 1999, the Florida Supreme Court approved the settlement. The Broin II cases, discussed above, arose out of the settlement of this case.
Health-Care Cost Recovery Cases

36


Table of Contents

Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
     Health-care cost recovery cases have been brought by a variety of plaintiffs. Other than certain governmental actions, these cases largely have been unsuccessful on remoteness grounds, which means that one who pays an injured person’s medical expenses is legally too remote to maintain an action against the person allegedly responsible for the injury.
     As of October 10, 2008, four health-care cost recovery cases were pending in the United States against RJR Tobacco, B&W, as its indemnitee, or both, as discussed below after the Master Settlement Agreement discussion.
     MSA. In June 1994, the Mississippi attorney general brought an action, Moore v. American Tobacco Co., against various industry members, including RJR Tobacco and B&W. This case was brought on behalf of the state to recover state funds paid for health care and other assistance to state citizens suffering from diseases and conditions allegedly related to tobacco use. Most other states, through their attorneys general or other state agencies, sued RJR Tobacco, B&W and other U.S. cigarette manufacturers based on similar theories. The cigarette manufacturer defendants, including RJR Tobacco and B&W, settled the first four of these cases scheduled for trial — Mississippi, Florida, Texas and Minnesota — by separate agreements with each such state.
     On November 23, 1998, the major U.S. cigarette manufacturers, including RJR Tobacco and B&W, entered into the Master Settlement Agreement with attorneys general representing the remaining 46 states, the District of Columbia, Puerto Rico, Guam, the Virgin Islands, American Samoa and the Northern Marianas. Effective on November 12, 1999, the Master Settlement Agreement settled all the health-care cost recovery actions brought by, or on behalf of, the settling jurisdictions and released various additional present and future claims.
     In the settling jurisdictions, the MSA released RJR Tobacco, B&W, and their affiliates and indemnitees, including RAI, from:
     • all claims of the settling states and their respective political subdivisions and other recipients of state health-care funds, relating to past conduct arising out of the use, sale, distribution, manufacture, development, advertising, marketing or health effects of, the exposure to, or research, statements or warnings about, tobacco products; and
     • all monetary claims of the settling states and their respective political subdivisions and other recipients of state health-care funds, relating to future conduct arising out of the use of or exposure to, tobacco products that have been manufactured in the ordinary course of business.
     Set forth below are tables depicting the unadjusted tobacco industry settlement payment schedule and the settlement payment schedule for RAI’s operating subsidiaries under the MSA, including the settlement agreements with the states of Mississippi, Florida, Texas and Minnesota, and related information for 2006 and beyond:
Unadjusted Original Participating Manufacturers’ Settlement Payment Schedule
                                                         
                                                    2012 and  
    2006     2007     2008     2009     2010     2011     thereafter  
First Four States’ Settlements: 1
                                                       
Mississippi Annual Payment
  $ 136     $ 136     $ 136     $ 136     $ 136     $ 136     $ 136  
Florida Annual Payment
    440       440       440       440       440       440       440  
Texas Annual Payment
    580       580       580       580       580       580       580  
Minnesota Annual Payment
    204       204       204       204       204       204       204  
Remaining States’ Settlement:
                                                       
Annual Payments 1
    7,004       7,004       8,004       8,004       8,004       8,004       8,004  
Base Foundation Funding
    25       25       25                          
Growers’ Trust 2
    500       500       500       295       295              

37


Table of Contents

Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
                                                         
                                                    2012 and  
    2006     2007     2008     2009     2010     2011     thereafter  
Offset by federal tobacco buyout 2
    (500 )     (500 )     (500 )     (295 )     (295 )            
 
                                         
Total
  $ 8,389     $ 8,389     $ 9,389     $ 9,364     $ 9,364     $ 9,364     $ 9,364  
 
                                         
RAI’s Operating Subsidiaries’ Settlement Expenses and Payment Schedule
                                                         
Settlement expenses
  $ 2,611     $ 2,821                                
Settlement cash payments
  $ 2,631     $ 2,616                                
Projected settlement expenses
              $ >2,700     $ >2,600     $ >2,600     $ >2,500     $ >2,500  
Projected settlement cash payments
              $ >2,800     $ >2,700     $ >2,600     $ >2,500     $ >2,500  
 
1   Subject to adjustments for changes in sales volume, inflation and other factors. All payments are to be allocated among the companies on the basis of relative market share.
 
2   The Growers’ Trust payments scheduled to expire in 2010 will be offset by obligations resulting from the federal tobacco buyout legislation, not included in this table, signed in October 2004. See “— Tobacco Buyout Legislation and Related Litigation.”
     The MSA also contains provisions restricting the marketing of tobacco products. Among these provisions are restrictions or prohibitions on the use of cartoon characters, brand-name sponsorships, apparel and other merchandise, outdoor and transit advertising, payments for product placement, free sampling and lobbying. Furthermore, the MSA required the dissolution of three industry-sponsored research and trade organizations.
     The MSA has materially adversely affected RJR Tobacco’s shipment volumes. RAI believes that these settlement obligations may materially adversely affect the results of operations, cash flows or financial position of RAI and RJR Tobacco in future periods. The degree of the adverse impact will depend, among other things, on the rate of decline in U.S. cigarette sales in the premium and value categories, RJR Tobacco’s share of the domestic premium and value cigarette categories, and the effect of any resulting cost advantage of manufacturers not subject to the MSA.
     Department of Justice Case. On September 22, 1999, the U.S. Department of Justice brought an action against RJR Tobacco, B&W and other tobacco companies in the U.S. District Court for the District of Columbia. The government initially sought to recover federal funds expended by the federal government in providing health care to smokers who developed diseases and injuries alleged to be smoking-related. In addition, the government sought, pursuant to the civil provisions of RICO, disgorgement of profits the government contends were earned as a consequence of a RICO racketeering “enterprise.” In September 2000, the court dismissed the government’s claims asserted under the Medical Care Recovery Act as well as those under the Medicare Secondary Payer provisions of the Social Security Act, but did not dismiss the RICO claims. In February 2005, the U.S. Court of Appeals for the District of Columbia ruled that disgorgement is not an available remedy in this case. The government’s petition for writ of certiorari with the U.S. Supreme Court was denied in October 2005. The non-jury, bench trial began in September 2004, and closing arguments concluded on June 10, 2005.
     On August 17, 2006, the court found certain defendants, including RJR Tobacco and B&W, liable for the RICO claims, but did not impose any direct financial penalties. The court instead enjoined the defendants from committing future racketeering acts, participating in certain trade organizations, making misrepresentations concerning smoking and health and youth marketing, and using certain brand descriptors such as “low tar,” “light,” “ultra light,” “mild” and “natural.” The court also ordered defendants to issue “corrective communications” on five subjects, including smoking and health and addiction, and to comply with further undertakings, including maintaining web sites of historical corporate documents and disseminating certain marketing information on a confidential basis to the government. In addition, the court placed restrictions on the ability of the defendants to dispose of certain assets for use in the United States, unless the transferee agrees to abide by the terms of the court’s order, and ordered the defendants to reimburse the U.S. Department of Justice its taxable costs incurred in connection with the case.
     Certain defendants, including RJR Tobacco, filed notices of appeal to the U.S. Court of Appeals for the District of Columbia on September 11, 2006. The government filed its notice of appeal on October 16, 2006. In addition, the

38


Table of Contents

Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
defendants, including RJR Tobacco, filed joint motions asking the district court to clarify and to stay its order pending the defendants’ appeal. On September 28, 2006, the district court denied the defendants’ motion to stay. On September 29, 2006, the defendants, including RJR Tobacco, filed a motion asking the court of appeals to stay the district court’s order pending the defendants’ appeal. The court granted the motion on October 31, 2006.
     On November 28, 2006, the court of appeals stayed the appeals pending the trial court’s ruling on the defendants’ motion for clarification. The defendants’ motion for clarification was granted in part and denied in part on March 16, 2007. The defendants’ motion as to the meaning and applicability of the general injunctive relief of the August 17, 2006 order was denied. The request for clarification as to the scope of the provisions in the order prohibiting the use of descriptors and requiring corrective statements at retail point of sale was granted. The court also ruled that the provisions prohibiting the use of express or implied health messages or descriptors do apply to the actions of the defendants taken outside of the United States. Oral argument occurred on October 14, 2008. A decision is pending.
     The stay of the district court’s order suspends the enforcement of the order pending the outcome of the defendants’ appeal. RJR Tobacco does not know the timing of an appellate decision or, if the order is affirmed, the compliance deadlines that will be imposed. If the order is affirmed without modification, then RJR Tobacco believes that certain provisions of the order, such as the ban on certain brand style descriptors and the corrective advertising requirements, would have adverse business effects on the marketing of RJR Tobacco’s current product portfolio and that such effects could be material. Also, if the order is affirmed, then RJR Tobacco would incur costs in connection with complying with the order, such as the costs of changing its current packaging to conform to the ban on certain brand descriptors and the costs of corrective communications. Given the uncertainty over the timing and substance of an appellate decision, RJR Tobacco currently is not able to estimate reasonably the costs of such compliance. Moreover, if the order were ultimately affirmed and RJR Tobacco were to fail to comply with the order on a timely basis, then RJR Tobacco could be subject to substantial monetary fines or penalties.
     International Cases. A number of foreign countries have filed suit against RJR Tobacco, B&W and other tobacco industry defendants to recover funds for health-care, medical and other assistance paid by those foreign governments to their citizens. No such cases currently are pending in the United States against RJR Tobacco and its affiliates or indemnitees.
     Three health-care reimbursement cases are pending against RJR Tobacco or B&W outside the United States, two in Canada and one in Israel. Pursuant to the terms of the 1999 sale of RJR Tobacco’s international tobacco business, JTI assumed RJR Tobacco’s liability, if any, in the health-care cost recovery cases brought by foreign countries.
     On November 12, 1998, the government of British Columbia enacted legislation creating a civil cause of action permitting the government to recover the costs of health-care benefits incurred for B.C. residents arising from tobacco-related disease. The government’s subsequent suit against Canadian defendants and foreign defendants, including RJR Tobacco was dismissed in February 2000, when the B.C. Supreme Court ruled that the legislation was unconstitutional and set aside service ex juris against the foreign defendants for that reason. The government then enacted a revised statute and brought a new action, filed in January 2001, and pending in Supreme Court, British Columbia. The plaintiff seeks to recover the present value of the total expenditure by the government for health-care benefits provided for insured persons resulting from tobacco-related disease or the risk of tobacco-related disease, the present value of the estimated total expenditure by the government for health-care benefits that reasonably could be expected to be provided for those insured persons resulting from tobacco-related disease or the risk of tobacco-related disease, court ordered interest, and costs, or in the alternative, special or increased costs. The plaintiff alleges that the defendants are liable under the following theories: defective product, failure to warn, sale of cigarettes to children and adolescents, strict liability, deceit and misrepresentation, and violation of trade practice and competition acts. Trial is scheduled for September 6, 2010.
     On September 1, 1998, the General Health Services filed a statement of claim against certain cigarette manufacturers, including RJR Tobacco and B&W, in the District Court of Jerusalem, Israel. The plaintiff seeks to recover the past and future value of the total expenditures for health-care services provided to residents of Israel resulting from tobacco-related disease, court ordered interest for past expenditures from date of filing the statement of claim, increased and/or punitive and/or exemplary damages and costs. The plaintiff alleges that the defendants are liable under the following theories: negligence, public nuisance, fraud, misleading advertisement, defective product, failure to warn, sale of cigarettes to children and adolescents, strict liability, deceit, concealment, misrepresentation and conspiracy. In 2002, the plaintiff obtained leave to serve RJR Tobacco and B&W outside the jurisdiction. On behalf of

39


Table of Contents

Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
RJR Tobacco, JTI filed a motion challenging the grant of leave, which was denied. JTI appealed the decision to the Supreme Court of Israel. A hearing occurred on March 28, 2005. A decision is pending.
     On March 13, 2008, a case was filed on behalf of Her Majesty the Queen in Right of the Province of New Brunswick, Canada against certain cigarette manufacturers, including RJR Tobacco, in the Trial Division in the Court of Queen’s Bench of New Brunswick. The plaintiff seeks to recover the present value of total expenditures by the Province for health care benefits resulting or expected to result from tobacco-related diseases or risk of tobacco-related diseases, costs or special or increased costs. The plaintiff alleges that the defendants are liable under the following theories: deceit and misrepresentation, failure to warn, promotion of cigarettes to children and adolescents, negligent design and manufacture, breaches of other common law, equitable and statutory duties and obligations and conspiracy and concerted action in Canada. On June 26, 2008, RJR Tobacco filed a notice of intent to defend.
     Native American Tribe Cases. As of October 10, 2008, one Native American tribe case was pending before a tribal court in South Dakota against RJR Tobacco and B&W, Crow Creek Sioux Tribe v. American Tobacco Co., a case filed in September 1997 in Tribal Court, Crow Creek Sioux, South Dakota. The plaintiffs seek to recover actual and punitive damages, restitution, funding of a clinical cessation program, funding of a corrective public education program, and disgorgement of unjust profits from sales to minors. The plaintiffs claim that the defendants are liable under the following theories: unlawful marketing and targeting of minors, contributing to the delinquency of minors, unfair and deceptive acts or practices, unreasonable restraint of trade and unfair method of competition, negligence, negligence per se, conspiracy and restitution of unjust enrichment. The case is dormant.
     Hospital Cases. As of October 10, 2008, one case brought by hospitals was pending against cigarette manufacturers, including RJR Tobacco and B&W: City of St. Louis v. American Tobacco Co., Inc., filed in November 1998, and pending in the Circuit Court of the City of St. Louis, Missouri. This case seeks recovery of uncompensated, unreimbursed health-care costs expended or to be expended by hospitals on behalf of patients who suffer, or have suffered, from illnesses allegedly resulting from the use of cigarettes. On June 28, 2005, the court granted the defendants’ motion for summary judgment as to claims for damages which accrued prior to November 16, 1993. The claims for damages which accrued after November 16, 1993, are still pending. The case is in discovery. Trial is scheduled for January 11, 2010. On July 11, 2008, certain defendants, including RJR Tobacco and B&W, filed a motion for summary judgment based on the plaintiffs’ lack of proof linking the defendants’ allegedly wrongful conduct with the claimed damages.
     Other Cases. On May 20, 2008, the National Committee to Preserve Social Security and Medicare filed a case against the major U.S. cigarette manufacturers, including RJR Tobacco, in the U.S. District Court for the Eastern District of New York. The case seeks to recover twice the amount paid by Medicare for the health care services provided to Medicare beneficiaries to treat their diseases attributable to smoking the defendants’ cigarettes from May 21, 2002 to the present, for which treatment the defendants allegedly were “required or responsible...to make payment” under the Medicare Secondary Payer Act. On July 21, 2008, the defendants filed a motion to dismiss for failure to state a claim and lack of standing. On the same day, the plaintiffs filed a motion for summary judgment as to liability under the Federal Rules of Civil Procedure 56(d)(2).
MSA-Enforcement and Validity
     As of October 10, 2008, there were 60 cases concerning the enforcement, validity or interpretation of the MSA in which RJR Tobacco or B&W is a party. This number includes those cases, discussed below, relating to disputed payments under the MSA.
     On March 28, 2005, the National Association of Attorneys General, referred to as NAAG, sent a notice, signed by 40 Attorneys General that one or more of the states intended to initiate proceedings against RJR Tobacco for violating Section III (r) of the MSA, the various Consent Decrees implementing the MSA and/or consumer fraud statutes in various states, all in connection with RJR Tobacco’s advertisements for Eclipse cigarettes. After a June 2005 meeting between representatives of RJR Tobacco and NAAG, the Vermont Attorney General filed suit in July 2005, in the Vermont Superior Court, Chittenden County, alleging that certain advertising for the Eclipse cigarette brand violated both the MSA and the Vermont Consumer Fraud Statute. The State of Vermont is seeking declaratory, injunctive, and monetary relief. Trial in this action began October 6, 2008, and is estimated to last four to six weeks.
     On April 13, 2005, the Mississippi Attorney General notified B&W of its intent to seek approximately $3.9 million in additional payments under the Mississippi Settlement Agreement. The Mississippi Attorney General asserts that B&W failed to report in its net operating profit or its shipments cigarettes manufactured by B&W under

40


Table of Contents

Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
contract for Star Tobacco or its parent, Star Scientific, Inc. On April 28, 2005, B&W advised the state that it did not owe the state any money. On August 11, 2005, the Mississippi Attorney General filed in the Chancery Court of Jackson County, Mississippi, a Notice of Violation, Motion to Enforce Settlement Agreement, and Request for an Accounting by Defendant Brown & Williamson Holdings, Inc., formerly known as Brown & Williamson Tobacco Corporation. In this filing, Mississippi estimated that its damages exceeded $5.0 million. This matter is currently in the discovery phase.
     On May 17, 2006, the State of Florida filed a motion, in the Circuit Court of the Fifteenth Judicial Circuit, in and for Palm Beach County, Florida, to enforce the Settlement Agreement, for an Accounting by Brown & Williamson Holdings, Inc., and for an Order of Contempt, raising substantially the same issues as raised by the Mississippi Attorney General and seeking approximately $12.4 million in additional payments under the Florida Settlement Agreement, as well as $17.0 million in interest payments. Discovery in this matter is underway.
     In December, 2007, the states of California, Connecticut, Illinois, Maine, Maryland, New York, Ohio, Pennsylvania and Washington sued RJR Tobacco in their respective state courts under the MSA consent decree claiming, among other things, that a Rolling Stone magazine editorial section and an adjacent Camel Farm advertisement included cartoon images prohibited under the MSA. The states are seeking monetary sanctions, injunctive relief and attorney’s fees and costs. A hearing on the State of Ohio’s claims occurred on January 17, 2008 and February 8, 2008. The judge issued his opinion on July 30, 2008, and found that while RJR Tobacco did not violate the cartoon ban in the consent decree in its own Rolling Stone advertisement, RJR Tobacco did violate the consent decree through its indirect use of cartoon images found in the Rolling Stone editorial. No monetary sanctions or other penalties were awarded to the State. The State’s attorneys’ fees and costs will be determined at a later hearing date. RJR Tobacco has filed a notice of appeal. After a similar hearing in Washington in May 2008, the court ruled in favor of RJR Tobacco and held that the company had not violated the ban on “cartoons.” Activity continues in the remaining states. In Stewart v. RJR Tobacco, two artists groups filed a class-action lawsuit on December 17, 2007, in California state court against RJR Tobacco and Rolling Stone’s publisher, Wenner Media, claiming their mention in the editorial section violated their right of publicity. The plaintiffs seek to recover actual damages in the amount of $750 per violation, per plaintiff and per each class member and punitive damages in an unspecified amount.
     NPM Adjustment. The MSA includes an adjustment, referred to as an NPM Adjustment, that potentially reduces the annual payment obligations of RJR Tobacco and the other participating manufacturers, with all participating manufacturers referred to as PMs. Certain requirements must be satisfied before the NPM Adjustment for a given year is available: (1) an independent auditor designated under the MSA must determine that the PMs have experienced a market share loss beyond a triggering threshold to those manufacturers that do not participate in the MSA, such non-participating manufacturers referred to as NPMs, and (2) in a binding arbitration proceeding, a firm of independent economic consultants must find that the disadvantages of the MSA were a significant factor contributing to the loss. When these two requirements are satisfied, the MSA provides that the NPM Adjustment applies to reduce the annual payment obligation of the PMs. However, an individual settling state may avoid its share of the NPM Adjustment if it had in place and diligently enforced during the entirety of the relevant year a “Qualifying Statute” that imposes escrow obligations on NPMs that are comparable to what the NPMs would have owed if they had joined the MSA. In such event, the state’s share of the NPM Adjustment is reallocated to other settling states, if any, that did not have in place and diligently enforce a Qualifying Statute.
     NPM Adjustment Claim for 2003. For 2003, the MSA independent auditor determined that the PMs suffered a market share loss sufficient to trigger an NPM Adjustment. In March 2006, the independent economic consulting firm issued a final, non-appealable determination that the disadvantages of the MSA were “a significant factor contributing” to the 2003 market share loss. Based on these determinations, on April 17, 2006, RJR Tobacco placed approximately $647 million of its MSA payment into a disputed payments account, in accordance with a procedure established by the MSA. That amount represented RJR Tobacco’s share of the 2003 NPM Adjustment as calculated by the MSA independent auditor. On March 28, 2007, the independent auditor issued revised calculations that reduced RJR Tobacco’s share of the NPM Adjustment for 2003 to approximately $615 million. As a result, on April 19, 2007, RJR Tobacco instructed the independent auditor to release to the settling states approximately $32 million from the disputed payments account.
     Following RJR Tobacco’s payment of a portion of its 2006 MSA payment into the disputed payments account, 37 of the settling states filed legal proceedings in their respective MSA courts seeking declaratory orders that they diligently enforced their Qualifying Statutes during 2003 and/or orders compelling RJR Tobacco and the other PMs that placed money in the disputed payments account to pay the disputed amounts to the settling states. In response, RJR

41


Table of Contents

Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
Tobacco and other PMs, pursuant to the MSA’s arbitration provisions, moved to compel arbitration of the parties’ dispute concerning the 2003 NPM Adjustment, including the states’ diligent enforcement claims, before a single, nationwide arbitration panel of three former federal judges. The settling states opposed these motions, arguing, among other things, that the issue of diligent enforcement must be resolved by MSA courts in each of the 52 settling states and territories.
     As of October 10, 2008, all 48 courts that had addressed the question whether the dispute concerning the 2003 NPM Adjustment is arbitrable had ruled that arbitration is required under the MSA. In 42 states, the orders compelling arbitration are final and/or non-appealable.
     At this time, it is not possible to estimate a date by which arbitration of the dispute concerning the 2003 NPM Adjustment will commence or how many states will ultimately participate.
     NPM Adjustment Claim for 2004. During 2006, proceedings were initiated with respect to an NPM Adjustment for 2004. The MSA independent auditor again determined that the PMs had suffered a market share loss sufficient to trigger an NPM Adjustment for 2004. On April 17, 2006, RJR Tobacco and other PMs initiated the “significant factor” proceeding before the independent economic consultant called for under the MSA with respect to the 2004 NPM Adjustment. On February 12, 2007, the independent economic consulting firm issued a final, non-appealable determination that the disadvantages of the MSA were “a significant factor contributing” to the 2004 market share loss. On April 16, 2007, RJR Tobacco placed approximately $561 million of its 2007 MSA payment into the disputed payments account. That amount represented RJR Tobacco’s share of the 2004 NPM Adjustment as calculated by the MSA independent auditor.
     NPM Adjustment Claim for 2005. During 2007, proceedings were initiated with respect to an NPM Adjustment for 2005. The MSA independent auditor again determined that the PMs had suffered a market share loss sufficient to trigger an NPM Adjustment for 2005. On April 18, 2007, RJR Tobacco and other PMs initiated the “significant factor” proceeding called for under the MSA with respect to the 2005 NPM Adjustment. On February 7, 2008, the independent economic consulting firm issued a final, non-appealable determination that the disadvantages of the MSA were “a significant factor contributing” to the 2005 market share loss. On April 15, 2008, RJR Tobacco placed approximately $431 million of its 2008 MSA payment into the disputed payments account. That amount represented RJR Tobacco’s share of the 2005 NPM Adjustment as calculated by the MSA independent auditor, net of certain slight adjustments to reflect revised independent auditor calculations of RJR Tobacco’s share of the 2003 and 2004 NPM Adjustments.
     NPM Adjustment Claim for 2006. During 2008, proceedings were initiated with respect to an NPM Adjustment for 2006. The MSA independent auditor again determined that the PMs had suffered a market share loss sufficient to trigger an NPM Adjustment for 2006. On April 29, 2008, RJR Tobacco and other PMs initiated the “significant factor” proceeding called for under the MSA with respect to the 2006 NPM Adjustment. On October 6, 2008, RJR Tobacco filed its initial briefs and expert reports in connection with the significant factor proceeding.
     Due to the uncertainty over the final resolution of the NPM Adjustment claims asserted by RJR Tobacco, no assurances can be made related to the amounts, if any, that will be realized.
Antitrust Cases
     A number of tobacco wholesalers and consumers have sued U.S. cigarette manufacturers, including RJR Tobacco and B&W, in federal and state courts, alleging that cigarette manufacturers combined and conspired to set the price of cigarettes in violation of antitrust statutes and various state unfair business practices statutes. In these cases, the plaintiffs asked the court to certify the lawsuits as class actions on behalf of other persons who purchased cigarettes directly or indirectly from one or more of the defendants. As of October 10, 2008, all of the federal and state court cases on behalf of indirect purchasers have been dismissed, except for one state court case pending in each of Kansas and in New Mexico.
     In Smith v. Philip Morris Cos., Inc., a case filed in February 2000, and pending in District Court, Seward County, Kansas, the court granted class certification on November 15, 2001, in an action brought against the major U.S. cigarette manufacturers, including RJR Tobacco and B&W, and the parent companies of the major U.S. cigarette manufacturers, including RJR, seeking to recover an unspecified amount in actual and punitive damages. The plaintiffs

42


Table of Contents

Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
allege that the defendants participated in a conspiracy to fix or maintain the price of cigarettes sold in the United States. The parties currently are engaged in discovery.
     In Romero v. Philip Morris Cos., Inc., a case filed in April 2000 in District Court, Rio Arriba County, New Mexico, the court granted class certification on May 14, 2003, in an action brought against the major U.S. cigarette manufacturers, including RJR Tobacco and B&W, and the parent companies of the major U.S. cigarette manufacturers, including RJR, seeking to recover an amount not to exceed $74,000 per class member in actual and punitive damages, exclusive of interest and costs. The plaintiffs allege that the defendants conspired to fix, raise, advance and/or stabilize prices for cigarettes in the State of New Mexico from at least as early as January 1, 1998, through the present. On June 30, 2006, the court granted the defendants’ motion for summary judgment. On August 14, 2006, the plaintiff appealed to the New Mexico Court of Appeals. The parties completed briefing of the issues on appeal on August 27, 2007, and await a decision.
Other Litigation and Developments
     By purchase agreement dated May 12, 1999, referred to as the 1999 Purchase Agreement, RJR and RJR Tobacco sold the international tobacco business to JTI. RJR and RJR Tobacco retained certain liabilities relating to the activities of Northern Brands, including those relating to a 1998 guilty plea entered in the U.S. District Court for the Northern District of New York, as well as an investigation conducted by the Royal Canadian Mounted Police, referred to as RCMP, for possible violations of Canadian law related to the activities that led to the Northern Brands guilty plea and certain conduct by Stanley Smith, a former executive of RJR-Macdonald, Inc., referred to as RJR-MI, which led to the termination of his severance agreement. Under its reading of the indemnification provisions of the 1999 Purchase Agreement, JTI has requested indemnification for any damages arising out of the matters described below.
    In February 2003, the RCMP filed criminal charges in the Province of Ontario against, and purported to serve summonses on, JTI-Macdonald Corp., referred to as JTI-MC, Northern Brands, R. J. Reynolds Tobacco International, Inc., referred to as RJR-TI, R. J. Reynolds Tobacco Co., Puerto Rico, referred to as RJR-PR, and eight individuals associated with RJR-MI and/or RJR-TI during the period January 1, 1991, through December 31, 1996. The charges allege fraud and conspiracy to defraud Canada and the Provinces of Ontario and Quebec in connection with the purchase, sale, export, import and/or re-export of cigarettes and/or fine cut tobacco. In October 2003, Northern Brands, RJR-TI and RJR-PR each challenged both the propriety of the service of the summonses and the jurisdiction of the court. On February 9, 2004, the Superior Court of Justice ruled in favor of these companies. The government filed a notice of appeal from that ruling on February 18, 2004, but did not perfect its appeal until May 8, 2007. At the oral argument on October 29, 2007, the Court of Appeal announced a unanimous decision in favor of the companies’ position and dismissed the government’s appeal. A final written order dismissing the appeal was entered by the Court of Appeal on December 3, 2007.
     A preliminary hearing was commenced on April 11, 2005, for the purpose of determining whether the Canadian prosecutor had sufficient evidence supporting the criminal charges to justify a trial of the defendants that had been properly served to date. On May 30, 2007, the court announced its decision to issue an order committing two of the accused, JTI-MC and Edward Lang, to stand trial on the charges filed in February 2003 and discharging the other six accused. JTI-MC and Mr. Lang separately filed papers seeking an order quashing the order committing them to stand trial, and the government filed papers seeking an order quashing the order discharging six of the accused. On December 19, 2007, JTI-MC abandoned its effort to have the order committing it to trial quashed. On February 19, 2008, the Superior Court of Justice in Ontario denied Mr. Lang’s request to quash the order committing him to trial. The court granted the government’s request to quash the order discharging six individuals and remanded the matter to the preliminary hearing judge for reconsideration. No appeals were taken from that decision.
     On July 31, 2007, each of the accused companies, including RJR-TI, RJR-PR and Northern Brands, and each of the remaining seven accused individuals were given notice that the Canadian prosecutor had requested the Attorney General of Ontario to consent to the issuance of preferred indictments against each of them. RJR-TI, RJR-PR and Northern Brands as well as the other accused filed written submissions with the Attorney General opposing the issuance of the indictments against them. On October 31, 2007, the office of the Attorney General of Ontario confirmed that the prosecutor’s request for preferred indictments against RJR-TI, RJR-PR and Northern Brands had been denied at that point in time.

43


Table of Contents

Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
    In July 2003, a Statement of Claim was filed against JTI-MC and others in the Superior Court of Justice, Ontario, Canada by Leslie and Kathleen Thompson. Mr. Thompson is a former employee of Northern Brands and JTI-MC’s predecessor, RJR-MI. Mr. and Mrs. Thompson have alleged breach of contract, breach of fiduciary duty and negligent misrepresentation, among other claims. They are seeking lost wages and other damages, including punitive damages, in an aggregate amount exceeding $12 million.
 
    On September 18, 2003, RJR, RJR Tobacco, RJR-TI, RJR-PR, and Northern Brands were served with a Statement of Claim filed in August 2003 by the Attorney General of Canada in the Superior Court of Justice, Ontario, Canada. Also named as defendants are JTI and a number of its affiliates. The Statement of Claim seeks to recover taxes and duties allegedly not paid as a result of cigarette smuggling and related activities. As filed, the Attorney General’s Statement of Claim seeks to recover $1.5 billion Canadian in compensatory damages and $50 million Canadian in punitive damages, as well as equitable and other forms of relief. However, in the Companies’ Creditor Arrangement Act proceeding described below, the Attorney General amended and increased Canada’s claim to $4.3 billion Canadian. The parties have agreed to a stay of all proceedings pending in the Superior Court of Justice, subject to notice by one of the parties that it wishes to terminate the stay. On January 19, 2007, the court ordered that the case be scheduled for trial no later than December 31, 2008, subject to further order of the court.
 
    In August 2004, the Quebec Ministry of Revenue (1) issued a tax assessment, covering the period January 1, 1990, through December 31, 1998, against JTI-MC for alleged unpaid duties, penalties and interest in an amount of about $1.36 billion Canadian; (2) issued an order for the immediate payment of that amount; and (3) obtained an ex parte judgment to enforce the payment of that amount. On August 24, 2004, JTI-MC applied for protection under the Companies’ Creditor Arrangement Act in the Ontario Superior Court of Justice, Toronto, Canada, referred to as CCAA Proceedings, and the court entered an order staying the Quebec Ministry of Revenue’s proceedings as well as other claims and proceedings against JTI-MC. The stay has been extended to July 21, 2009. In November 2004, JTI-MC filed a motion in the Superior Court, Province of Quebec, District of Montreal, seeking a declaratory judgment to set aside, annul and declare inoperative the tax assessment and all ancillary enforcement measures and to require the Quebec Minister of Revenue to reimburse JTI-MC for funds unduly appropriated, along with interest and other relief. Pursuant to a court-imposed deadline, Canada and several Provinces filed Crown claims against JTI-MC in the CCAA Proceedings in the following amounts: Canada, $4.3 billion Canadian; Ontario, $1.5 billion Canadian; New Brunswick, $1.5 billion Canadian; Quebec, $1.4 billion Canadian; British Columbia, $450 million Canadian; Nova Scotia, $326 million Canadian; Prince Edward Island, $75 million Canadian and Manitoba, $23 million Canadian. In the CCAA Proceedings, the Canadian federal government and some of the provincial governments have asserted that they can make the same tax and related claims against RJR and certain of its subsidiaries, including RJR Tobacco. To date, none of those provincial governments have filed and served RJR or any of its affiliates with a formal Statement of Claim like the Canadian federal government did in August and September 2003. Discussions regarding possible agreed-upon procedures for adjudicating and appellate review of the claims and defenses asserted in the CCAA Proceedings are taking place. Without waiving any of their rights and defenses, RJR and certain of its subsidiaries, including RJR Tobacco, may participate in those proceedings, if procedures are agreed upon, approved by the court and implemented.
 
    On November 17, 2004, a Statement of Claim was filed against JTI-MC in the Supreme Court of British Columbia by Stanley Smith, a former executive of RJR-MI, for alleged breach of contract and other legal theories. Mr. Smith is claiming $840,000 Canadian for salary allegedly owed under his severance agreement with RJR-MI, as well as other unspecified compensatory and punitive damages.
 
    In a letter dated March 31, 2006, counsel for JTI stated that JTI would be seeking indemnification under the 1999 Purchase Agreement for any damages it may incur or may have incurred arising out of a Southern District of New York grand jury investigation, a now-terminated Eastern District of North Carolina grand jury investigation, and various actions filed by the European Community and others in the U.S. District Court for the Eastern District of New York, referred to as the EDNY, against RJR Tobacco and certain of its affiliates on November 3, 2000, August 6, 2001, and (as discussed in greater detail below) October 30, 2002, and against JTI on January 11, 2002.
 
      On December 14, 2007, the European Community and 26 of its member states entered into a series of agreements with JTI and/or its subsidiaries regarding, principally, contraband and counterfeit cigarettes

44


Table of Contents

Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
      bearing JTI trademarks in the European Community. Collectively, those agreements resolved, in pertinent part, all claims that the European Community and the member states either had or might have had prior to December 14, 2007 against JTI and/or its subsidiaries with respect to any such contraband and counterfeit cigarettes and claims for which JTI could become the subject of a claim for indemnity by RJR under the terms of the 1999 Purchase Agreement. In addition, the European Community and signatory member states agreed to release RJR and its affiliates from those same claims.
     Although RJR and RJR Tobacco recognize that, under certain circumstances, they may have indemnification obligations to JTI under the 1999 Purchase Agreement, RJR and RJR Tobacco disagree with JTI as to whether the circumstances relating to any of these matters give rise to any indemnification obligation by RJR and RJR Tobacco. RJR and RJR Tobacco conveyed their position to JTI, and the parties have agreed to resolve their differences at a later time. In the interim, RJR and RJR Tobacco are paying defense costs and expenses in connection with certain of the Canadian litigation described above. Indemnification to JTI was $10 million in the first nine months of 2008 and $6 million in the first nine months of 2007. In addition, RJR has liabilities of $94 million that were recorded in 1999 in connection with certain of the indemnification claims asserted by JTI. For further information on the JTI indemnification claims, see “— Other Contingencies” below.
     On May 15, 2007, RAI was served with a subpoena issued by the U.S. District Court for the Middle District of North Carolina. The subpoena seeks documents relating primarily to the business of RJR-TI regarding the manufacture and sale of Canadian brand cigarettes during the period 1990 through 1996. The subpoena was issued at the request of Canada pursuant to a Mutual Legal Assistance Treaty between the United States and Canada.
     On October 30, 2002, the European Community and ten of its member states filed a complaint in the EDNY against RJR, RJR Tobacco and several currently and formerly related companies. The complaint contains many of the same or similar allegations found in an earlier complaint, now dismissed, filed in August 2001 and also alleges that the defendants, together with certain identified and unidentified persons, engaged in money laundering and other conduct violating civil RICO and a variety of common laws. The complaint also alleges that the defendants manufactured cigarettes that were eventually sold in Iraq in violation of U.S. sanctions. The plaintiffs seek compensatory, punitive and treble damages among other types of relief. This matter has been stayed. The European Community and the member states have recently suggested that they may file similar claims regarding the U.S. tobacco business of B&W, which was acquired in 2004 in the B&W business combination.
     RJR Tobacco was named a defendant in a number of lawsuits originally filed in various federal courts in 2002 by plaintiffs alleging descent from persons held in slavery in the United States and seeking damages from numerous corporate defendants for having allegedly profited from historic slavery. In October 2002, those actions were consolidated by the Judicial Panel on Multidistrict Litigation for pre-trial proceedings in the U.S. District Court for the Northern District of Illinois. On July 6, 2005, the court dismissed the entire action on a variety of grounds. On December 13, 2006, the U.S. Court of Appeals for the Seventh Circuit affirmed dismissal in all respects but one. It remanded some cases for further proceedings limited to the claims by some plaintiffs that present-day representations about historic ties to slavery by some defendants violated state consumer fraud laws. On October 1, 2007, the U.S. Supreme Court denied plaintiffs’ petition for a writ of certiorari. The plaintiffs in all but one of the cases either voluntarily dismissed their claims or otherwise abandoned the litigation. On August 11, 2008, the district court granted the defendants’ motion to dismiss the “remaining plaintiffs” and terminated the case. However, the motion to dismiss excluded plaintiffs Timothy and Chester Hurdle, who filed a third amended complaint on July 31, 2007. No ruling was made on the motion to dismiss the Hurdle plaintiffs and the plaintiffs named in the third amended complaint.
     On May 23, 2001, and July 30, 2002, Star Scientific, Inc., referred to as Star, filed two patent infringement actions, which have been consolidated, against RJR Tobacco in the U.S. District Court for the District of Maryland. Both patents at issue are entitled “Method of Treating Tobacco to Reduce Nitrosamine Content, and Products Produced Thereby,” and bear U.S. Patent Nos. 6,202,649 and 6,425,401. The plaintiffs sought: the entry of an injunction restraining RJR Tobacco from further acts of infringement, inducement of infringement, or contributory infringement of the patents; an award of damages, including a reasonable royalty, to compensate for the infringement; an award of enhanced damages on account that the defendant’s conduct was willful; an award of pre-judgment interest and a further award of post-judgment interest; an award of reasonable attorneys’ fees; and an order requiring RJR Tobacco to deliver up to the court for destruction all products manufactured from any process which infringes upon, directly or indirectly or otherwise, any claim of such patent. RJR Tobacco filed counterclaims seeking a declaration that the claims of the two Star patents are invalid, unenforceable and not infringed by RJR Tobacco. Between January 31 and February 8, 2005, the court held a first bench trial on RJR Tobacco’s affirmative defense and counterclaim based upon inequitable

45


Table of Contents

Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
conduct. Additionally, in response to the court’s invitation, RJR Tobacco filed two summary judgment motions on January 20, 2005.
     On January 19, 2007, the court granted RJR Tobacco’s motion for summary judgment of invalidity based on indefiniteness. The court granted in part and denied in part RJR Tobacco’s other summary judgment motion concerning the effective filing date of the patents in suit. On June 26, 2007, the court ruled that Star’s patents are unenforceable due to inequitable conduct by Star and its representatives in the U.S. Patent & Trademark Office. On June 26, 2007, the court also entered final judgment in favor of RJR Tobacco and against Star, dismissing all of Star’s claims with prejudice. On June 27, 2007, Star filed a notice of appeal with the U.S. Court of Appeals for the Federal Circuit. Oral argument occurred on March 7, 2008, and the judges asked for a letter brief concerning the inequitable conduct issue addressing circumstances regarding intent to deceive and circumstances surrounding the transfer of files during Star’s patent procurement activities. On July 9, 2007, RJR Tobacco filed a bill of costs seeking reimbursement of its recoverable costs as the prevailing party, and a motion seeking reimbursement of its attorneys’ fees and excess costs incurred in defending Star’s lawsuit. By agreement of the parties, the trial court deferred that motion pending the appeal. On August 25, 2008, the Federal Circuit issued a decision reversing the district court’s holdings that Star’s patents are unenforceable due to inequitable conduct and invalid for indefiniteness, and remanded the case to the district court for further proceedings on the issues of validity and infringement. On September 2, 2008, Star filed a motion for re-assignment of the case on remand to a new trial judge. On September 5, 2008, the Federal Circuit denied that motion. The Federal Circuit denied RJR Tobacco’s combined petition for panel rehearing and rehearing en banc on October 22, 2008.
     A Civil Investigative Demand, referred to as the CID, was issued by the Federal Trade Commission, referred to as the FTC, to RJR Tobacco on August 23, 2007, to determine whether RJR Tobacco’s advertising and marketing related to the Camel No. 9 cigarette brand may violate the FTC Act. The CID requires RJR Tobacco to produce documents and answer interrogatories. On January 7, 2008, RJR Tobacco certified as complete its production of documents to the FTC.
     Finally, in the first quarter of 2005, Commonwealth Brands, Inc., referred to as Commonwealth, was served with an individual smoking and health case, Croft v. Akron Gasket in Cuyahoga County, Ohio. Commonwealth requested indemnity from RJR Tobacco pursuant to the Asset Purchase Agreement dated July 24, 1996, between Commonwealth and B&W, referred to as the 1996 Purchase Agreement. As a result of the B&W business combination, RJR Tobacco agreed to indemnify Commonwealth for this claim to the extent, if any, required by the 1996 Purchase Agreement. The scope of the indemnity will be at issue and has not been determined.
Smokeless Tobacco Litigation
     As of October 10, 2008, Conwood Company, LLC was a defendant in six actions brought by individual plaintiffs in West Virginia state court seeking damages in connection with personal injuries allegedly sustained as a result of the usage of the Conwood companies’ smokeless tobacco products. These actions are pending before the same West Virginia court as the 687 consolidated individual smoker cases against RJR Tobacco, B&W, as RJR Tobacco’s indemnitee, or both. Pursuant to the Court’s December 3, 2001 order, the smokeless tobacco claims and the defendants remain severed.
     Pursuant to a second amended complaint filed in September 2006, Conwood Company, LLC is a defendant in Vassallo v. United States Tobacco Company, pending in the Eleventh Circuit Court in Miami-Dade County, Florida. The individual plaintiff in this case alleges that he sustained personal injuries, including addiction and cancer, as a result of his use of smokeless tobacco products, allegedly including products manufactured by the Conwood companies. The plaintiff seeks unspecified compensatory and consequential damages in an amount greater than $15,000. There is not a punitive damages demand in this case, though the plaintiff retains the right to seek leave of court to add such a demand later. Discovery is underway.
Tobacco Buyout Legislation and Related Litigation
     On October 22, 2004, the President signed the Fair and Equitable Tobacco Reform Act of 2004, referred to as FETRA, eliminating the U.S. government’s tobacco production controls and price support program. The buyout of tobacco quota holders provided for in FETRA is funded by a direct quarterly assessment on every tobacco product manufacturer and importer, on a market-share basis measured on volume to which federal excise tax is applied. The aggregate cost of the buyout to the industry is approximately $9.9 billion, including approximately $9.6 billion payable

46


Table of Contents

Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
to quota tobacco holders and growers through industry assessments over ten years and approximately $290 million for the liquidation of quota tobacco stock. As a result of the tobacco buyout legislation, the MSA Phase II obligations established in 1999 will be continued as scheduled through the end of 2010, but will be offset against the tobacco quota buyout obligations. RAI’s operating subsidiaries’ annual expense under FETRA, excluding the tobacco stock liquidation assessment, is estimated to be approximately $230 million to $260 million.
     RAI’s operating subsidiaries will record the FETRA assessment on a quarterly basis as cost of goods sold. RAI’s operating subsidiaries estimate that their overall share of the buyout will approximate $2.4 billion to $2.8 billion prior to the deduction of permitted offsets under the MSA. In addition, future market pricing could impact the carrying value of inventory, and adversely affect RJR Tobacco’s financial position and results of operations.
     As noted above, the MSA Phase II obligations will be offset against the tobacco quota buyout obligations. Because growers in two states, Maryland and Pennsylvania, did not participate in the quota system, they are not eligible for payments under FETRA. Given that the assessments paid by tobacco product manufacturers and importers under FETRA would fully offset their MSA Phase II payment obligations, the growers in Maryland and Pennsylvania would no longer receive payments under the MSA Phase II program. Thus, the growers in these two states would not receive payment under either FETRA or the MSA Phase II program.
     On December 17, 2004, Maryland and Pennsylvania filed in the North Carolina Business Court a Motion for Clarification or Modification of the Trust, that is, the Growers Trust that created the MSA Phase II obligations. They later supplemented this filing with a Statement of Claim, filed on June 24, 2005. Maryland and Pennsylvania contend that they are entitled to relief from the operation of the tax offset adjustment provision of the Growers Trust and that payments under the Growers Trust to the growers in their states should continue. Following discovery, the parties filed cross-motions for summary judgment on May 5, 2006. On August 17, 2007, the Business Court issued an Order and Opinion granting summary judgment in favor of Maryland and Pennsylvania and denying summary judgment to the tobacco manufacturers, including RJR Tobacco, that were the settlors of the Growers Trust. The Business Court ruled that the Growers Trust, as written and without judicial modification, requires continuing payments to the Growers Trust for the benefit of tobacco growers in Maryland and Pennsylvania. RJR Tobacco and the other tobacco manufacturer/settlors filed their Notice of Appeal on September 14, 2007. On January 14, 2008, RJR Tobacco and the other tobacco manufacturer/settlors filed a petition seeking direct discretionary review by the North Carolina Supreme Court. On February 25, 2008, the North Carolina Supreme Court denied the petition. On March 17, 2008, RJR Tobacco and the other tobacco manufacturer/settlors filed their opening brief before the North Carolina Court of Appeals. Maryland and Pennsylvania filed a response brief on March 21, 2008. RJR Tobacco and the other tobacco manufactuer/settlors filed a reply brief on June 9, 2008. On August 20, 2008, oral argument was held before the North Carolina Court of Appeals. The case is now pending decision.
ERISA Litigation
     On May 13, 2002, in Tatum v. The R.J.R. Pension Investment Committee of the R. J. Reynolds Tobacco Company Capital Investment Plan, an employee of RJR Tobacco filed a class-action suit in the U.S. District Court for the Middle District of North Carolina, alleging that the defendants, RJR, RJR Tobacco, the RJR Employee Benefits Committee and the RJR Pension Investment Committee, violated the Employee Retirement Income Security Act of 1974, referred to as ERISA. The actions about which the plaintiff complains stem from a decision made in 1999 by RJR Nabisco Holdings Corp., subsequently renamed Nabisco Group Holdings Corp., referred to as NGH, to spin off RJR, thereby separating NGH’s tobacco business and food business. As part of the spin-off, the 401(k) plan for the previously related entities had to be divided into two separate plans for the now separate tobacco and food businesses. The plaintiff contends that the defendants violated ERISA by not overriding an amendment to RJR’s 401(k) plan requiring that, prior to February 1, 2000, the stock funds of the companies involved in the food business, NGH and Nabisco Holdings Corp., referred to as Nabisco, be eliminated as investment options from RJR’s 401(k) plan. In his complaint, the plaintiff requests, among other things, that the court require the defendants to pay as damages to the RJR 401(k) plan an amount equal to the subsequent appreciation that was purportedly lost as a result of the liquidation of the NGH and Nabisco funds.
     On July 29, 2002, the defendants filed a motion to dismiss, which the court granted on December 10, 2003. On December 14, 2004, the U.S. Court of Appeals for the Fourth Circuit reversed the dismissal of the complaint and remanded the case for further proceedings. On January 20, 2005, the defendants filed a second motion to dismiss on other grounds. On March 7, 2007, the court granted the plaintiff leave to file an amended complaint and denied all pending motions as moot. On April 6, 2007, the defendants moved to dismiss the amended complaint. On May 31, 2007, the court granted the motion in part and denied it in part, dismissing all claims against the RJR Employee Benefits Committee and the RJR Pension Investment Committee. The remaining defendants, RJR and RJR Tobacco, filed their answer and affirmative defenses on June 14, 2007. On June 28, 2007, the plaintiff filed a motion to amend the complaint to add as parties defendant the six members of the RJR Pension Investment Committee and the RJR Employee Benefits Committee. On March 13, 2008, the court denied this motion. On November 19, 2007, the plaintiff

47


Table of Contents

Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
filed a motion for class certification, which the court granted on September 29, 2008. Court ordered mediation occurred on July 10, 2008, but no resolution of the case was reached at that time. On May 29, 2008, the defendants filed a motion for judgment on the pleadings, which asked the court to dismiss the claims asserted by class members who voluntarily transferred their 401(k) investments from the NGH and Nabisco funds before January 31, 2000. That motion remains outstanding. Finally, on September 18, 2008, each of the plaintiffs and the defendants filed motions for summary judgment; briefing on these motions is continuing.
Employment Litigation
     On March 19, 2007, in Marshall v. R.J. Reynolds Tobacco Co., the plaintiff filed a collective action complaint against RJR Tobacco in the U.S. District Court for the Western District of Missouri alleging violations of the Fair Labor Standards Act, referred to as the FLSA. The allegations include failure to keep accurate records of all hours worked by RJR Tobacco’s employees and failure to pay wages and overtime compensation to non-exempt retail representatives. The opt-in period to join the collective action ended on May 1, 2008, with 423 current or former retail representatives having opted in to the lawsuit.
     Two new cases alleging violations of the FLSA were filed in February 2008: Radcliffe v. R.J. Reynolds Tobacco Co., filed on February 14, 2008, in federal court in California, was served on May 9, 2008; and Dinino v. R.J. Reynolds Tobacco Co., filed on February 29, 2008, in federal court in New York, was served on April 18, 2008. The Dinino and Radcliffe matters have been transferred to the Missouri court in conjunction with the already pending Marshall case due to the similarity of issues to be resolved. The deadline for plaintiffs in the Dinino and Radcliffe matters to move for Rule 23 class certification of the state law claims is November 6, 2008. The total number of former and current retail representatives that could be included out of New York and California for Rule 23 class certification is limited to approximately 44 from New York and 61 from California.
Environmental Matters
     RAI and its subsidiaries are subject to federal, state and local environmental laws and regulations concerning the discharge, storage, handling and disposal of hazardous or toxic substances. Such laws and regulations provide for significant fines, penalties and liabilities, sometimes without regard to whether the owner or operator of the property knew of, or was responsible for, the release or presence of hazardous or toxic substances. In addition, third parties may make claims against owners or operators of properties for personal injuries and property damage associated with releases of hazardous or toxic substances. In the past, RJR Tobacco has been named a potentially responsible party with third parties under the Comprehensive Environmental Response, Compensation and Liability Act with respect to several superfund sites. RAI and its subsidiaries are not aware of any current environmental matters that are expected to have a material adverse effect on the business, results of operations or financial position of RAI or its subsidiaries.
     Regulations promulgated by the U.S. Environmental Protection Agency and other governmental agencies under various statutes have resulted in, and likely will continue to result in, substantial expenditures for pollution control, waste treatment, plant modification and similar activities. RAI and its subsidiaries are engaged in a continuing program to comply with federal, state and local environmental laws and regulations, and dependent upon the probability of occurrence and reasonable estimation of cost, accrue or disclose any material liability. Although it is difficult to reasonably estimate the portion of capital expenditures or other costs attributable to compliance with environmental laws and regulations, RAI does not expect such expenditures or other costs to have a material adverse effect on the business, results of operations or financial position of RAI or its subsidiaries.
Other Contingencies
     In connection with the sale of the international tobacco business to JTI, on May 12, 1999, pursuant to the purchase agreement, RJR and RJR Tobacco agreed to indemnify JTI against:
    any liabilities, costs and expenses arising out of the imposition or assessment of any tax with respect to the international tobacco business arising prior to the sale, other than as reflected on the closing balance sheet;
 
    any liabilities, costs and expenses that JTI or any of its affiliates, including the acquired entities, may incur after the sale with respect to any of RJR’s or RJR Tobacco’s employee benefit and welfare plans; and

48


Table of Contents

Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
    any liabilities, costs and expenses incurred by JTI or any of its affiliates arising out of certain activities of Northern Brands.
     As described above in “— Litigation Affecting the Cigarette Industry — Other Litigation and Developments,” RJR Tobacco has received several claims for indemnification from JTI. Although RJR and RJR Tobacco recognize that, under certain circumstances, they may have indemnification obligations to JTI under the 1999 Purchase Agreement, RJR and RJR Tobacco disagree whether the circumstances described in such claims give rise to any indemnification obligations by RJR and RJR Tobacco. RJR and RJR Tobacco have conveyed their position to JTI, and the parties have agreed to resolve their differences at a later date. RJR has liabilities totaling $94 million that were recorded in 1999 in connection with these indemnification claims.
     RJR Tobacco, Santa Fe, the Conwood companies and Lane have entered into agreements to indemnify certain distributors and retailers from liability and related defense costs arising out of the sale or distribution of their products. Additionally, Santa Fe has entered into an agreement to indemnify a supplier from liability and related defense costs arising out of the sale or use of Santa Fe’s products. The cost has been, and is expected to be, insignificant. RJR Tobacco, Santa Fe, the Conwood companies and Lane believe that the indemnified claims are substantially similar in nature and extent to the claims that they are already exposed to by virtue of their having manufactured those products.
     Under certain circumstances, any fair value that results in a liability position of certain interest rate swaps may require full collateralization with cash or securities.
     Except as otherwise noted above, RAI is not able to estimate the maximum potential amount of future payments, if any, related to these indemnification obligations.
Note 13–Shareholders’ Equity
                                                 
                            Accumulated              
                            Other     Total        
    Common     Paid-In     Accumulated     Comprehensive     Shareholders’     Comprehensive  
    Stock     Capital     Deficit     Loss     Equity     Income  
Balance as of December 31, 2007
  $     $ 8,653     $ (873 )   $ (314 )   $ 7,466          
Net income
                1,080             1,080     $ 1,080  
Retirement benefits SFAS No. 158, net of $9 million tax expense
                      13       13       13  
Unrealized loss on long-term investments, net of $12 million tax benefit
                      (18 )     (18 )     (18 )
Cumulative translation adjustment, net of $5 million tax benefit
                      (11 )     (11 )     (11 )
 
                                             
Total comprehensive income
                                  $ 1,064  
 
                                             
Dividends — $2.55 per share
                (748 )           (748 )        
Common stock repurchased
          (207 )                 (207 )        
Equity incentive award plan and stock-based compensation
          11                   11          
Excess tax benefit on stock-based compensation plans
          2                   2          
 
                                     
Balance as of September 30, 2008
  $     $ 8,459     $ (541 )   $ (330 )   $ 7,588          
 
                                     
     On February 5, 2008, the board of directors of RAI authorized the repurchase of up to $30 million of outstanding shares of RAI common stock to offset the dilution from shares issued under certain equity-based benefit plans. This $30 million repurchase program was superseded on April 29, 2008, when RAI’s board of directors authorized RAI’s repurchase, from time to time on or before April 30, 2009, of up to $350 million of outstanding shares of RAI common stock in open-market or privately negotiated transactions. The repurchases are subject to prevailing market and business conditions, and the program may be terminated or suspended at any time. In connection with the share repurchase program, RAI and B&W entered into an agreement, pursuant to which B&W has agreed to participate in the repurchase program on a basis approximately proportionate with B&W’s 42% ownership of RAI’s equity.

49


Table of Contents

Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
     Due to RAI’s incorporation in North Carolina, which does not recognize treasury shares, any shares repurchased are cancelled at the time of repurchase. As of September 30, 2008, RAI had repurchased and cancelled 3,817,095 shares of RAI common stock for $207 million under the above repurchase programs.
     On February 5, 2008, the board of directors of RAI approved a grant, to key employees of RAI and its subsidiaries, of shares of restricted RAI common stock under the Reynolds American Inc. Long-Term Incentive Plan, referred to as the LTIP, effective March 6, 2008. The 321,991 restricted shares were granted based on the per share closing price of RAI common stock on March 6, 2008, of $61.89. On August 1, 2008, 594 additional shares were granted based on the $55.13 per share closing price of RAI common stock on such date. The shares of the restricted RAI common stock generally will vest on March 6, 2011. As an equity-based grant, compensation expense includes the vesting period elapsed. Dividends on shares of outstanding restricted stock, which are paid concurrently with dividends on outstanding unrestricted shares of stock, are recognized as a reduction of equity.
     On each of February 5, 2008, May 6, 2008, and July 18, 2008, RAI’s board of directors declared a quarterly cash dividend of $0.85 per common share, or $3.40 on an annualized basis.
Note 14–Segment Information
     RAI’s reportable operating segments are RJR Tobacco and Conwood. The RJR Tobacco segment consists of the primary operations of R. J. Reynolds Tobacco Company. The Conwood segment consists of the Conwood companies and Lane. RAI’s wholly owned operating subsidiaries Santa Fe and GPI, among others, are included in All Other. The segments were identified based on how RAI’s chief operating decision maker allocates resources and assesses performance.
     RAI’s largest reportable operating segment, RJR Tobacco, is the second largest cigarette manufacturer in the United States. RJR Tobacco’s largest-selling cigarette brands, CAMEL, KOOL, PALL MALL, DORAL and WINSTON, are five of the ten best-selling brands of cigarettes in the United States as of September 30, 2008. Those brands, and its other brands, including SALEM, MISTY and CAPRI, are manufactured in a variety of styles and marketed in the United States. RJR Tobacco also manages contract manufacturing of cigarettes and tobacco products through arrangements with BAT affiliates. On January 1, 2008, the contract manufacturing business of GPI was transferred to RJR Tobacco.
     RAI’s other reportable operating segment, Conwood, is the second largest smokeless tobacco products manufacturer in the United States. Conwood’s primary brands include its largest-selling moist snuff brands, GRIZZLY and KODIAK, two of the seven best-selling brands of moist snuff in the United States. Conwood’s other products include loose leaf chewing tobacco, dry snuff, plug and twist tobacco products. Conwood’s products currently hold the first or second position in market share in each category. In addition, Conwood also distributes a variety of other tobacco products including WINCHESTER and CAPTAIN BLACK little cigars, and BUGLER roll-your-own tobacco.
     Santa Fe manufactures and markets cigarettes and other tobacco products under the NATURAL AMERICAN SPIRIT brand. As of January 1, 2008, the management of super premium brands, including DUNHILL and STATE EXPRESS 555, was transferred to Santa Fe from RJR Tobacco. GPI manufactures and exports tobacco products to U.S. territories, U.S. duty-free shops and U.S. overseas military bases and manages the international businesses of Conwood and Santa Fe. The financial position and results of operations of these operating segments do not meet the materiality criteria to be reportable.
     The amounts presented for prior periods have been reclassified to reflect the current segment composition.
     Intersegment revenues and items below the operating income line of the consolidated statements of income are not presented by segment, since they are excluded from the measure of segment profitability reviewed by RAI’s chief operating decision maker.

50


Table of Contents

Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
     Segment Data:
                                 
    For the Three Months     For the Nine Months  
    Ended September 30,     Ended September 30,  
    2008     2007     2008     2007  
Net sales:
                               
RJR Tobacco
  $ 1,977     $ 2,019     $ 5,798     $ 5,995  
Conwood
    181       166       536       495  
All Other
    114       112       334       303  
 
                       
Consolidated net sales
  $ 2,272     $ 2,297     $ 6,668     $ 6,793  
 
                       
 
                               
Operating income:
                               
RJR Tobacco
  $ 293     $ 499     $ 1,231     $ 1,483  
Conwood
    98       90       275       260  
All Other
    35       37       112       107  
Corporate expense
    (27 )     (24 )     (76 )     (79 )
 
                       
Consolidated operating income
  $ 399     $ 602     $ 1,542     $ 1,771  
 
                       
 
                               
Reconciliation to income from continuing operations before income taxes and extraordinary item:
                               
Operating income
  $ 399     $ 602     $ 1,542     $ 1,771  
Interest and debt expense
    68       81       208       257  
Interest income
    (16 )     (33 )     (51 )     (94 )
Gain on termination of joint venture
                (328 )      
Other (income) expense, net
    13       (7 )     3       8  
 
                       
Income from continuing operations before income taxes and extraordinary item
  $ 334     $ 561     $ 1,710     $ 1,600  
 
                       
                 
    September 30,     December 31,  
    2008     2007  
Assets:
               
RJR Tobacco
  $ 15,480     $ 15,956  
Conwood
    4,481       4,559  
All Other
    1,386       1,104  
Corporate
    15,831       16,336  
Elimination adjustments
    (18,760 )     (19,326 )
 
           
Consolidated assets
  $ 18,418     $ 18,629  
 
           
Note 15–Related Party Transactions
     RAI’s operating subsidiaries engage in transactions with related parties in the normal course of business. The following is a summary of balances and transactions with affiliates of BAT.
Balances:
                 
    September 30,   December 31,
    2008   2007  
Receivables
  $ 67     $ 80  
Payables
    2       7  
Deferred revenue
    13       35  
Transactions for the nine months ended September 30:
                 
    2008   2007
Net sales
  $ 338     $ 374  
Legal indemnification expenses
          2  
Purchases
    11       13  
Research and development services
    2       2  

51


Table of Contents

Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
     RAI’s operating subsidiaries have entered into various transactions with affiliates of BAT. RAI’s operating subsidiaries sell contract-manufactured cigarettes, processed strip leaf, pipe tobacco and little cigars to BAT affiliates. Pricing for contract-manufactured cigarettes was generally calculated based on 2004 prices, using B&W’s forecasted 2004 manufacturing costs plus 10%, increased by a multiple equal to the increase in the Producer Price Index for subsequent years, reported by the U.S. Bureau of Labor Statistics. During the nine months ended September 30, 2008, net sales to BAT affiliates, primarily cigarettes, represented 5% of RAI’s total net sales.
     RJR Tobacco recorded deferred sales revenue relating to leaf sold to BAT affiliates that had not been delivered as of September 30, 2008, given that RJR Tobacco had a legal right to bill the BAT affiliates. Leaf sales revenue to BAT affiliates will be recognized when the product is shipped to the customer.

52


Table of Contents

Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
Note 16—RAI Guaranteed, Unsecured Notes — Condensed Consolidating Financial Statements
     The following condensed consolidating financial statements have been prepared pursuant to Rule 3-10 of Regulation S-X, relating to the guarantors of RAI’s $4.4 billion guaranteed, unsecured notes. RAI’s direct, wholly owned subsidiaries and certain of its indirectly owned subsidiaries have fully and unconditionally, and jointly and severally, guaranteed these notes. The following condensed consolidating financial statements include: the accounts and activities of RAI, the parent issuer; RJR, RJR Tobacco, the Conwood companies, Conwood Holdings, Inc., Santa Fe, Lane, GPI, RJR Acquisition Corp., and certain of RJR Tobacco’s other subsidiaries, the guarantors; other indirect subsidiaries of RAI that are not guarantors; and elimination adjustments.
Condensed Consolidating Statements of Income
(Dollars in Millions)
                                         
    Parent             Non-              
    Issuer     Guarantors     Guarantors     Eliminations     Consolidated  
For the Three Months Ended September 30, 2008
                                       
Net sales
  $     $ 2,148     $ 41     $ (33 )   $ 2,156  
Net sales, related party
          116                   116  
Cost of products sold
          1,242       20       (33 )     1,229  
Selling, general and administrative expenses
    8       349       18             375  
Amortization expense
          5                   5  
Restructuring charge
    6       81       4             91  
Trademark impairment charge
          173                   173  
 
                             
Operating income (loss)
    (14 )     414       (1 )           399  
Interest and debt expense
    65       2       1             68  
Interest income
          (10 )     (6 )           (16 )
Intercompany interest (income) expense
    (23 )     22       1              
Intercompany dividend income
          (11 )           11        
Other expense, net
    1       11       1             13  
 
                             
Income (loss) before income taxes
    (57 )     400       2       (11 )     334  
Provision for (benefit from) income taxes
    (21 )     144                   123  
Equity income from subsidiaries
    247       3             (250 )      
 
                             
Net income
  $ 211     $ 259     $ 2     $ (261 )   $ 211  
 
                             
 
                                       
For the Three Months Ended September 30, 2007
                                       
Net sales
  $     $ 2,170     $ 33     $ (29 )   $ 2,174  
Net sales, related party
          123                   123  
Cost of products sold
          1,263       15       (28 )     1,250  
Selling, general and administrative expenses
    12       413       16       (1 )     440  
Amortization expense
          5                   5  
 
                             
Operating income (loss)
    (12 )     612       2             602  
Interest and debt expense
    78       3                   81  
Interest income
    (1 )     (30 )     (2 )           (33 )
Intercompany interest (income) expense
    (27 )     26       1              
Intercompany dividend income
          (11 )           11        
Other (income) expense, net
    1       (4 )     (4 )           (7 )
 
                             
Income (loss) before income taxes and extraordinary item
    (63 )     628       7       (11 )     561  
Provision for (benefit from) income taxes
    (22 )     225                   203  
Equity income from subsidiaries
    399       7             (406 )      
 
                             
Net income
  $ 358     $ 410     $ 7     $ (417 )   $ 358  
 
                             

53


Table of Contents

Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
Condensed Consolidating Statements of Income
(Dollars in Millions)
                                         
    Parent             Non-              
    Issuer     Guarantors     Guarantors     Eliminations     Consolidated  
For the Nine Months Ended September 30, 2008
                                       
Net sales
  $     $ 6,307     $ 117     $ (94 )   $ 6,330  
Net sales, related party
          338                   338  
Cost of products sold
          3,737       55       (94 )     3,698  
Selling, general and administrative expenses
    17       1,082       49             1,148  
Amortization expense
          16                   16  
Restructuring charge
    6       81       4             91  
Trademark impairment charge
          173                   173  
 
                             
Operating income (loss)
    (23 )     1,556       9             1,542  
Interest and debt expense
    200       7       1             208  
Interest income
    (1 )     (38 )     (12 )           (51 )
Intercompany interest (income) expense
    (63 )     59       4              
Intercompany dividend income
          (32 )           32        
Gain on termination of joint venture
                (328 )           (328 )
Other expense, net
    3                         3  
 
                             
Income (loss) before income taxes
    (162 )     1,560       344       (32 )     1,710  
Provision for (benefit from) income taxes
    (57 )     686       1             630  
Equity income from subsidiaries
    1,185       344             (1,529 )      
 
                             
Net income
  $ 1,080     $ 1,218     $ 343     $ (1,561 )   $ 1,080  
 
                             
 
                                       
For the Nine Months Ended September 30, 2007
                                       
Net sales
  $     $ 6,404     $ 80     $ (65 )   $ 6,419  
Net sales, related party
          374                   374  
Cost of products sold
          3,800       32       (64 )     3,768  
Selling, general and administrative expenses
    41       1,157       39             1,237  
Amortization expense
          17                   17  
 
                             
Operating income (loss)
    (41 )     1,804       9       (1 )     1,771  
Interest and debt expense
    246       11                   257  
Interest income
    (3 )     (88 )     (3 )           (94 )
Intercompany interest (income) expense
    (89 )     86       3              
Intercompany dividend income
          (32 )           32        
Other (income) expense, net
    23       (6 )     (9 )           8  
 
                             
Income (loss) before income taxes and extraordinary item
    (218 )     1,833       18       (33 )     1,600  
Provision for (benefit from) income taxes
    (73 )     662       1             590  
Equity income from subsidiaries
    1,156       17             (1,173 )      
 
                             
Income before extraordinary item
    1,011       1,188       17       (1,206 )     1,010  
Extraordinary item — gain on acquisition
          1                   1  
 
                             
Net income
  $ 1,011     $ 1,189     $ 17     $ (1,206 )   $ 1,011  
 
                             

54


Table of Contents

Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
Condensed Consolidating Statements of Cash Flows
(Dollars in Millions)
                                         
    Parent             Non-              
    Issuer     Guarantors     Guarantors     Eliminations     Consolidated  
For the Nine Months Ended September 30, 2008
                                       
Cash flows from (used in) operating activities
  $ 649     $ 899     $ 32     $ (752 )   $ 828  
 
                             
Cash flows from (used in) investing activities:
                                       
Purchases of short-term investments
    (8 )     (48 )                 (56 )
Proceeds from sale of short-term investments
          208                   208  
Proceeds from settlement of long-term investments
          6                   6  
Capital expenditures
          (90 )     (5 )           (95 )
Distributions from equity investees
                27             27  
Proceeds from termination of joint venture
                164             164  
Other, net
          10                   10  
Net intercompany investments
          (1 )     1              
Intercompany notes receivable
    40       (28 )           (12 )      
 
                             
Net cash flows from investing activities
    32       57       187       (12 )     264  
 
                             
Cash flows from (used in) financing activities:
                                       
Dividends paid on common stock
    (752 )     (720 )           720       (752 )
Dividends paid on preferred stock
    (32 )                 32        
Excess tax benefit from stock-based compensation
    2                         2  
Proceeds from stock options exercised
    1                         1  
Repurchase of common stock
    (207 )                       (207 )
Other, net
    1                         1  
Intercompany notes payable
    98       (40 )     (70 )     12        
 
                             
Net cash flows (used in) from financing activities
    (889 )     (760 )     (70 )     764       (955 )
 
                             
Effect of exchange rate changes on cash and cash equivalents
            (23 )           (23 )
 
                             
Net change in cash and cash equivalents
    (208 )     196       126             114  
Cash and cash equivalents at beginning of period
    243       1,885       87             2,215  
 
                             
Cash and cash equivalents at end of period
  $ 35     $ 2,081     $ 213     $     $ 2,329  
 
                             
 
                                       
For the Nine Months Ended September 30, 2007
                                       
Cash flows from (used in) operating activities
  $ 702     $ 672     $ 1     $ (87 )   $ 1,288  
 
                             
Cash flows from (used in) investing activities:
                                       
Purchases of short-term investments
          (3,663 )                 (3,663 )
Proceeds from sale of short-term investments
          4,154                   4,154  
Capital expenditures
    (7 )     (82 )     (6 )           (95 )
Distributions from (investments in) equity investees
          (1 )     10             9  
Other, net
          (1 )     (3 )           (4 )
Intercompany notes receivable
    40       (295 )           255        
 
                             
Net cash flows from investing activities
    33       112       1       255       401  
 
                             
Cash flows from (used in) financing activities:
                                       
Dividends paid on common stock
    (665 )     (55 )           55       (665 )
Dividends paid on preferred stock
    (32 )                 32        
Repayment of long-term debt
    (254 )     (75 )                 (329 )
Issuance of long-term debt
    1,547                         1,547  
Repayment of term loan
    (1,542 )                       (1,542 )
Deferred debt issuance cost
    (15 )                       (15 )
Excess tax benefit from stock-based compensation
    1                         1  
Repurchase of common stock
    (60 )                       (60 )
Intercompany notes payable
    288       (40 )     7       (255 )      
 
                             
Net cash flows from (used in) financing activities
    (732 )     (170 )     7       (168 )     (1,063 )
 
                             
Net change in cash and cash equivalents
    3       614       9             626  
Cash and cash equivalents at beginning of period
    296       1,065       72             1,433  
 
                             
Cash and cash equivalents at end of period
  $ 299     $ 1,679     $ 81     $     $ 2,059  
 
                             

55


Table of Contents

Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
Condensed Consolidating Balance Sheets
(Dollars in Millions)
                                         
    Parent             Non-              
    Issuer     Guarantors     Guarantors     Eliminations     Consolidated  
September 30, 2008
                                       
Assets
                                       
Cash and cash equivalents
  $ 35     $ 2,081     $ 213     $     $ 2,329  
Short-term investments
    8       44                   52  
Accounts receivable, net
          64       15             79  
Accounts receivable, related party
          67                   67  
Notes receivable
          1       32             33  
Other receivables
    35       27       1             63  
Inventories
          1,039       35       (2 )     1,072  
Deferred income taxes, net
    16       836                   852  
Prepaid expenses and other
    7       131       5             143  
Short-term intercompany notes and interest receivable
    81       58             (139 )      
Other intercompany receivables
    216                   (216 )      
 
                             
Total current assets
    398       4,348       301       (357 )     4,690  
Property, plant and equipment, net
    7       1,022       24             1,053  
Trademarks, net
          3,229                   3,229  
Goodwill
          8,166       8             8,174  
Other intangibles, net
          188       3             191  
Long-term intercompany notes
    2,080       1,409             (3,489 )      
Investment in subsidiaries
    11,240       433             (11,673 )      
Other assets and deferred charges
    170       773       165       (27 )     1,081  
 
                             
Total assets
  $ 13,895     $ 19,568     $ 501     $ (15,546 )   $ 18,418  
 
                             
 
                                       
Liabilities and shareholders’ equity
                                       
Tobacco settlement accruals
  $     $ 2,159     $     $     $ 2,159  
Accounts payable and other accrued liabilities
    410       884       33             1,327  
Due to related party
          2                   2  
Deferred revenue, related party
          13                   13  
Current maturities of long-term debt
    189       11                   200  
Short-term intercompany notes and interest payables
    36       81       22       (139 )      
Other intercompany payables
          215       1       (216 )      
 
                             
Total current liabilities
    635       3,365       56       (355 )     3,701  
Intercompany notes
    1,409       2,080             (3,489 )      
Long-term debt (less current maturities)
    4,183       121                   4,304  
Deferred income taxes, net
          1,247             (27 )     1,220  
Long-term retirement benefits (less current portion)
    50       1,104       12             1,166  
Other noncurrent liabilities
    30       408       1             439  
Shareholders’ equity
    7,588       11,243       432       (11,675 )     7,588  
 
                             
Total liabilities and shareholders’ equity
  $ 13,895     $ 19,568     $ 501     $ (15,546 )   $ 18,418  
 
                             
 
                                       
December 31, 2007
                                       
Assets
                                       
Cash and cash equivalents
  $ 243     $ 1,885     $ 87     $     $ 2,215  
Short-term investments
          377                   377  
Accounts receivable, net
          61       12             73  
Accounts receivable, related party
          80                   80  
Notes receivable
          1                   1  
Other receivables
    7       18                   25  
Inventories
          1,167       31       (2 )     1,196  
Deferred income taxes, net
    11       833       1             845  
Prepaid expenses and other
    6       169       3       2       180  
Short-term intercompany notes and interest receivable
    82       127             (209 )      
Other intercompany receivables
    153             23       (176 )      
 
                             

56


Table of Contents

Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
                                         
    Parent             Non-              
    Issuer     Guarantors     Guarantors     Eliminations     Consolidated  
Total current assets
    502       4,718       157       (385 )     4,992  
Property, plant and equipment, net
    8       1,046       20       (1 )     1,073  
Trademarks, net
          3,407                   3,407  
Goodwill
          8,166       8             8,174  
Other intangibles, net
          199       3             202  
Long-term intercompany notes
    2,120       1,310             (3,430 )      
Investment in subsidiaries
    10,848       104             (10,952 )      
Other assets and deferred charges
    186       571       49       (25 )     781  
 
                             
Total assets
  $ 13,664     $ 19,521     $ 237     $ (14,793 )   $ 18,629  
 
                             
 
                                       
Liabilities and shareholders’ equity
                                       
Tobacco settlement accruals
  $     $ 2,449     $     $     $ 2,449  
Accounts payable and other accrued liabilities
    391       993       27       1       1,412  
Due to related party
          5       2             7  
Deferred revenue, related party
          35                   35  
Short-term intercompany notes and interest payable
    34       82       93       (209 )      
Other intercompany payables
          176             (176 )      
 
                             
Total current liabilities
    425       3,740       122       (384 )     3,903  
Intercompany notes
    1,310       2,120             (3,430 )      
Long-term debt
    4,383       132                   4,515  
Deferred income taxes, net
          1,209             (25 )     1,184  
Long-term retirement benefits (less current portion)
    44       1,112       11             1,167  
Other noncurrent liabilities
    36       358                   394  
Shareholders’ equity
    7,466       10,850       104       (10,954 )     7,466  
 
                             
Total liabilities and shareholders’ equity
  $ 13,664     $ 19,521     $ 237     $ (14,793 )   $ 18,629  
 
                             

57


Table of Contents

Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
Note 17–RJR Guaranteed, Unsecured Notes Condensed Consolidating Financial Statements
     The following condensed consolidating financial statements have been prepared pursuant to Rule 3-10 of Regulation S-X, relating to the guarantees of RJR’s $72 million unsecured notes. RAI and certain of its direct or indirect, wholly owned subsidiaries, have fully and unconditionally, and jointly and severally, guaranteed these notes. The following condensed consolidating financial statements include: the accounts and activities of RAI, the parent guarantor; RJR, the issuer of the debt securities; RJR Tobacco, RJR Acquisition Corp. and certain of RJR’s other subsidiaries, the other guarantors; other subsidiaries of RAI and RJR, including Santa Fe, Lane and the Conwood companies that are not guarantors; and elimination adjustments.
Condensed Consolidating Statements of Income
(Dollars in Millions)
                                                 
    Parent             Other     Non-              
    Guarantor     Issuer     Guarantors     Guarantors     Eliminations     Consolidated  
For the Three Months Ended September 30, 2008
                                               
Net sales
  $     $     $ 1,923     $ 291     $ (58 )   $ 2,156  
Net sales, related party
                114       2             116  
Cost of products sold
                1,186       101       (58 )     1,229  
Selling, general and administrative expenses
    8             302       65             375  
Amortization expense
                6       (1 )           5  
Restructuring charge
    6             81       4             91  
Trademark impairment charge
                173                   173  
 
                                   
Operating income (loss)
    (14 )           289       124             399  
Interest and debt expense
    65       2             1             68  
Interest income
          (1 )     (10 )     (5 )           (16 )
Intercompany interest (income) expense
    (23 )     (1 )     (22 )     46              
Intercompany dividend income
          (11 )                 11        
Other expense, net
    1       10       1       1             13  
 
                                   
Income (loss) before income taxes
    (57 )     1       320       81       (11 )     334  
Provision for (benefit from) income taxes
    (21 )     (5 )     123       26             123  
Equity income from subsidiaries
    247       200       4             (451 )      
 
                                   
Net income
  $ 211     $ 206     $ 201     $ 55     $ (462 )   $ 211  
 
                                   
 
                                               
For the Three Months Ended September 30, 2007
                                               
Net sales
  $     $     $ 1,963     $ 256     $ (45 )   $ 2,174  
Net sales, related party
                120       3             123  
Cost of products sold
                1,211       84       (45 )     1,250  
Selling, general and administrative expenses
    12             366       62             440  
Amortization expense
                5                   5  
 
                                   
Operating income (loss)
    (12 )           501       113             602  
Interest and debt expense
    78       3                         81  
Interest income
    (1 )           (27 )     (5 )           (33 )
Intercompany interest (income) expense
    (27 )           (21 )     48              
Intercompany dividend income
          (11 )                 11        
Other (income) expense, net
    1       (4 )     1       (5 )           (7 )
 
                                   
Income (loss) before income taxes and extraordinary item
    (63 )     12       548       75       (11 )     561  
Provision for (benefit from) income taxes
    (22 )     (1 )     204       22             203  
Equity income from subsidiaries
    399       355       10             (764 )      
 
                                   
Net income
  $ 358     $ 368     $ 354     $ 53     $ (775 )   $ 358  
 
                                   

58


Table of Contents

Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
Condensed Consolidating Statements of Income
(Dollars in Millions)
                                                 
    Parent             Other     Non-              
    Guarantor     Issuer     Guarantors     Guarantors     Eliminations     Consolidated  
For the Nine Months Ended September 30, 2008
                                               
Net sales
  $     $     $ 5,646     $ 846     $ (162 )   $ 6,330  
Net sales, related party
                332       6             338  
Cost of products sold
                3,563       297       (162 )     3,698  
Selling, general and administrative expenses
    17       1       921       209             1,148  
Amortization expense
                16                   16  
Restructuring charge
    6             81       4             91  
Trademark impairment charge
                173                   173  
 
                                   
Operating income (loss)
    (23 )     (1 )     1,224       342             1,542  
Interest and debt expense
    200       7             1             208  
Interest income
    (1 )     (2 )     (35 )     (13 )           (51 )
Intercompany interest (income) expense
    (63 )     (7 )     (69 )     139              
Intercompany dividend income
          (32 )                 32        
Gain on termination of joint venture
                      (328 )           (328 )
Other (income) expense, net
    3       (2 )     2                   3  
 
                                   
Income (loss) before income taxes
    (162 )     35       1,326       543       (32 )     1,710  
Provision for (benefit from) income taxes
    (57 )           616       71             630  
Equity income from subsidiaries
    1,185       1,055       345             (2,585 )      
 
                                   
Net income
  $ 1,080     $ 1,090     $ 1,055     $ 472     $ (2,617 )   $ 1,080  
 
                                   
 
                                               
For the Nine Months Ended September 30, 2007
                                               
Net sales
  $     $     $ 5,796     $ 733     $ (110 )   $ 6,419  
Net sales, related party
                363       11             374  
Cost of products sold
                3,636       242       (110 )     3,768  
Selling, general and administrative expenses
    41             1,021       175             1,237  
Amortization expense
                16       1             17  
 
                                   
Operating income (loss)
    (41 )           1,486       326             1,771  
Interest and debt expense
    246       11                         257  
Interest income
    (3 )     (4 )     (76 )     (11 )           (94 )
Intercompany interest (income) expense
    (89 )     (2 )     (54 )     145              
Intercompany dividend income
          (32 )                 32        
Other (income) expense, net
    23       (6 )     1       (10 )           8  
 
                                   
Income (loss) before income taxes and extraordinary item
    (218 )     33       1,615       202       (32 )     1,600  
Provision for (benefit from) income taxes
    (73 )     (1 )     597       67             590  
Equity income from subsidiaries
    1,156       1,039       20             (2,215 )      
 
                                   
Income before extraordinary item
    1,011       1,073       1,038       135       (2,247 )     1,010  
Extraordinary item-gain on acquisition
                1                   1  
 
                                   
Net income
  $ 1,011     $ 1,073     $ 1,039     $ 135     $ (2,247 )   $ 1,011  
 
                                   

59


Table of Contents

Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
Condensed Consolidating Statements of Cash Flows
(Dollars in Millions)
                                                 
    Parent             Other     Non-              
    Guarantor     Issuer     Guarantors     Guarantors     Eliminations     Consolidated  
For the Nine Months Ended September 30, 2008
                                               
Cash flows from (used in) operating activities
  $ 649     $ 646     $ 841     $ 75     $ (1,383 )   $ 828  
 
                                   
Cash flows from (used in) investing activities:
                                               
Purchases of short-term investments
    (8 )     (11 )     (28 )     (9 )           (56 )
Proceeds from sale of short-term investments
                208                   208  
Proceeds from settlement of long-term investments
                6                   6  
Capital expenditures
                (55 )     (40 )           (95 )
Distributions from equity investees
                      27             27  
Proceeds from termination of joint venture
                      164             164  
Other, net
          3       7                   10  
Net intercompany investments
                (1 )     1              
Intercompany notes receivable
    40       71       (100 )           (11 )      
 
                                   
Net cash flows from investing activities
    32       63       37       143       (11 )     264  
 
                                   
Cash flows from (used in) financing activities:
                                               
Dividends paid on common stock
    (752 )     (650 )     (631 )     (70 )     1,351       (752 )
Dividends paid on preferred stock
    (32 )                       32        
Excess tax benefit from stock-based compensation
    2                               2  
Proceeds from stock options exercised
    1                               1  
Repurchase of common stock
    (207 )                             (207 )
Other, net
    1                               1  
Intercompany notes payable
    98       2             (111 )     11        
 
                                   
Net cash flows (used in) from financing activities
    (889 )     (648 )     (631 )     (181 )     1,394       (955 )
 
                                   
Effect of exchange rate changes on cash and cash equivalents
                    (23 )           (23 )
 
                                   
Net change in cash and cash equivalents
    (208 )     61       247       14             114  
Cash and cash equivalents at beginning of period
    243       25       1,623       324             2,215  
 
                                   
Cash and cash equivalents at end of period
  $ 35     $ 86     $ 1,870     $ 338     $     $ 2,329  
 
                                   
 
                                               
For the Nine Months Ended September 30, 2007
                                               
Cash flows from (used in) operating activities
  $ 702     $ 220     $ 440     $ 152     $ (226 )   $ 1,288  
 
                                   
Cash flows from (used in) investing activities:
                                               
Purchases of short-term investments
          (2 )     (3,559 )     (102 )           (3,663 )
Proceeds from sale of short-term investments
          120       4,034                   4,154  
Capital expenditures
    (7 )           (66 )     (22 )           (95 )
Distributions from (investment in) equity investees
                (1 )     10             9  
Net intercompany investments
          (260 )     260                    
Other, net
          (1 )           (3 )           (4 )
Intercompany notes receivable
    40             (337 )           297        
 
                                   
Net cash flows from (used in) investing activities
    33       (143 )     331       (117 )     297       401  
 
                                   
Cash flows from (used in) financing activities:
                                               
Dividends paid on common stock
    (665 )           (139 )     (55 )     194       (665 )
Dividends paid on preferred stock
    (32 )                       32        
Repayment of long-term debt
    (254 )     (75 )                       (329 )
Issuance of long-term debt
    1,547                               1,547  
Repayment of term loan
    (1,542 )                             (1,542 )
Deferred debt issuance cost
    (15 )                             (15 )
Excess tax benefit from stock-based compensation
    1                               1  
Repurchase of common stock
    (60 )                             (60 )
Intercompany notes payable
    288                   9       (297 )      
 
                                   
Net cash flows used in financing activities
    (732 )     (75 )     (139 )     (46 )     (71 )     (1,063 )
 
                                   
Net change in cash and cash equivalents
    3       2       632       (11 )           626  
Cash and cash equivalents at beginning of period
    296       22       848       267             1,433  
 
                                   
 
                                               
Cash and cash equivalents at end of period
  $ 299     $ 24     $ 1,480     $ 256     $     $ 2,059  
 
                                   

60


Table of Contents

Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
Condensed Consolidating Balance Sheets
(Dollars in Millions)
                                                 
    Parent             Other                    
    Guarantor     Issuer     Guarantors     Non-Guarantors     Eliminations     Consolidated  
September 30, 2008
                                               
Assets
                                               
Cash and cash equivalents
  $ 35     $ 86     $ 1,870     $ 338     $     $ 2,329  
Short-term investments
    8       10       25       9             52  
Accounts receivable, net
                35       44             79  
Accounts receivable, related party
                65       2             67  
Note receivable
          1             32             33  
Other receivables
    35       2       21       5             63  
Inventories
                785       289       (2 )     1,072  
Deferred income taxes, net
    16             817       19             852  
Prepaid expenses and other
    7             129       12       (5 )     143  
Short-term intercompany notes and interest receivable
    81       35       450             (566 )      
Other intercompany receivables
    216                   19       (235 )      
 
                                   
Total current assets
    398       134       4,197       769       (808 )     4,690  
Property, plant and equipment, net
    7             884       163       (1 )     1,053  
Trademarks, net
                1,689       1,540             3,229  
Goodwill
                5,303       2,871             8,174  
Other intangibles, net
                188       3             191  
Long-term intercompany notes
    2,080       207       1,408             (3,695 )      
Investment in subsidiaries
    11,240       9,652       416             (21,308 )      
Other assets and deferred charges
    170       39       737       166       (31 )     1,081  
 
                                   
Total assets
  $ 13,895     $ 10,032     $ 14,822     $ 5,512     $ (25,843 )   $ 18,418  
 
                                   
 
                                               
Liabilities and shareholders’ equity
                                               
Tobacco settlement accruals
  $     $     $ 2,135     $ 24     $     $ 2,159  
Accounts payable and other accrued liabilities
    410       6       817       99       (5 )     1,327  
Due to related party
                2                   2  
Deferred revenue, related party
                13                   13  
Current maturities of long-term debt
    189       11                         200  
Short-term intercompany notes and interest payable
    36       404       2       124       (566 )      
Other intercompany payables
          69       166             (235 )      
 
                                   
Total current liabilities
    635       490       3,135       247       (806 )     3,701  
Intercompany notes
    1,409                   2,286       (3,695 )      
Long-term debt (less current maturities)
    4,183       121                         4,304  
Deferred income taxes, net
                692       559       (31 )     1,220  
Long-term retirement benefits (less current portion)
    50       17       1,035       64             1,166  
Other noncurrent liabilities
    30       91       308       10             439  
Shareholders’ equity
    7,588       9,313       9,652       2,346       (21,311 )     7,588  
 
                                   
Total liabilities and shareholders’ equity.
  $ 13,895     $ 10,032     $ 14,822     $ 5,512     $ (25,843 )   $ 18,418  
 
                                   
 
                                               
December 31, 2007
                                               
Assets
                                               
Cash and cash equivalents
  $ 243     $ 25     $ 1,623     $ 324     $     $ 2,215  
Short-term investments
                377                   377  
Accounts receivable, net
                41       32             73  
Accounts receivable, related party
                75       5             80  
Notes receivable
          1                         1  
Other receivables
    7       1       14       3             25  
Inventories
                908       290       (2 )     1,196  
Deferred income taxes, net
    11       1       814       19             845  
Prepaid expenses and other
    6             168       6             180  

61


Table of Contents

Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
                                                 
    Parent             Other                    
    Guarantor     Issuer     Guarantors     Non-Guarantors     Eliminations     Consolidated  
Short-term intercompany notes and interest receivable
    82       109       446             (637 )      
Other intercompany receivables
    153                   29       (182 )      
 
                                   
Total current assets
    502       137       4,466       708       (821 )     4,992  
Property, plant and equipment, net
    8             936       130       (1 )     1,073  
Trademarks, net
                1,867       1,540             3,407  
Goodwill
                5,302       2,872             8,174  
Other intangibles, net
                199       3             202  
Long-term intercompany notes
    2,120       225       1,310             (3,655 )      
Investment in subsidiaries
    10,848       9,240       87             (20,175 )      
Other assets and deferred charges
    186       34       534       51       (24 )     781  
 
                                   
Total assets
  $ 13,664     $ 9,636     $ 14,701     $ 5,304     $ (24,676 )   $ 18,629  
 
                                   
 
                                               
Liabilities and shareholders’ equity
                                               
Tobacco settlement accruals
  $     $     $ 2,425     $ 24     $     $ 2,449  
Accounts payable and other accrued liabilities
    391       5       873       143             1,412  
Due to related party
                4       3             7  
Deferred revenue, related party
                35                   35  
Short-term intercompany notes and interest payable
    34       403       3       197       (637 )      
Other intercompany payables
          14       168             (182 )      
 
                                   
Total current liabilities
    425       422       3,508       367       (819 )     3,903  
Intercompany notes
    1,310             2       2,343       (3,655 )      
Long-term debt
    4,383       132                         4,515  
Deferred income taxes, net
          2       643       563       (24 )     1,184  
Long-term retirement benefits (less current portion)
    44       18       1,046       59             1,167  
Other noncurrent liabilities
    36       92       262       4             394  
Shareholders’ equity
    7,466       8,970       9,240       1,968       (20,178 )     7,466  
 
                                   
Total liabilities and shareholders’ equity
  $ 13,664     $ 9,636     $ 14,701     $ 5,304     $ (24,676 )   $ 18,629  
 
                                   

62


Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
     The following is a discussion and analysis of RAI’s business, initiatives, critical accounting policies and its consolidated results of operations and financial condition. Following the overview and discussion of business initiatives, the critical accounting policies disclose certain accounting policies that are material to RAI’s results of operations and financial condition for the periods presented in this report. The discussion and analysis of RAI’s results of operations compares the third quarter of 2008 with the third quarter of 2007 and the first nine months of 2008 with the first nine months of 2007. Disclosures related to liquidity and financial condition complete management’s discussion and analysis. You should read this discussion and analysis of RAI’s consolidated financial condition and results of operations in conjunction with the financial information included in the condensed consolidated financial statements (unaudited).
Overview and Initiatives
     RAI’s reportable operating segments are RJR Tobacco and Conwood. RJR Tobacco consists of the primary operations of R. J. Reynolds Tobacco Company. Conwood consists of the Conwood companies and Lane. RAI’s wholly owned operating subsidiaries Santa Fe and GPI, among others, are included in All Other.
     Santa Fe manufactures and markets cigarettes and other tobacco products under the NATURAL AMERICAN SPIRIT brand. Beginning January 1, 2008, the management of super premium brands, including DUNHILL and STATE EXPRESS 555 cigarette brands, was transferred to Santa Fe from RJR Tobacco. GPI manufactures and exports tobacco products to U.S. territories, U.S. duty-free shops and U.S. overseas military bases and manages the international businesses of Conwood and Santa Fe.
RJR Tobacco
     RAI’s largest reportable operating segment, RJR Tobacco, is the second largest cigarette manufacturer in the United States. RJR Tobacco’s largest selling cigarette brands, CAMEL, KOOL, PALL MALL, DORAL and WINSTON, are five of the ten best-selling brands of cigarettes in the United States as of September 30, 2008. Those brands, and its other brands, including SALEM, MISTY and CAPRI, are manufactured in a variety of styles and marketed in the United States to meet a range of adult smoker preferences. RJR Tobacco also manages contract manufacturing of cigarettes and tobacco products through arrangements with BAT affiliates. On January 1, 2008, the contract manufacturing business of GPI transferred to RJR Tobacco.
     RJR Tobacco primarily conducts business in the highly competitive U.S. cigarette market with a few large manufacturers and many smaller participants. The international rights to substantially all of RJR Tobacco’s brands were sold in 1999 to JTI. In addition, in connection with the B&W business combination in 2004, RAI entered into a non-competition agreement with BAT under which RAI’s operating subsidiaries generally are prohibited, subject to certain exceptions, from manufacturing and marketing certain tobacco products outside the United States until July 2009.
     The U.S. cigarette market is a mature market in which overall consumer demand has declined since 1981 and is expected to continue to decline. Trade inventory adjustments may result in short-term changes in demand for RJR Tobacco’s products when wholesale and retail tobacco distributors adjust the timing of their purchases of product to manage their inventory levels. RJR Tobacco believes it is not appropriate for it to speculate on other external factors that may impact the purchasing decisions of the wholesale and retail tobacco distributors.
     RJR Tobacco’s brand portfolio strategy is based upon three categories: growth, support and non-support. The growth brands consist of the premium brand CAMEL, and a value brand, PALL MALL. The support brands include four premium brands, KOOL, WINSTON, SALEM and CAPRI, and two value brands, DORAL and MISTY, all of which receive limited marketing support. During the third quarter of 2008, RJR Tobacco announced that it was changing its brand portfolio strategy and reclassifying KOOL to a support brand from a growth brand. The key objectives of the portfolio strategy are to ensure the long-term market share growth of the growth brands while managing the support brands for long-term sustainability and profitability. All remaining brands are non-support brands, and are managed to maximize near-term profitability.
     In addition to its brand portfolio strategy, RJR Tobacco remains focused on the following items in response to the continuing challenges of an intensely regulated and competitive environment:

63


Table of Contents

    its efforts to broaden its business with new types of tobacco products;
 
    its focus on continuous productivity improvement and complexity reduction; and
 
    its commitment to keep its cost structure in line with the company’s performance.
     RJR Tobacco is committed to building and maintaining a portfolio of profitable brands. RJR Tobacco’s marketing programs are designed to strengthen brand image, build brand awareness and loyalty, and switch adult smokers of competing brands to RJR Tobacco brands. In addition to building strong brand equity, RJR Tobacco’s marketing approach utilizes a retail pricing strategy, including discounting at retail, to defend certain brands’ shares of market against competitive pricing pressure. RJR Tobacco’s competitive pricing methods include list price changes, discounting programs, such as retail buydowns, free product promotions and consumer coupons. Retail buydowns refer to payments made to the retailer to reduce the price that consumers pay at retail. Consumer coupons are distributed by a variety of methods, including in, or on, the cigarette pack and by direct mail. Free product promotions include offers such as “Buy 2 packs, Get 1 pack free.” The need for competitive pricing has increased significantly over time as a result of, among other things, higher state excise taxes and the strength of deep-discount brands. Deep-discount brands are brands marketed by manufacturers that are not original participants in the MSA, and accordingly, do not have cost structures burdened with MSA payments to the same extent as the original participating manufacturers.
     Competition is based primarily on brand positioning, including price, product attributes and packaging, consumer loyalty, promotions, advertising and retail presence. Cigarette brands produced by the major manufacturers generally require competitive pricing, substantial marketing support, retail programs and other incentives to maintain or improve market position or to introduce a new brand style. RJR Tobacco, other cigarette manufacturers and smokeless tobacco manufacturers also are introducing products in a new smokeless, spitless category, known as snus. CAMEL Snus is pasteurized tobacco that is currently sold in a small pouch that provides discreet and convenient tobacco consumption. RJR Tobacco expanded the sale of CAMEL Snus into a total of 17 markets in the first half of 2008 and is planning to expand nationally in 2009.
     In September 2008, RJR Tobacco completed a comprehensive business analysis to evaluate the best way to continue to improve performance, efficiency and competitive position. As a result, RJR Tobacco announced changes to its organizational structure to streamline non-core business processes and programs in order to allocate additional resources to strategic growth initiatives. RJR Tobacco has determined to evolve its operations to a total tobacco business model that includes both cigarettes and innovative smokeless tobacco products. In October 2008, RJR Tobacco announced its intent to introduce a new line of modern, smoke-free tobacco products called CAMEL Dissolvables that include CAMEL Orbs, Sticks and Strips. CAMEL Dissolvables are made of finely milled tobacco, and dissolve completely in the mouth. They are designed to provide current adult smokers and smokeless tobacco users with additional, convenient alternative ways to enjoy tobacco products. CAMEL Dissolvables will be launched in lead markets in the first half of 2009.
Conwood
     RAI’s other reportable segment, Conwood, is the second largest smokeless tobacco products manufacturer in the United States. Conwood’s primary brands include its largest selling moist snuff brands, GRIZZLY and KODIAK, two of the seven best-selling brands of moist snuff in the United States, and LEVI GARRETT, a loose leaf brand. Conwood’s other products include dry snuff, plug and twist tobacco products. Conwood also distributes a variety of other tobacco products including WINCHESTER and CAPTAIN BLACK little cigars, and BUGLER roll-your-own tobacco.
     The moist snuff category is divided into premium and price-value brands. The moist snuff category has developed many of the characteristics of the larger cigarette market, including pricing tiers with intense competition, focused marketing programs and significant product innovation. GRIZZLY, the nation’s largest price-value brand, has led to Conwood’s increased share of the smokeless market. KODIAK is Conwood’s leading premium brand.
     In contrast to the declining U.S. cigarette market, U.S. moist snuff volumes grew at over 7% for the first nine months of 2008 compared with the first nine months of 2007, driven by the accelerated growth of price-value brands. Profit margins on moist snuff products are generally higher than on cigarette products. Moist snuff’s growth is partially

64


Table of Contents

attributable to cigarette smokers switching from cigarettes to smokeless tobacco products or using both. Within the moist snuff category, premium brands have lost market share to price-value brands, led by GRIZZLY, in recent years.
     Conwood faces significant competition in the smokeless tobacco categories. Similar to the cigarette market, competition is based primarily on brand positioning and price, as well as product attributes and packaging, consumer loyalty, promotions, advertising and retail presence. Recently, Altria Group Inc., parent company of Philip Morris USA Inc., announced it expected to complete its acquisition of UST Inc., the largest smokeless tobacco products manufacturer in the United States, in January 2009. RAI believes the acquisition of UST by Altria could have a negative impact on the businesses of Conwood and RJR Tobacco.
Critical Accounting Policies
     GAAP requires estimates and assumptions to be made that affect the reported amounts in RAI’s condensed consolidated financial statements (unaudited) and accompanying notes. Some of these estimates require difficult, subjective and/or complex judgments about matters that are inherently uncertain, and as a result, actual results could differ from those estimates. Due to the estimation processes involved, the following summarized accounting policies and their application are considered to be critical to understanding the business operations, financial condition and results of operations of RAI and its subsidiaries.
Litigation
     RAI discloses information concerning litigation for which an unfavorable outcome is more than remote. RAI and its subsidiaries record their legal expenses and other litigation costs and related administrative costs as selling, general and administrative expenses as those costs are incurred. RAI and its subsidiaries will record any loss related to litigation at such time as an unfavorable outcome becomes probable and the amount can be reasonably estimated. When the reasonable estimate is a range, the recorded loss will be the best estimate within the range. If no amount in the range is a better estimate than any other amount, the minimum amount of the range will be recorded.
     As discussed in note 12 to condensed consolidated financial statements (unaudited), RJR Tobacco, the Conwood companies and their affiliates, including RAI, and indemnitees, have been named in a number of tobacco-related legal actions, proceedings or claims seeking damages in amounts ranging into the hundreds of millions or even billions of dollars. Unfavorable judgments have been returned in a number of tobacco-related cases and state enforcement actions. As of October 10, 2008, RJR Tobacco had paid approximately $12 million since January 1, 2006, related to such unfavorable judgments.
     RAI and its subsidiaries believe that they have valid bases for appeal of adverse verdicts against them and have valid defenses to all actions, and they intend to defend all actions vigorously. RAI’s management continues to conclude that the loss of any particular smoking and health tobacco litigation claim against RJR Tobacco or its affiliates or indemnitees, including B&W, or the loss of any particular claim concerning the use of smokeless tobacco against the Conwood companies, when viewed on an individual basis, is not probable or estimable. RJR has liabilities totaling $94 million that were recorded in 1999 in connection with certain indemnification claims, unrelated to smoking and health. These claims were asserted by JTI against RJR and RJR Tobacco, concerning the activities of Northern Brands and related litigation.
     Litigation is subject to many uncertainties, and it is possible that some of the tobacco-related legal actions, proceedings or claims could ultimately be decided against RJR Tobacco, the Conwood companies or their affiliates, including RAI, and indemnitees. Any unfavorable outcome of such actions could have a material adverse effect on the consolidated results of operations, financial position or cash flows of RAI or its subsidiaries.
Settlement Agreements
     RJR Tobacco, Santa Fe and Lane are participants in the Master Settlement Agreement, and RJR Tobacco is a participant in other state settlement agreements related to governmental health-care cost recovery actions. Their obligations and the related expense charges under the MSA are subject to adjustments based upon, among other things, the volume of cigarettes sold by the operating subsidiaries, their relative market share and inflation. Since relative market share is based on cigarette shipments, the best estimate of the allocation of charges to RJR Tobacco under these agreements is recorded in cost of products sold as the products are shipped. Adjustments to these estimates are recorded in the period that the change becomes probable and the amount can be reasonably estimated. The Conwood companies are not

65


Table of Contents

participants in the MSA. For more information related to historical and expected settlement expenses and payments under the MSA, see “-Litigation Affecting the Cigarette Industry-Health-Care Cost Recovery Cases-MSA” and “-MSA-Enforcement and Validity” in note 12 to condensed consolidated financial statements (unaudited).
Income Taxes
     Tax law requires certain items to be included in taxable income at different times than is required for book reporting purposes under SFAS No. 109, “Accounting for Income Taxes.” These differences may be permanent or temporary in nature. FIN No. 48, “Accounting for Uncertainty in Income Taxes,” clarifies SFAS No. 109 by providing guidance for consistent reporting of uncertain income tax positions recognized in a company’s financial statements.
     RAI determines its annual effective income tax rate based on forecasted pre-tax book income and forecasted permanent book and tax differences. The rate is established at the beginning of the year and is evaluated on a quarterly basis. Any changes to the forecasted information may cause the effective rate to be adjusted. Additional tax, interest, and penalties associated with uncertain tax positions are recognized in tax expense on a quarterly basis.
     To the extent that any book and tax differences are temporary in nature, that is, the book realization will occur in a different period than the tax realization, a deferred tax asset or liability is established as required under SFAS No. 109. To the extent that a deferred tax asset is created, management evaluates RAI’s ability to realize this asset. Management currently believes it is more likely than not that the deferred tax assets recorded in RAI’s condensed consolidated balance sheet (unaudited) will be realized. To the extent a deferred tax liability is established under SFAS No. 109, it is recorded, tracked and, once it becomes currently due and payable, paid to the taxing authorities.
     The condensed consolidated financial statements (unaudited) reflect management’s best estimate of RAI’s current and deferred tax liabilities and assets. Future events, including but not limited to, additional resolutions with taxing authorities could have an impact on RAI’s current estimate of tax liabilities, realization of tax assets and upon RAI’s effective income tax rate.
Restructuring Charge
     During the third quarter of 2008, RAI and certain of its operating subsidiaries recorded charges related to workforce reductions in accordance with the provisions of SFAS No. 112, “Employers’ Accounting for Postemployment Benefits,” and SFAS No. 88, “Employers’ Accounting for Settlements and Curtailments of Defined Benefit Pension Plans and for Termination Benefits.” The calculation of severance pay requires management to estimate the population of employees to be terminated and the timing of their severance from employment. The calculation of benefits charges requires actuarial assumptions including determination of discount rates. These restructuring charges were based on management’s best estimate at the time of the restructuring. The status of the restructuring activities is reviewed on a quarterly basis and any adjustments to the reserve, which could differ from previous estimates, would be recorded as an adjustment to operating income. See note 3 to condensed consolidated financial statements (unaudited) for more information related to restructuring charges.
Trademark Impairment
     During the third quarter of 2008, RJR Tobacco recorded a trademark impairment charge related to its KOOL brand in accordance with the provisions of SFAS No. 142, “Goodwill and Other Intangible Assets.” RAI generally engages an independent appraisal firm to assist it in determining the fair value of its reporting units’ trademarks with indefinite lives annually in the fourth quarter or more frequently if events indicate that the asset might be impaired. The determination of fair value involves considerable estimates and judgment, including, among other things, developing forecasts of future cash flows and determining an appropriate discount rate. Although RAI believes it has based its impairment testing and impairment charges on reasonable estimates and assumptions, the use of different estimates and assumptions could result in materially different results. Generally, if the current competitive environment worsens or RAI’s operating companies’ strategic initiatives adversely affect their financial performance, the fair value of goodwill, trademarks and other intangibles could be impaired in future periods. See note 2 to condensed consolidated financial statements (unaudited) for more information related to RJR Tobacco’s trademark impairment.

66


Table of Contents

Recently Adopted Accounting Pronouncements
     Effective January 1, 2008, RAI adopted SFAS No. 157, “Fair Value Measurements,” for financial assets and financial liabilities. SFAS No. 157 does not require any new fair value measurements but provides a definition of fair value, establishes a framework for measuring fair value and expands disclosure about fair value measurements. RAI will adopt SFAS No. 157 for nonfinancial assets and nonfinancial liabilities on January 1, 2009. The adoption of SFAS No. 157 on financial assets and financial liabilities did not have a material impact on RAI’s consolidated results of operations, financial position or cash flows. RAI is currently assessing the impact of SFAS No. 157 for nonfinancial assets and nonfinancial liabilities on its consolidated results of operations, financial position and cash flows.
     On October 10, 2008, the FASB issued FSP No. FAS 157-3, “Determining the Fair Value of a Financial Asset When the Market for That Asset Is Not Active.” FSP FAS 157-3 clarifies the application of SFAS No. 157, “Fair Value Measurements,” in a market that is not active and provides an example to illustrate key considerations in determining the fair value of a financial asset when the market for that financial asset is not active. FSP FAS 157-3 is effective immediately, including prior periods for which financial statements have not been issued. RAI has adopted FSP FAS 157-3 effective with the financial statements ended September 30, 2008. The adoption of FSP FAS 157-3 had no impact on RAI’s consolidated results of operations, financial position or cash flows.
Recently Issued Accounting Pronouncements
     In March 2008, the FASB issued SFAS No. 161, “Disclosures about Derivative Instruments and Hedging Activities-an amendment of FASB Statement No. 133.” SFAS No. 161 seeks qualitative disclosures about the objectives and strategies for using derivatives, quantitative data about the fair value of and gains and losses on derivative contracts, and details of credit-risk-related contingent features in hedged positions. SFAS No. 161 also seeks enhanced disclosure around derivative instruments in financial statements, accounting under SFAS No. 133, “Accounting for Derivative Instruments and Hedging Activities,” and how hedges affect an entity’s financial position, financial performance and cash flows. SFAS No. 161 is effective for RAI as of January 1, 2009. RAI does not expect the adoption of SFAS No. 161 to have a material impact on its consolidated results of operations, financial position or cash flows.
     In April 2008, the FASB issued FSP No. FAS 142-3, “Determination of the Useful Life of Intangible Assets.” FSP FAS 142-3 amends the factors that should be considered in developing renewal or extension assumptions used to determine the useful life of a recognized intangible asset under SFAS No. 142, “Goodwill and Other Intangible Assets.” The objective of FSP FAS 142-3 is to improve the consistency between the useful life of a recognized intangible asset under SFAS No. 142 and the period of expected cash flows used to measure the fair value of the asset under SFAS No. 141(R) and GAAP. FSP FAS 142-3 is effective for financial statements issued for years beginning after December 15, 2008, and interim periods within those years and is applied prospectively to intangible assets acquired after the effective date. RAI does not expect the adoption of FSP FAS 142-3 to have a material impact on its financial position, results of operations or cash flows.

67


Table of Contents

Results of Operations
                                                 
    Three Months Ended     Nine Months Ended  
    September 30,     September 30,  
                    %                     %  
    2008     2007     Change     2008     2007     Change  
Net sales:1
RJR Tobacco
  $ 1,977     $ 2,019       (2.1 )%   $ 5,798     $ 5,995       (3.3 )%
Conwood
    181       166       9.0 %     536       495       8.3 %
All Other
    114       112       1.8 %     334       303       10.2 %
 
                                       
Net sales
    2,272       2,297       (1.1 )%     6,668       6,793       (1.8 )%
Cost of products sold1, 2
    1,229       1,250       (1.7 )%     3,698       3,768       (1.9 )%
Selling, general and administrative expenses
    375       440       (14.8 )%     1,148       1,237       (7.2 )%
Amortization expense
    5       5             16       17       (5.9 )%
Restructuring charge
    91           NM3     91           NM3
Trademark impairment charge
    173           NM3     173           NM3
Operating income:
                                               
RJR Tobacco
    293       499       (41.3 )%     1,231       1,483       (17.0 )%
Conwood
    98       90       10.2 %     275       260       6.0 %
All Other
    35       37       (5.4 )%     112       107       4.7 %
Corporate expense
    (27 )     (24 )     12.5 %     (76 )     (79 )     (3.8 )%
 
                                       
Operating income
  $ 399     $ 602       (33.7 )%   $ 1,542     $ 1,771       (12.9 )%
 
                                       
 
1  Excludes excise taxes of:
 
RJR Tobacco
  $ 438     $ 474             $ 1,276     $ 1,413          
Conwood
    5       5               15       14          
All Other
    49       42               138       117          
 
                                       
 
  $ 492     $ 521             $ 1,429     $ 1,544          
 
                                       
 
2   See below for further information related to MSA settlement and federal tobacco buyout expense included in cost of products sold.
 
3   Percentage change not meaningful.
     In the third quarter of 2008, RAI and RJR Tobacco announced changes in their organizational structures to streamline non-core business processes and programs in order to allocate additional resources to strategic growth initiatives. The reorganizations will result in the elimination of approximately 600 full-time jobs, expected to be substantially completed by December 31, 2009.
     Under existing benefit plans, $84 million of severance-related cash benefits and $7 million of non-cash pension-related benefits comprised a restructuring charge of $91 million. Of this charge, $81 million was recorded in the RJR Tobacco segment. None of the cash portion of the charge was paid as of September 30, 2008. The cash benefits are expected to be substantially paid by December 31, 2010. Cost savings related to the restructuring are expected to be $42 million in 2009, $53 million in 2010 and $55 million on an annualized basis thereafter.
RJR Tobacco
     Net Sales
     Domestic cigarette shipment volume, in billions of units for RJR Tobacco and the industry, was as follows1:
                                                 
    Three Months Ended   Nine Months Ended
    September 30,   September 30,
    2008   2007   % Change   2008   2007   % Change
Growth brands:
                                               
CAMEL excluding non-filter
    6.3       6.2       0.6 %     17.7       18.5       (4.3 )%
PALL MALL
    2.4       1.8       33.9 %     6.2       5.3       17.6 %
 
                                               

68


Table of Contents

                                                 
    Three Months Ended   Nine Months Ended
    September 30,   September 30,
    2008   2007   % Change   2008   2007   % Change
Total growth brands
    8.7       8.1       8.1 %     23.9       23.8       0.6 %
 
                                               
Support brands2
    11.6       13.3       (12.7 )%     35.5       39.7       (10.5 )%
Non-support brands
    2.8       3.6       (23.2 )%     8.4       11.1       (24.2 )%
 
                                               
Total domestic
    23.1       25.0       (7.5 )%     67.8       74.6       (9.0 )%
 
                                               
 
                                               
Total premium
    14.4       15.6       (8.0 )%     42.5       46.5       (8.6 )%
Total value
    8.7       9.4       (6.7 )%     25.3       28.0       (9.7 )%
Premium/Total mix
    62.2 %     62.6 %             62.7 %     62.4 %        
 
Industry3:
                                               
Premium
    66.1       69.1       (4.4 )%     190.2       198.2       (4.0 )%
Value
    25.5       25.8       (1.0 )%     71.5       72.6       (1.4 )%
 
                                               
Total domestic
    91.6       94.9       (3.4 )%     261.7       270.7       (3.3 )%
 
                                               
 
                                               
Premium/Total mix
    72.2 %     72.9 %             72.7 %     73.2 %        
 
1   Amounts presented in this table are rounded on an individual basis and, accordingly, may not sum on an aggregate basis. Percentages are calculated on unrounded numbers.
 
2   During the third quarter of 2008, the KOOL brand was reclassified from a growth brand to a support brand.
 
3   Based on information from Management Science Associates, Inc., referred to as MSAi. Prior year amounts have been restated to reflect current methodology.
     RJR Tobacco’s net sales are dependent upon its shipment volume in a declining market, premium versus value-brand mix and list pricing, offset by promotional spending, trade incentives and federal excise taxes. RJR Tobacco’s net sales for the third quarter of 2008 decreased $42 million, or 2.1%, from the comparable prior-year quarter, including $161 million attributable to lower volume, partially offset by higher pricing, net of promotional spending. RJR Tobacco’s domestic shipment volume decreased 7.5% in the third quarter of 2008 compared with the prior-year quarter. RJR Tobacco’s decreases in net sales and shipment volume reflect a decrease in consumption, wholesale inventory reductions and the impact of RJR Tobacco’s discontinuation of certain lower-priced, low-margin brands as well as several non-core styles of other brands, including CAMEL. In addition, RJR Tobacco’s consumers are believed to be more price-sensitive than consumers of competing brands and, therefore, are more negatively affected by the current adverse economic pressures. Industry shipment volume for the third quarter of 2008 was down 3.4% from the comparable quarter in the prior year.
     RJR Tobacco’s net sales for the first nine months of 2008 decreased $197 million, or 3.3%, from the first nine months of 2007. Lower volume of $575 million, partially offset by higher pricing, net of promotional spending, account for the difference. Total domestic shipment volume decreased 9.0% in the first nine months of 2008 compared with the first nine months of 2007. Industry shipment volume for the first nine months of 2008 was down 3.3% compared with the first nine months of 2007.
     RJR Tobacco’s full-year shipment volume decline in 2008 compared with 2007 is expected to be approximately 8%, inclusive of the impact of the KOOL repositioning.
     The shares of RJR Tobacco as a percentage of total share of U.S. retail cigarette sales according to data1 from Information Resources, Inc./Capstone Research Inc., collectively referred to as IRI, were as follows:
                                         
    For the Three Months Ended2
    September 30,   June 30,   Share Point   September 30,   Share Point
    2008   2008   Change   2007   Change
Growth brands:
                                       
CAMEL excluding non-filter
    8.1 %     8.0 %     0.2       8.0 %     0.1  
PALL MALL
    2.7 %     2.6 %     0.1       2.1 %     0.5  
 
                                       
Total growth brands
    10.8 %     10.5 %     0.3       10.1 %     0.7  

69


Table of Contents

                                         
    For the Three Months Ended2
    September 30,   June 30,   Share Point   September 30,   Share Point
    2008   2008   Change   2007   Change
Support brands3
    13.8 %     13.9 %     (0.1 )     14.5 %     (0.7 )
 
                                       
Non-support brands
    3.5 %     3.6 %     (0.1 )     4.3 %     (0.8 )
 
                                       
 
                                       
Total domestic
    28.2 %     28.1 %     0.1       29.0 %     (0.8 )
 
1   Retail share of U.S. cigarette sales data is included in this document because it is used by RJR Tobacco primarily as an indicator of the relative performance of industry participants, and brands and market trends. You should not rely on the market share data reported by IRI as being a precise measurement of actual market share because IRI is not able to effectively track all volume. Moreover, you should be aware that in a product market experiencing overall declining consumption, a particular product can experience increasing market share relative to competing products, yet still be subject to declining consumption volumes.
 
2   Amounts presented in this table are rounded on an individual basis and, accordingly, may not sum on an aggregate basis.
 
3   During the third quarter of 2008, the KOOL brand was reclassified from a growth brand to a support brand.
     The retail share of market of CAMEL’s filtered styles increased slightly in the third quarter of 2008 compared with the prior quarter and the third quarter of 2007. During the first half of 2008, CAMEL launched updated packaging and smoother blends for its core styles. CAMEL also introduced CAMEL Crush in test markets during the first quarter of 2008. CAMEL Crush is an innovative cigarette that uses RJR Tobacco’s technology to provide adult smokers the option of changing each cigarette from regular to menthol by crushing a capsule in the filter. CAMEL Crush was expanded nationally during the third quarter of 2008. Continuing its planned expansion in 2008, CAMEL Snus is currently in 17 markets and is planned to be expanded nationally in 2009. Additionally, in October 2008, RJR Tobacco introduced a new line of modern, smoke-free tobacco products called CAMEL Dissolvables that include CAMEL Orbs, Sticks and Strips. CAMEL Dissolvables are made of finely milled tobacco, and dissolve completely in the mouth. They are designed to provide current adult smokers and smokeless tobacco users with additional, convenient alternative ways to enjoy tobacco products. CAMEL Dissolvables will be launched in lead markets in the first half of 2009.
     PALL MALL’s market share increased 0.1 share points in the third quarter of 2008 compared with the previous quarter and increased 0.5 share points from the comparable quarter of 2007. PALL MALL’s growth is believed to be the result of the brand’s position as a product that offers a longer-lasting cigarette at a value price. PALL MALL introduced more stylish, round-corner packs in the second quarter of 2008.
     The combined share of market of RJR Tobacco’s growth brands during the first nine months of 2008 showed improvement over the comparative prior-year period. However, as expected, the decline in share of support and non-support brands more than offset the gains on the growth brands.
     Operating Income
     RJR Tobacco’s operating income for the third quarter of 2008 decreased $206 million to $293 million, or 14.8% of net sales, from $499 million, or 24.7% of net sales, in the comparable prior-year quarter. For the nine months ended September 30, 2008, RJR Tobacco’s operating income decreased $252 million to $1,231 million, or 21.2% of net sales, from $1,483 million, or 24.7% of net sales, for the first nine months of 2007. The change in brand portfolio strategy and reclassification of the KOOL brand to a support brand from a growth brand in the third quarter of 2008 triggered a non-cash trademark impairment of $173 million. This charge was based on the excess of KOOL’s carrying value over its fair value using the present value of estimated future cash flows assuming a discount rate of 10.5%. The discount rate was determined by adjusting the enterprise discount rate by an appropriate risk premium to reflect an asset group risk. In addition, RJR Tobacco incurred a restructuring charge of $81 million in the third quarter of 2008 as a result of streamlining non-core business processes and programs and eliminating approximately 540 full-time positions. The trademark impairment charge and restructuring charge were partially offset by higher pricing, improvements in productivity and higher levels of undiscounted wholesale inventory. Additionally, RJR Tobacco’s volume and operating income were negatively impacted by the discontinuation of certain lower-priced, low-margin brands as well as several non-core styles of other brands, including CAMEL.

70


Table of Contents

     RJR Tobacco’s MSA settlement and federal tobacco buyout expenses, included in cost of products sold, are detailed in the schedule below:
                                 
    For The Three Months     For The Nine Months  
    Ended September 30,     Ended September 30,  
    2008     2007     2008     2007  
Settlements
  $ 686     $ 712     $ 2,050     $ 2,120  
 
                       
Federal tobacco quota buyout.
  $ 57     $ 59     $ 180     $ 197  
 
                       
     MSA expenses are expected to be approximately $2.7 billion in 2008, subject to adjustment for changes in volume and other factors, and the federal tobacco quota buyout is expected to be approximately $250 million in 2008. For additional information, see “—Litigation Affecting the Cigarette Industry-Health-Care Cost Recovery Cases — MSA” and “—Tobacco Buyout Legislation and Related Litigation” in note 12 to condensed consolidated financial statements (unaudited).
     Selling, general and administrative expenses include the costs of litigating and administering product liability claims, as well as other legal expenses. RJR Tobacco’s product liability defense costs were $21 million and $16 million for the three months, and $72 million and $67 million for the nine months, ended September 30, 2008 and 2007, respectively.
     “Product liability” cases generally include the following types of smoking and health related cases:
    Individual Smoking and Health;
 
    Engle Progeny;
 
    Broin II;
 
    Class Actions; and
 
    Health-Care Cost Recovery Cases.
     “Product liability defense costs” include the following items:
    direct and indirect compensation, fees and related costs and expenses for internal legal and related administrative staff administering product liability claims;
 
    fees and cost reimbursements paid to outside attorneys;
 
    direct and indirect payments to third party vendors for litigation support activities;
 
    expert witness costs and fees; and
 
    payments to fund legal defense costs for the now dissolved Council for Tobacco Research-U.S.A.
     Numerous factors affect the amount of product liability defense costs. The most important factors are the number of cases pending and the number of cases in trial or in preparation for trial (that is, with active discovery and motions practice). See “—Litigation Affecting the Cigarette Industry—Overview” for detailed information regarding the number and type of cases pending, and “—Litigation Affecting the Cigarette Industry—Scheduled Trials” for detailed information regarding the number and nature of cases in trial and scheduled for trial through September 30, 2009, in note 12 to condensed consolidated financial statements (unaudited).
     RJR Tobacco expects that the factors described above will continue to have the primary impact on its product liability defense costs in the future. Given the level of activity in cases in preparation for trial, in trial and on appeal, and the amount of product liability defense costs incurred by RJR Tobacco in the past, RJR Tobacco’s recent

71


Table of Contents

experiences in defending its product liability cases, and the reasonably anticipated level of activity in RJR Tobacco’s pending cases and possible new cases, RJR Tobacco does not expect that the variances in its product liability defense costs will be significantly different than they have been historically, aside from the assumption of certain B&W litigation and the increased individual case filings in Florida due to the Engle decision. See “—Litigation Affecting the Cigarette Industry—Engle Progeny Cases” and “—Litigation Affecting the Cigarette Industry—Class Action Suits—Engle Case” in note 12 to condensed consolidated financial statements (unaudited) for additional information. However, it is possible that adverse developments in the factors discussed above, as well as other circumstances beyond the control of RJR Tobacco, could have a material adverse effect on the financial condition, results of operations or cash flows of RAI or its subsidiaries. Those other circumstances beyond the control of RJR Tobacco include the results of present and future trials and appeals, and the development of possible new theories of liability by plaintiffs and their counsel.
Conwood
     The moist snuff shipment volume, in millions of cans, for Conwood was as follows:
                                                 
    For the Three Months Ended September 30,1   For the Nine Months Ended September 30,1
    2008   2007   % Change   2008   2007   % Change
Premium:
                                               
KODIAK
    13.6       12.9       5.5 %     39.5       39.9       (1.0 )%
Other
    0.7       0.8       (6.5 )%     2.1       2.4       (11.1 )%
 
                                               
Total Premium
    14.3       13.6       4.8 %     41.6       42.2       (1.6 )%
Price-value:
                                               
GRIZZLY
    69.8       61.4       13.6 %     205.9       174.9       17.7 %
Other
    0.4       0.7       (42.1 )%     1.3       1.8       (24.3 )%
 
                                               
Total Price-value
    70.2       62.1       12.9 %     207.2       176.7       17.3 %
 
                                               
Total moist snuff
    84.5       75.8       11.5 %     248.8       218.9       13.7 %
 
                                               
 
1   Amounts presented in this table are rounded on an individual basis and, accordingly, may not sum on an aggregate basis. Percentages are calculated on unrounded numbers.
The Conwood shares of the moist snuff category as a percentage of total share of U.S. shipments of moist snuff, according to distributor reported data1 processed by MSAi, were as follows:
                                         
    For the Three Months Ended2
    September 30,   June 30,   Share Point   September 30,   Share Point
    2008   2008   Change   2007   Change
Premium:
                                       
KODIAK
    4.2 %     3.9 %     0.3       4.3 %     (0.1 )
Other
    0.3 %     0.2 %     0.1       0.3 %      
 
                                       
Total Premium
    4.5 %     4.2 %     0.3       4.6 %     (0.1 )
Price-value:
                                       
GRIZZLY
    23.4 %     23.4 %           21.2 %     2.1  
Other
    0.1 %     0.2 %     (0.1 )     0.2 %     (0.1 )
 
                                       
Total Price-value
    23.5 %     23.6 %     (0.1 )     21.4 %     2.1  
 
                                       
Total moist snuff
    28.0 %     27.8 %     0.2       26.0 %     2.0  
 
                                       
 
1   Distributor shipments-to-retail share of U.S. moist snuff is included in this document because it is used by Conwood primarily as an indicator of the relative performance of industry participants, and brands and market trends. You should not rely on the market share data reported by distributors and processed by MSAi as being a precise measurement of actual market share because this distributor data set is not able to effectively track all volume.
 
2   Amounts presented in this table are rounded on an individual basis and, accordingly, may not sum on an aggregate basis.

72


Table of Contents

     Net Sales
     Conwood’s net sales for the third quarter of 2008 were $181 million compared with $166 million in the third quarter of 2007. Net sales for the first nine months of 2008 were $536 million compared with $495 million for the first nine months of 2007. Moist snuff sales generated the increases over prior-year periods led by GRIZZLY, Conwood’s leading price-value moist snuff brand.
     GRIZZLY had a share position of 23.4% of moist snuff shipments in the third quarter of 2008, stable with the previous quarter and an increase of 2.1 points from the third quarter of 2007. In 2008, Conwood expanded nationally the launch of two new GRIZZLY styles, GRIZZLY Wintergreen Pouches and GRIZZLY Snuff, to build on the brand’s momentum and aid in its share growth. The shipment share of KODIAK, Conwood’s leading premium moist snuff brand, increased compared with the prior quarter due to increased promotions, but declined slightly compared with prior-year quarter due to competitive promotional activity and core markets being burdened by high tobacco taxes and tough economies.
     Operating Income
     Conwood’s operating income for the third quarter of 2008 increased to $98 million, or 54.1% of net sales, from $90 million, or 53.5% of net sales, in the comparable prior-year quarter. Operating income for the first nine months of 2008 increased to $275 million, or 51.3% of net sales, from $260 million, or 52.4% of net sales, for the first nine months of 2007. These changes are due to increased price-value volume and higher pricing offset by increased promotional spending.
RAI Consolidated
     Gain on termination of joint venture of $328 million in 2008 related to the termination of the Reynolds-Gallaher International Sarl joint venture. See note 4 to condensed consolidated financial statements (unaudited) for additional information related to the joint venture termination.
     Other (income) expense, net was $13 million expense in the third quarter of 2008 compared with $7 million of income in the third quarter of 2007. For the nine months ended September 30, 2008, other (income) expense, net was $3 million expense, which consisted primarily of $3 million of foreign exchange losses and a $2 million realized loss on investments and higher bank fees, offset by a gain of $5 million related to the sale of a non-consolidated equity investment. Other (income) expense, net of $8 million expense for the first nine months of 2007 included the expensing of the unamortized debt fees associated with a term loan that RAI prepaid in full in June 2007, which more than offset foreign exchange gain and equity income.
     Provision for income taxes was $123 million, or an effective rate of 36.8%, in the third quarter of 2008 compared with $203 million, or an effective rate of 36.2%, in the third quarter of 2007. The provision for income taxes for the first nine months of 2008 was $630 million, or an effective rate of 36.8%, compared with $590 million, or an effective rate of 36.9%, in the first nine months of 2007. The effective rate for the first nine months of 2008 was favorably impacted by a lower tax rate related to the gain on the termination of the Reynolds-Gallaher International Sarl joint venture. The effective tax rates exceeded the federal statutory rate of 35% primarily due to the impact of state taxes and certain non-deductible items, offset by the domestic production activities deduction of the American Jobs Creation Act, enacted on October 22, 2004.
Liquidity and Financial Condition
Liquidity
     At present, the principal sources of liquidity for RAI’s operating subsidiaries’ businesses and operating needs are internally generated funds from their operations and intercompany loans and advances, mainly from RAI and RJR. The principal capital resources and sources of liquidity for RAI and RJR, in turn, are proceeds from issuances of debt securities by RAI and RJR and the RAI Credit Facility described below under “— Borrowing Arrangements.” Cash flows from operating activities are believed to be sufficient for the foreseeable future to enable the operating subsidiaries to meet their obligations under the MSA, to fund their capital expenditures and to make payments to RAI

73


Table of Contents

and RJR that, when combined with RAI’s and RJR’s cash balances, will enable RAI and RJR to make their required debt-service payments, and enable RAI to pay dividends to its shareholders.
     The negative impact, if any, on the sources of liquidity that could result from a decrease in demand for products due to short-term inventory adjustments by wholesale and retail distributors, changes in competitive pricing or accelerated declines in consumption, cannot be predicted. RAI cannot predict its cash requirements or those of its subsidiaries related to any future settlements or judgments, including cash required to be held in escrow or to bond any appeals, if necessary, and RAI makes no assurance that it or its subsidiaries will be able to meet all of those requirements.
     As of September 30, 2008, RAI held investments primarily in money market funds, commercial paper, auction rate notes and mortgage-backed securities. In September 2008, certain money market funds were reclassified to short-term investments from cash equivalents due to liquidity restrictions by the fund managers. Given such restrictions, these funds will not be available until the underlying investments mature or are sold. Adverse changes in financial markets during 2007 caused certain auction rate notes and mortgage-backed securities to revalue lower than their carrying value and become less liquid. Auction rate notes and mortgage-backed securities will not become liquid until a successful auction occurs or a buyer is found. RAI intends, and has the ability, to hold these money market funds, auction rate notes and mortgage-backed securities for a period of time sufficient to allow for sale, redemption or anticipated recovery in fair value. RAI considers the auction rate notes and mortgage-backed securities to be temporarily impaired as of September 30, 2008.
Cash Flows
     Net cash flows from operating activities were $828 million in the first nine months of 2008, compared with $1,288 million in the first nine months of 2007. This change was driven primarily by higher MSA and tax payments, partially offset by lower pension funding in 2008.
     Net cash flows from investing activities were $264 million in the first nine months of 2008, compared with $401 million in the prior-year period. This change was primarily driven by proceeds received as a result of the termination of the joint venture in 2008 compared with higher short-term investing net proceeds in the prior-year period.
     Net cash flows used in financing activities were $955 million in the first nine months of 2008, compared with $1,063 million in the prior-year period. This change was due to prior-year repayment of long-term debt, offset by higher stock repurchases and higher dividends per share in the current-year period.
Borrowing Arrangements
     As of September 30, 2008, RAI’s total consolidated debt consisted of RAI Notes in the aggregate principal amount of $4.3 billion, with maturity dates ranging from 2009 to 2037, and RJR notes in the aggregate principal amount of $129 million, with maturity dates ranging from 2009 to 2015.
     RAI and RJR use interest rate swaps to manage interest rate risk on a portion of their debt obligations. Under certain conditions, any fair value that results in a liability position of certain interest rate swaps may require full collateralization with cash or securities.
     At their option, RAI and RJR, as applicable, may redeem any or all of their outstanding fixed rate notes, in whole or in part at any time, subject to the payment of a make-whole premium. RAI’s floating rate notes are redeemable at par on any interest payment date after December 15, 2008.
     On June 28, 2007, RAI entered into the Credit Facility. The Credit Facility provides for a five-year, $550 million revolving credit facility, which may be increased to $900 million at the discretion of the lenders upon the request of RAI. The Credit Facility’s maturity date of June 28, 2012, may be extended, at the discretion of the lenders upon RAI’s request, in two separate one-year increments.

74


Table of Contents

     Lenders and their respective commitments in the Credit Facility, which are several, not joint, commitments, are listed below:
         
Lender   Commitment  
JP Morgan Chase Bank, N.A.
  $ 52.89  
Citibank N.A.
    52.89  
Morgan Stanley Bank
    52.00  
Lehman Commercial Paper Inc.
    52.00  
Mizuho Corporate Bank, Ltd.
    52.00  
General Electric Capital Corporation
    52.00  
AG First Farm Credit Bank
    52.00  
Goldman Sachs Bank USA
    35.00  
Wachovia Bank, National Association
    35.00  
The Bank of Nova Scotia
    35.00  
The Bank of New York
    35.00  
Farm Credit Services of Minnesota Valley, PCA DBA FCS Commercial Finance Group
    20.00  
City National Bank of New Jersey
    14.22  
Farm Credit Bank of Texas
    10.00  
 
     
 
  $ 550.00  
 
     
     On October 9, 2008, Wells Fargo & Company reaffirmed that it is proceeding with its merger with Wachovia Corporation, the parent company of Wachovia Bank, National Association, pursuant to which Wells Fargo will acquire all of Wachovia Corporation and all its business and its obligations.
     At September 30, 2008, RAI had $12 million in letters of credit outstanding under the Credit Facility. At such date, no borrowings were outstanding, and the remaining $538 million of the Credit Facility was available for borrowing.
     On October 5, 2008, LCPI filed for protection under Chapter 11 of the federal Bankruptcy Code. RAI has never borrowed under the Credit Facility, but given LCPI’s bankruptcy filing, there can be no assurance that LCPI would loan to RAI LCPI’s pro rata share of any borrowing requests made by RAI. Subject to the terms and conditions in the Credit Facility, RAI has the right to replace a lender in certain circumstances, including upon a lender defaulting in its obligation to make loans. If any lender were to default in its obligation to make loans, there can be no assurance as to when or whether RAI could find an acceptable replacement lender.
     The Guarantors have guaranteed RAI’s obligations under the Credit Facility and under the Notes. During the second quarter of 2008, the collateral securing the Credit Facility, Notes and related guarantees was released as a result of certain corporate credit ratings actions by S&P and Moody’s. The collateral for the Credit Facility, Notes and related guarantees will be reinstated if RAI’s corporate credit rating issued by each of S&P and Moody’s is lowered to at least one level below the lowest rating level established as investment grade, or if RAI’s corporate credit rating issued by either S&P or Moody’s is lowered to at least two levels below the lowest rating level established as investment grade. For more information on the release of collateral, see note 10 to condensed consolidated financial statements (unaudited).
     Prior to the credit ratings actions described above, RAI had pledged substantially all of its assets, including the stock of its direct subsidiaries, to secure its obligations under the Credit Facility, and the Guarantors had pledged substantially all of their assets to secure their guarantees of RAI’s obligations under the Credit Facility. Also prior to such credit ratings actions, the Notes and related guarantees had been secured by any Principal Property, as such term is defined in the indenture governing the Notes, of RAI and certain of the Guarantors, and the stock, indebtedness or other obligations of RJR Tobacco.
     Concerns about, or lowering of, RAI’s ratings by S&P or Moody’s could have an adverse impact on RAI’s ability to access the debt markets and could increase borrowing costs. However, given the cash balances and operating performance of RAI and its subsidiaries, RAI’s management believes that such concerns about, or lowering of, such ratings would not have a material adverse impact on RAI’s cash flows.
     RAI, RJR and their affiliates were in compliance with all covenants and restrictions imposed by their indebtedness at September 30, 2008.

75


Table of Contents

Dividends
     On July 18, 2008, the board of directors of RAI declared a quarterly cash dividend of $0.85 per common share. The dividend was paid on October 1, 2008, to shareholders of record as of September 10, 2008.
     On an annualized basis, the dividend rate is $3.40 per common share. The dividend reflects RAI’s dividend policy of paying dividends to the holders of RAI’s common stock in an aggregate amount that is approximately 75% of RAI’s annual consolidated net income.
Share Repurchases
     On April 29, 2008, RAI’s board of directors authorized RAI’s repurchase, from time to time on or before April 30, 2009, of up to $350 million of outstanding shares of RAI common stock in open market or privately negotiated transactions. The repurchases are subject to prevailing market and business conditions, and the program may be terminated or suspended at any time. In connection with the share repurchase program, RAI and B&W entered into an agreement, pursuant to which B&W has agreed to participate in the repurchase program on a basis approximately proportionate with B&W’s 42% ownership of RAI’s equity. This repurchase program supersedes the $30 million repurchase program authorized by RAI’s board of directors on February 5, 2008, to offset the dilution from shares issued under certain equity-based benefit plans.
     Due to RAI’s incorporation in North Carolina, which does not recognize treasury shares, the shares repurchased are cancelled at the time of repurchase. As of September 30, 2008, RAI had repurchased and cancelled 3,817,095 shares of RAI common stock for $207 million under the above share repurchase programs.
Capital Expenditures
     RAI’s operating subsidiaries’ cash capital expenditures were $95 million for each of the first nine months of 2008 and 2007. RAI’s operating subsidiaries plan to spend an additional $40 million to $50 million for capital expenditures in the fourth quarter of 2008, funded primarily by cash flows from operations. Most of the capital spending will be done in the RJR Tobacco segment. RAI’s operating subsidiaries’ capital expenditure programs are expected to continue at a level sufficient to support their strategic and operating needs. There were no material long-term commitments for capital expenditures as of September 30, 2008.
Retirement Benefits
     Due to the adverse changes in the financial markets, RAI’s pension assets have been negatively impacted. Through September 30, 2008, the overall year-to-date rate of return on the investments for the pension assets was approximately negative 16.3%. RAI is assessing the asset allocation and investment strategy to determine if any adjustments may be appropriate in light of changes in the accounting for and regulation of pension plans, such as the adoption of the Pension Protection Act of 2006. Depending on the results of any new asset allocation and investment strategy, RAI may lower the expected long-term return on pension assets, referred to as the ELTRA. The ELTRA, current asset performance and the discount rate may impact the funded status of RAI’s pension plans, and possibly increase the funding requirements and pension expense in 2009.
Governmental Activity
     The marketing, sale, taxation and use of tobacco products have been subject to substantial regulation by government and health officials for many years. Various state governments have adopted or are considering, among other things, legislation and regulations that would:
    significantly increase their taxes on tobacco products;
 
    restrict displays, advertising and sampling of tobacco products;
 
    establish fire standards compliance for cigarettes;
 
    raise the minimum age to possess or purchase tobacco products;

76


Table of Contents

    restrict or ban the use of certain flavorings, including menthol, in tobacco products, or the use of certain flavor descriptors in the marketing of tobacco products;
 
    require the disclosure of ingredients used in the manufacture of tobacco products;
 
    require the disclosure of nicotine yield information for cigarettes based on a machine test method different from that required by the U.S. Federal Trade Commission, referred to as the FTC;
 
    impose restrictions on smoking in public and private areas; and
 
    restrict the sale of tobacco products directly to consumers or other unlicensed recipients, including over the Internet.
     In addition, during 2009, the U.S. Congress likely will reconsider legislation regarding the regulation of tobacco products by the U.S. Food and Drug Administration, referred to as the FDA, as well as a further increase in the federal excise tax on cigarettes and other tobacco products. The U.S. Congress also may consider legislation regarding:
    regulation of environmental tobacco smoke;
 
    implementation of national fire standards compliance for cigarettes;
 
    the FTC’s cigarette test method;
 
    regulation of the retail sale of tobacco products over the Internet and in other non-face-to-face retail transactions, such as by mail order and telephone; and
 
    banning of the delivery of tobacco products by the U.S. Postal Service.
     Together with manufacturers’ price increases in recent years and substantial increases in state and federal taxes on tobacco products, these developments have had and will likely continue to have an adverse effect on the sale of tobacco products.
     In February 2007, legislation was introduced in the U.S. House of Representatives and the U.S. Senate that would have given the FDA broad regulatory authority over tobacco products. The proposals would have granted the FDA authority to impose product standards, including standards relating to, among other things, nicotine yields and smoke constituents, and would have reinstated the FDA’s 1996 proposed legislation that would have restricted marketing. The proposed legislation also would have governed modified risk products, including tobacco products using the descriptors “light”, “mild”, “low” or similar descriptors, and would have imposed new and larger warning labels on tobacco products. The U.S. Senate Health, Education, Labor and Pensions Committee approved the FDA regulation bill on August 1, 2007. The Health Subcommittee of the Energy and Commerce Committee of the U.S. House of Representatives held a hearing on the bill on October 3, 2007, and passed H.R. 1108, the Family Smoking Prevention and Tobacco Control Act, on March 11, 2008. The full House Energy and Commerce Committee passed the bill on April 2, 2008. During the Committee’s consideration of the bill, changes were made granting small manufacturers additional time to comply with certain portions of the proposed regulatory scheme. Retailers received some clarification on enforcement penalties, but none of the changes could be classified as substantially changing the scope of the bill. On July 30, 2008, the U.S. House of Representatives passed the bill by a vote of 326-102. Congress recently adjourned without any further action on the bill. In 2009, it is likely that Congress will again take up the issue of FDA regulation of tobacco products.
     Cigarettes are subject to substantial excise taxes in the United States. The federal excise tax per pack of 20 cigarettes is $0.39. In 2007, the U.S. Senate and U.S. House of Representatives approved an increase of $0.61 in the excise tax per pack of cigarettes, and significant tax increases on other tobacco products, to fund expansion of the State Children’s Health Insurance Program, referred to as SCHIP. The President vetoed the bill on October 3, 2007. On October 18, 2007, the U.S. House of Representatives failed to override the President’s veto of the bill. Subsequently, the U.S. Congress passed a slightly revised version of the SCHIP bill, and the President vetoed the bill on December 12, 2007. In January 2008, by a vote of 152-260, the U.S. House of Representatives failed to override the veto. In between the passage of the revised legislation and the override vote, the U.S. Congress passed an extension of SCHIP through

77


Table of Contents

March of 2009 without a tax increase. At this time, RAI does not know whether any excise tax bill will be approved to fund SCHIP or any other federal program. The adoption of any such increase could have a material adverse effect on the business and results of operations of RJR Tobacco.
     All states and the District of Columbia currently impose excise taxes at levels ranging from $0.07 per pack in South Carolina to $2.75 per pack in New York. As of September 30, 2008, the weighted average state cigarette excise tax per pack, calculated on a 12-month rolling average basis, was approximately $1.019, an increase compared to the 12-month rolling average of $0.914 as of December 31, 2007. As of September 30, 2008, three states had passed excise tax per pack increases in 2008: New York, a $1.25 increase, from $1.50 to $2.75 per pack, effective June 3, 2008; Massachusetts, a $1.00 increase, from $1.51 to $2.51 per pack, effective July 1, 2008; and New Hampshire, which approved a $0.25 increase, from $1.08 to $1.33 per pack, effective October 15, 2008. In addition, on January 1, 2008, the cigarette excise tax increased by $1.00 per pack in two states as a result of legislation passed in 2007: Maryland, from $1.00 to $2.00, and Wisconsin, from $0.77 to $1.77. On July 1, 2008, Vermont increased its cigarette excise tax rate by $0.20, to $1.99 per pack, the result of an increase passed in 2006 and implemented in 2006 and 2008. Hawaii increased its cigarette excise tax on September 30, 2008, as a result of a $1.20 tax passed in 2006, which is being implemented in $0.20 increments until 2011. Certain city and county governments, such as New York and Chicago, also impose substantial excise taxes on cigarettes sold in those jurisdictions. The District of Columbia passed a $1.00 per pack increase, from $1.00 to $2.00, effective October 1, 2008.
     Cigars are generally taxed by states on an ad valorem basis, ranging from 5% in South Carolina to 75% in Alaska and Washington. Other states have unit-based tax schemes for cigars or tax little cigars the same as cigarettes.
     The federal excise tax on smokeless tobacco products currently is $0.195 per pound for chewing tobacco, and $0.585 per pound for snuff. The federal tax on small cigars, defined as those weighing three pounds or less per thousand, is $1.828 per thousand. Large cigars are taxed at a rate of 20.719% of the manufacturer’s price, with a cap of $48.75 per thousand.
     Forty-nine states also subject smokeless tobacco to excise taxes and the Commonwealth of Pennsylvania, which currently levies no tax on other tobacco products, may consider one during its current legislative session. As of September 30, 2008, 35 states taxed moist snuff, and 46 states taxed chewing tobacco, on an ad valorem basis at rates that range from 5% in South Carolina to 90% in Massachusetts. Other states have a unit tax or a weight-based tax. In 2008, two states passed legislation that changed their tax on moist snuff from an ad valorem tax to a weight-based tax: Utah’s tax changed from 35% to $0.75 per ounce, and New York’s tax changed from 37% to $0.96 per ounce, both effective July 1, 2008. Legislation to convert from an ad valorem to a weight-based tax also has been introduced in approximately 14 other states since January 1, 2008.
     On October 25, 2006, the Alcohol and Tobacco Tax and Trade Bureau of the U.S. Department of Treasury, referred to as the TTB, issued a Notice of Proposed Rulemaking, proposing changes to the regulations that govern the classification and labeling of cigars and cigarettes for federal excise tax purposes. The TTB now is considering written comments that were received prior to the March 26, 2007, deadline. Both the CAPTAIN BLACK and WINCHESTER little cigar brands manufactured by Lane, which are classified and sold as “little cigars,” would be re-classified as “cigarettes” under these proposed regulations. Although it is not possible to fully assess and quantify the negative impact of the proposed regulations, if adopted, on the little cigar products of Lane, the immediate impact would be to increase the federal excise tax on such products by more than tenfold. In addition, if little cigars are classified as cigarettes for federal excise tax purposes, it is possible that the states would take the position that MSA obligations also apply to these products.
     On July 8, 2008, the FTC published a notice in the Federal Register, stating its proposal to rescind its guidance, issued in 1966, indicating that factual statements of tar and nicotine yields based on the Cambridge Filter Method generally will not violate the FTC Act. Specifically, the FTC sought public comments, which were due on September 12, 2008, to address the following two questions: (1) “Should the Commission rescind its guidance that generally permits factual statements about tar and nicotine yields when such statements are based on a single test method the Cambridge Filter Method?”; and (2) “What effect, if any, would the Commission’s proposal likely have on consumers’ purchases of cigarettes and/or their smoking behavior? Will these changes be likely to affect smoking intensity, brand choice, and/or the decision whether to quit smoking, and if so, how? How else would the proposal likely affect consumers?” If it withdraws its guidance, the FTC has stated in its notice that advertisers should not use terms such as “per FTC method” or other phrases that state or imply FTC endorsement or approval of the Cambridge Filter Method or other machine-based test methods. The FTC has not indicated when it will publish final guidance on this issue. RJR Tobacco is currently unable to assess whether the proposed action by the FTC, if implemented, would have a material effect on RAI’s results of operations, financial position or cash flows.

78


Table of Contents

     In 2003, the New York Office of Fire Prevention and Control issued a final standard with accompanying regulations that requires all cigarettes offered for sale in New York State after June 28, 2004, to achieve specified test results when placed on ten layers of filter paper in controlled laboratory conditions. The cigarettes that RAI’s operating companies sell in New York State comply with this standard. As of September 30, 2008, 36 states in addition to New York, as well as Washington, D.C., had enacted fire standards compliance legislation of their own, adopting the same testing standard set forth in the OFPC regulations described above. Similar legislation is being considered in a number of other states. Consistent with these state legislative trends and its effort to increase productivity and reduce complexity, on October 25, 2007, RJR Tobacco announced its plans to voluntarily convert all its brands to fire standards compliant paper by the end of 2009. Varying standards from state to state could have an adverse effect on the business or results of operations of RJR Tobacco.
     On July 28, 2008, the San Francisco Board of Supervisors passed a ban on the sale of tobacco products in some pharmacies. The ban is effective October 1, 2008. A similar ban is also under consideration by the Boston Public Health Commission.
     It is not possible to determine what additional federal, state or local legislation or regulations relating to smoking or cigarettes will be enacted or to predict the effect of new legislation or regulations on RJR Tobacco or the cigarette industry in general, but any new legislation or regulations could have an adverse effect on RJR Tobacco or the cigarette industry in general. Similarly, it is not possible to determine what additional federal, state or local legislation or regulations relating to smokeless tobacco products will be enacted or to predict the effect of new regulation on Conwood or smokeless tobacco products in general, but any new legislation or regulations could have an adverse effect on Conwood.
Tobacco Buyout Legislation
     For information relating to tobacco buyout legislation, see “—Tobacco Buyout Legislation and Related Litigation” in note 12 to condensed consolidated financial statements (unaudited).
Other Contingencies
     For information relating to other contingencies of RAI, RJR, RJR Tobacco and Conwood, see “— Other Contingencies” in note 12 to condensed consolidated financial statements (unaudited).
Off-Balance Sheet Arrangements
     RAI has no off-balance sheet arrangements that have or are reasonably likely to have a current or future material effect on its financial position, results of operations, liquidity, capital expenditures or capital resources.
Cautionary Information Regarding Forward-Looking Statements
     Statements included in this report that are not historical in nature are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements regarding future events or the future performance or results of RAI and its subsidiaries inherently are subject to a variety of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include:
    the substantial and increasing regulation and taxation of tobacco products, including the possible regulation of tobacco products by the FDA and a possible increase in the federal excise tax on tobacco products;
 
    the possibility of further restrictions or bans on the use of certain flavorings, including menthol, in tobacco products, or the use of certain flavor descriptors in the marketing of tobacco products;
 
    various legal actions, proceedings and claims relating to the sale, distribution, manufacture, development, advertising, marketing and claimed health effects of tobacco products that are pending or may be instituted against RAI or its subsidiaries;

79


Table of Contents

    the potential difficulty of obtaining bonds as a result of litigation outcomes;
 
    the substantial payment obligations and limitations on the advertising and marketing of cigarettes under the MSA;
 
    the continuing decline in volume in the domestic cigarette industry and RAI’s dependence on the U.S. cigarette industry;
 
    concentration of a material amount of sales with a single customer or distributor;
 
    competition from other manufacturers, including any new entrants in the marketplace;
 
    increased promotional activities by competitors, including deep-discount cigarette brands;
 
    the success or failure of new product innovations and acquisitions;
 
    the responsiveness of both the trade and consumers to new products, marketing strategies and promotional programs;
 
    the ability to achieve efficiencies in the businesses of RAI’s operating companies, including outsourcing functions, without negatively affecting sales;
 
    the reliance on a limited number of suppliers for certain raw materials;
 
    the cost of tobacco leaf and other raw materials and other commodities used in products;
 
    the effect of market conditions on foreign currency exchange rate risk, interest rate risk and the return on corporate cash;
 
    declining liquidity in the financial markets, including bankruptcy of lenders participating in the Credit Facility and decreased availability of money market funds;
 
    the impairment of goodwill and other intangible assets, including trademarks;
 
    the effect of market conditions on the performance of pension assets or any adverse effects of any new legislation or regulations changing pension expense accounting or required pension funding levels;
 
    the substantial amount of RAI debt;
 
    the rating of RAI’s securities;
 
    any restrictive covenants imposed under RAI’s debt agreements;
 
    the possibility of fire, violent weather and other disasters that may adversely affect manufacturing and other facilities;
 
    the significant ownership interest of B&W, RAI’s largest shareholder, in RAI and the rights of B&W under the governance agreement between the companies;
 
    the expiration of the standstill provisions of the governance agreement; and
 
    the potential existence of significant deficiencies or material weaknesses in internal control over financial reporting that may be identified during the performance of testing required under Section 404 of the Sarbanes-Oxley Act of 2002.
          Due to these uncertainties and risks, you are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this report. Except as provided by federal securities laws, RAI is not

80


Table of Contents

required to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.
Item 3. Quantitative and Qualitative Disclosures about Market Risk
     Market risk represents the risk of loss that may impact the consolidated financial position, results of operations and cash flows due to adverse changes in financial market prices and rates. RAI and its subsidiaries are exposed to interest rate risk directly related to their normal investing and funding activities. In addition, RAI and its subsidiaries have exposure to foreign currency exchange rate risk concerning obligations for, and service agreements related to, foreign operations denominated in euros, British pounds, Swiss francs, Chinese renminbi and Japanese yen. RAI and its subsidiaries have established policies and procedures to manage their exposure to market risks and use major institutions, that are believed to be creditworthy at the time the contracts are entered, as counterparties to minimize their investment and credit risk. Frequently, these institutions are also members of the bank group that provide RAI credit, and management believes this further minimizes the risk of nonperformance. Derivative financial instruments are not used for trading or speculative purposes.
     The table below provides information about RAI’s financial instruments, as of September 30, 2008, that are sensitive to changes in interest rates. The table presents notional amounts and weighted average interest rates by contractual maturity dates for the years ending December 31:
                                                                 
                                                            Fair
    2008   2009   2010   2011   2012   Thereafter   Total   Value1
Investments
                                                               
Variable Rate
  $ 2,339                 $ 27           $ 108     $ 2,474     $ 2,474  
Average Interest Rate
    0.9 %                 4.1 %           4.2 %     1.1 %      
Debt
                                                               
Fixed Rate
        $ 200     $ 300           $ 450     $ 3,060     $ 4,010     $ 3,919  
Average Interest Rate 2
          7.9 %     6.5 %           7.3 %     7.3 %     7.3 %      
Variable Rate
                    $ 400                 $ 400     $ 382  
Average Interest Rate 2
                      3.7 %                 3.7 %      
Swaps
                                                               
Notional Amount 3
                          $ 450     $ 1,150     $ 1,600     $ 106  
Average Variable Interest Pay Rate2
                            4.6 %     4.1 %     4.2 %      
Average Fixed Interest Receive Rate2
                            7.3 %     7.1 %     7.1 %      
 
1   Fair values are based on current market rates available or on rates available for instruments with similar terms and maturities and quoted market values.
 
2   Based upon contractual interest rates for fixed rate indebtedness or current market rates for LIBOR plus negotiated spreads for variable rate indebtedness.
 
3   RAI has swapped $1.6 billion of fixed rate debt to variable rate debt.
     RAI’s exposure to foreign currency transactions was not material to its results of operations for the nine months ended September 30, 2008, but may be in future periods in relation to activity associated with international operations of RAI’s subsidiaries. RAI currently has no hedges for its exposure to foreign currency. See “–Liquidity and Financial Condition” in Item 2 for additional information.
Item 4. Controls and Procedures
  (a)   RAI’s chief executive officer and chief financial officer have concluded that RAI’s disclosure controls and procedures were effective as of the end of the period covered by this report, based on their evaluation of these controls and procedures.
 
  (b)   There have been no changes in RAI’s internal controls over financial reporting that occurred during the third quarter of 2008 that have materially affected, or are reasonably likely to materially affect, RAI’s internal controls over financial reporting.

81


Table of Contents

PART II – Other Information
Item 1. Legal Proceedings
     For a discussion of the litigation and legal proceedings pending against RJR Tobacco, Conwood or their affiliates, including RAI and RJR, or indemnitees, including B&W, see note 12 to condensed consolidated financial statements (unaudited) and “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Critical Accounting Policies – Litigation” included in Part I, Item 2.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
     RAI conducts its business through its subsidiaries and is dependent on the earnings and cash flows of its subsidiaries to satisfy its obligations and other cash needs. For more information, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations–Liquidity and Financial Condition” in Part I, Item 2. RAI believes that the provisions of the Credit Facility and the guarantees of the Credit Facility, interest rate swaps and Notes will not impair its payment of quarterly dividends.
     The following table summarizes RAI’s purchases of its common stock during the third quarter of 2008:
                                 
                    Total Number of   Approximate Dollar
                    Shares Purchased   Value that May Yet
    Total Number   Average Price   as Part of Publicly   Be Purchased Under
    of Shares   Paid per   Announced Plans or   the Plans or
    Purchased 1   Share   Programs   Programs 2
July 1, 2008 to July 31, 2008
    4,809     $ 55.06           $ 232  
 
                               
August 1, 2008 to August 31, 2008
    1,251,275     $ 55.93       1,248,855     $ 162  
 
                               
September 1, 2008 to September 30, 2008
    369,136     $ 53.49       365,175     $ 143  
 
                               
 
                               
Third Quarter Total
    1,625,220     $ 55.37       1,614,030     $ 143  
 
                               
 
1   RAI repurchases and cancels shares of its common stock forfeited with respect to the tax liability associated with certain option exercises and vesting of restricted stock grants under the LTIP.
 
2   On April 29, 2008, the board of directors of RAI authorized the repurchase, on or before April 30, 2009, of up to $350 million of outstanding shares of RAI common stock. Concurrent with this authorization, the board of directors rescinded the $30 million repurchase authorized on February 5, 2008.

82


Table of Contents

     Item 6. Exhibits
(a) Exhibits
     
Exhibit Number   Description
 
   
31.1
  Certification of Chief Executive Officer relating to RAI’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2008.
 
   
31.2
  Certification of Chief Financial Officer relating to RAI’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2008.
 
   
32.1
  Certification of Chief Executive Officer and Chief Financial Officer relating to RAI’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2008, pursuant to Section 18 U.S.C. §1350, adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

83


Table of Contents

SIGNATURE
     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
         
 
  REYNOLDS AMERICAN INC.
(Registrant)
   
 
       
 
  /s/ Thomas R. Adams
 
Thomas R. Adams
   
 
  Executive Vice President and    
 
  Chief Financial Officer    
Date: October 24, 2008

84